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The resurgence, and eventual rise to prominence in the field of tissue engineering, that 
electrospinning has experienced over the last decade speaks to the simplicity and 
adaptability of the process.  Electrospinning has been used for the fabrication of tissue 
engineering scaffolds intended for use in nearly every part of the human body: blood 
vessel, cartilage, bone, skin, nerve, connective tissue, etc.  Diverse as the aforementioned 
tissues are in both form and function, electrospinning has found a niche in the repair of 
each due to its capacity to consistently create non-woven structures of fibers ranging 
from nano-to-micron size in diameter.  These structures have had success in tissue 
engineering applications because of their ability to mimic the body’s natural structural 
framework, the extracellular matrix.  In this study we examine a number of different 
   xvi
techniques for altering scaffold properties (i.e. mechanical strength, degradation rate, 
permeability, and bioactivity) to create electrospun structures tailored to unique tissue 
specific applications; the end goal being the creation of a cellularized tissue engineering 
ligament analogue.  To alter the mechanical properties of electrospun structures while 
maintaining high levels of bioactivity, synthetic polymers such as polydioxanone were 
blended in solution with naturally occurring proteins like elastin and fibrinogen prior to 
electrospinning.  Cross-linking of electrospun structures, using glutaraldehyde, 
carbodiimide hydrochloride, and genipin, was also investigated as a means to both 
improve the mechanical stability and slow the rate of degradation of the structures.  Fiber 
orientation and scaffold anisotropy were controlled through varying fabrication 
parameters, and proved effective in altering the mechanical properties of the structures.  
Finally, major changes in the structure of electrospun scaffolds were achieved through 
the implementation of air-gap electrospinning.  Scaffolds created through air-gap 
electrospinning exhibited higher porosity’s than their traditionally fabricated 
counterparts, allowing for greater cell penetration into the scaffold.  Overall, this 
collection of results provides insight into the diversity of electrospinning and reveals 
innumerous options, both pre and post fabrication, for the tissue engineer to create site-
specific engineering scaffolds capable of mimicking both the form and function of native 
tissue.   
 
  
 
CHAPTER 1 Tissue Engineering of the Extracellular Matrix 
 
 
INTRODUCTION 
 
Tissue engineering is an interdisciplinary field aimed at the application of the 
principles and methods of engineering and the life sciences toward the fundamental 
understanding of structure-function relationships in normal and pathological mammalian 
tissues and the development of biological substitutes to restore, maintain, or improve 
tissue functions [1-6].  Typically this involves collaborative efforts between materials 
scientists, cell and molecular biologists, immunologists, surgeons, and engineers to create 
replacement tissues that will be accepted by the body and promote native extracellular 
matrix (ECM) production.  This requires the use of materials that do not activate 
catabolic pathways in the body, ultimately leading to fibrous encapsulation or destruction 
of the material [5-8].       
Natural and synthetic ECM analogues have played a vital role in the field of tissue 
engineering since the early 1980s [1, 9, 10].  Improvements in the fabrication process as 
well as scaffold structure continue to occur in hopes of finding an ideal scaffold for each 
specific tissue engineering application.  The overall function of the biodegradable 
scaffold is to create a 3D microenvironment that will provide the necessary support for 
transplanted or host cells to induce normal physiologic regeneration and function.  
 1 
   2
Ideally, the scaffold should mimic the native ECM it is going to replace.  In order for this 
to happen, several design considerations should be taken into account including 
fabrication, structure, biocompatibility, and biodegradability [9].  Many different 
materials have been used to create scaffolds for different tissue engineering applications, 
each one offering different features and characteristics.  More information will be given 
later in this chapter about these design considerations and the different materials used to 
fabricate various ECM analogues. 
Fabrication techniques for scaffolds range from traditional engineering methods 
such as solvent casting and particulate leaching, to computer aided design technologies 
consisting of techniques such as 3-D printing and solid free form fabrication.  Other 
processes include textile techniques such as electrospinning and weaving, and 
decellularization of tissues [11].  The process of electrospinning to create tissue 
engineered ECM analogues will be discussed extensively later in this text. 
 
TISSUE ENGINERING 
 
The use of isolated cells or cell substitutes is the most direct tissue engineering 
approach, typically using autologous or allogenic cells as therapeutic agents.  This allows 
for the replacement of cells in areas of damaged tissue, ultimately using the cell’s ability 
for replication to promote tissue repair and resumed function [4, 5].  These cells can be 
differentiated and tissue specific (i.e. injecting chondrocytes into cartilage [12]) or can be 
undifferentiated, generic stem cells that could be injected into areas of damaged tissue 
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and allowed to differentiate as needed [8, 13].  The upside of such an approach is the 
avoidance of surgery, as well as the ability to manipulate cells as needed in vitro prior to 
their implantation into the body.  However, the major drawback of this approach is the 
time required to culture a usable number of cells.  Without the presence of a large 
universal cell bank, cells must be taken from a donor and cultured to a usable number 
prior to implantation in their eventual recipient [4, 8]. 
 Another approach to tissue engineering is the use of either pre-cellularized or 
acellular ECM analogues.  The use of matrix analogues may be the most challenging, 
albeit potentially the most beneficial, approach to tissue engineering.  The ultimate goal 
of this approach to tissue engineering is to enhance the body’s ability to heal and repair 
itself by introducing a scaffold that the body recognizes and incorporates directly into the 
reparative process of the tissue.  These systems are meant to mimic the native 
extracellular ECM and can serve as a structural framework for both cells and signaling 
molecules using the body as a bioreactor, exerting normal physiologic biomechanical and 
biochemical signals upon the scaffold.  The idea being that the ECM analogue will 
induce cells to more accurately reproduce their normal physiological behavior, thereby 
improving tissue regeneration and repair [1, 14, 15].  A number of tissue-inducing 
signaling molecules have been incorporated into ECM analogue scaffolds to aid this 
process.  These signaling molecules can include a wide number of cytokines and 
chemokines to promote cell growth, instruct differentiation, and promote cellular 
migration [5].  Since they are open to immunological attack, much research has been 
done on the material composition of these matrix analogue systems in order to produce 
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matrices that elicit little to no immune response and most closely mimic both the 
structure and function of native ECM.   
 
Native ECM.  Mammalian tissue is composed of two major components: cells 
(both parenchymal and mesenchymal) and ECM.  A large majority of tissue volume is 
composed of the ECM component, which also provides much of a tissue’s geometric 
shape.  From a structural standpoint, the ECM is a complex arrangement of proteins and 
polysaccharides such as collagen, hyaluronic acid, proteoglycans, glycosaminoglycans, 
and elastin.  These ECM components are constantly being synthesized, secreted, oriented, 
and modified by the cellular components that they support.  Historically, the function of 
native ECM was only believed to be as a structural framework for tissues.  However, it is 
now understood that the ECM, through interaction with receptors on the surfaces of cells, 
directly takes part in promoting cell adhesion, migration, growth, differentiation, and 
apoptosis.  The ECM also plays a role in cytokine activity and intracellular signaling.  
Growth factors and signaling molecules can be stored within ECM to preserve against 
their degradation, or they can attach to the surface of the ECM to present themselves 
more efficiently to cell receptors [5, 7, 16].   
   5
Table 1.1. Some major ECM components, their function, and location.  Adapted from 
[5]. 
 
Component Function Location 
Collagen 
Tissue architecture, tensile 
strength, cell-matrix 
interaction, matrix-matrix 
interaction 
Widely distributed 
Elastin Tissue architecture, elasticity Tissues requiring elasticity (lung, blood vessel, skin) 
Proteoglycans 
Cell-matrix interaction, 
matrix-matrix interaction, 
cell proliferation, cell 
migration 
Widely distributed 
Hyaluronan 
Cell-matrix interaction, 
matrix-matrix interaction, 
cell proliferation, cell 
migration 
Widely distributed 
Laminin Basement membrane component, cell migration Basement membranes 
Fibronectin 
Tissue architecture, cell-
matrix interaction, matrix-
matrix interaction, cell 
proliferation, cell migration 
Widely distributed 
Fibrinogen Cell proliferation, cell migration, hemostasis Blood, wound healing 
 
Interactions between cells and the ECM are complex and dynamic, and play 
critical roles during development, wound healing, and environmental maintenance (figure 
1.1).  During development, cell-ECM interaction is responsible for pattern formation, 
morphogenesis, and phenotype acquisition and maintenance.  During wound healing clot 
formation, inflammation, formation of granulation tissue, and remodeling are all 
mediated by cell-ECM interaction.  Initial attraction and adhesion of cells to the ECM is 
induced by multiple, low affinity charge and hydrophobic interactions.  During the 
spreading phase of adhesion, heterodimeric transmembrane proteins known as integrins 
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on the cell surface bind to specific small peptide fragment sequences on the ECM 
molecules.  This allows for cells to bind to the ECM, through focal adhesions, and 
promote direct communication between the two.  Integrin binding is both specific and 
reversible and allows cells to differentiate, secrete and absorb matrix, and transmit signals 
[7].  Signals are sent from the ECM across the cell membrane to soluble molecules in the 
cytoplasm and through direct connections with the cytoskeleton and into the cell nucleus, 
evoking a cellular response, termed “outside-in” signaling.  This direct contact allows for 
stronger, more specific signaling than through the release of diffusible signaling 
molecules.  Cell-ECM interactions can also be of an “inside-out” nature, when changes 
within the cell feed back to alter the activity of surface receptors, ultimately creating 
changes in the integrin and non-integrin receptors in focal adhesions [7].  In what is 
known as dynamic reciprocity, the cellular response to the ECM signaling can often alter 
the state of the ECM.  For example cells may release matrix metalloproteases to break 
down an overly dense ECM to allow for their migration or proliferation [5, 16]. 
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Figure 1.1. ECM-cell interaction depicting integrin receptors. Reprinted from [5]. 
 
ECM Analogue Scaffolds.  As complex a structure as the native ECM has been 
revealed to be, it should be no surprise that the creation of a successful engineered ECM 
analogue has proven to be extremely challenging. Ideally, one would like to mimic both 
the fibrillar form and the complex function of the native ECM [11, 17, 18].  To attain a 
successful ECM analogue scaffold, there are several design and material criteria that 
must be met.  First and foremost, the scaffolding material should be subjected to the same 
standards as any other biomaterial implanted in the body, namely, the scaffold should not 
initiate any adverse tissue or immune reactions.  For many applications, scaffolding 
materials should be biodegradable or bioabsorbable at a rate that will allow for their 
gradual incorporation into the surrounding tissue without any fibrous encapsulation or 
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residual evidence of their presence [6, 10, 11, 17].  ECM analogue scaffolds have been 
fabricated from an extensive array of materials through a number of different fabrication 
techniques.  A wide number of different polymers, both synthetic and natural in origin, 
have been used as ECM analogues.  The most common matrix materials in use today are 
polymers such as poly(glycolic acid) (PGA), poly(lactic acid) (PLA), and their 
copolymer poly(lactide-co-glycolide) (PLGA).  However there has also been extensive 
work done with polycaprolactone (PCL) and polydioxanone (PDO), as well as some 
polyanhydrides, polyorthoesters, polycarbonates, and polyfumarates [6, 17].  As for ECM 
analogues engineered from natural materials, collagens [19], elastin [20], fibrinogen [21], 
and silk [22] have been used.  ECM substitutes of this variety have the potential for a 
greater upside than their synthetic counterparts due to the fact that they are constructed 
from native ECM materials and may be expected to retain some of their biologic behavior 
[6, 23].  Inorganic materials such as hydroxyapatite (HA), tricalciumphosphate, ceramics, 
and glass have also been used [6, 24].  Both the materials and their fabrication techniques 
will be discussed in detail later in this text. 
 The architecture of the scaffold is every bit as important as the material from 
which it is fabricated.  As previously stated, an ECM analogue should mimic the form of 
the native ECM.  To be ideal, this ECM analogue would need to mimic the topographical 
features and geometry on the macro-scale, micro-scale, and even nano-scale levels, as 
each influences cell response to the scaffold [25].  Native ECM is composed of nanoscale 
fibers that can provide structural integrity to tissues.  Recent advances in fabrication 
techniques (self-assembly, phase separation, and electrospinning) have made the creation 
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of consistently nanofibrous scaffolds possible.  The use of nanofibrous scaffolds creates 
structures with a very high surface area to volume ratio to support cell growth and 
infiltration [10, 18, 26].  In addition, the morphological similarities between the 
nanofibrous structures and the native ECM are believed to improve cellular response and 
overall biocompatibility [18].   
Success as a tissue-engineering scaffold in many applications is ultimately 
dependant upon the ability for cells to infiltrate the ECM analogue, migrate throughout its 
thickness, proliferate, and restore normal physiologic function [27, 28].  The scaffold’s 
porous structure, a combination of microporous (pore diameters < 2 nm), mesoporous 
(pores with diameter 2 nm – 50 nm), or macroporous (pore diameters > 50 nm) void 
spaces, plays a major role in cellular penetration [23, 29].  As yet there has been no 
concrete claim to an ideal pore diameter, but it has been documented that pores with a 
small diameter, yet larger than the diameter of a cell, are favorable [10].  Not only do the 
pores of an ECM analogue scaffold need to be of a sufficient size for tissue growth to 
occur, but they also need to be open and interconnected.  Interconnectivity refers to the 
extent of which pores are connected with their neighboring pores, and has a large effect 
on nutrient and waste diffusion, cell migration, and overall scaffold permeability [6, 30, 
31].  The terms porosity and permeability are often incorrectly used interchangeably in 
the realm of tissue engineering and in the consideration of ECM analogue scaffolds.  By 
definition, porosity is the amount of void space contained within a structure, while 
permeability is a measure of the ease of which a fluid can move through the structure.  
Matrix permeability ultimately depends on the combination of scaffold porosity, pore size 
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and distribution, pore interconnectivity, and pore orientation and scaffold porosity to 
determine the hydraulic permeability of an ECM analogue scaffold [30, 31]. 
While not commonly reported for tissue engineered scaffolds, permeability and 
porosity are extremely important to ECM analogue success.  Healthy, living tissue in vivo 
relies on the microvasculature to distribute blood and exchange metabolites through a 
combination of diffusion over short distances and flow-limited exchange.  There are 
currently no tissue engineered products that contain their own pre-vascularised capillary 
bed to provide nutrients to the structure, chaining their initial effectiveness to the limits of 
passive diffusion [32].  The limitations of diffusion based nutrient transport restrict the 
maximum thickness of avascular tissue engineered constructs to less than 2 mm [33].  
Scaffolds with increased porosity and permeability help to promote the diffusion of 
nutrients to cellular constituents, while promoting the diffusion of metabolic waste away 
from the cells.  An increase in nutrient penetration distance will promote cell migration 
away from the scaffold periphery, and the presence of interconnected macropores will 
augment their ability to migrate [30, 31].  The degradation behavior of synthetic polymer 
based scaffolds is also controlled in part by the permeability of the ECM analogue.  Low 
porosity and permeability scaffolds made of poly(α-hydroxy acids) have exhibited 
increased rates of degradation due to an increase in autocatalytic activity.  Essentially, as 
the polymers breakdown via hydrolysis, the acidic byproducts become trapped within the 
scaffold and lower the local pH.  This reduced pH then accelerates the degradation of the 
polymer from the inside out resulting in a rapid loss of mechanical stability [30, 34]. 
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SYNTHETIC SCAFFOLDS 
 
Synthetic scaffolds, as mentioned above, have been used as ECM analogues and 
offer many advantages over natural polymers, as well as limitations.  For one, the 
material properties of synthetic polymers can be controlled to suit specific functions, and 
therefore, can be more beneficial as a scaffold for multiple tissue engineering 
applications.  In addition, many synthetic polymers are bioresorbable and have a known 
degradation rate, mechanical strength, and are readily available, and therefore, 
degradation time should not vary significantly between hosts [11].  Synthetic scaffolds 
provide many positive characteristics for their use as scaffolding materials, and almost 
seem to be the answer for ideal tissue engineering scaffolds, but the key dilemma is they 
lack one of the major requirements of an ECM analog.  Although the surface and 
structural characteristics of synthetic polymers can be controlled, they are synthetic, as 
their name implies, and therefore, are deficient in the biological component of the native 
ECM [1, 35].  Another disadvantage is that the degradation products of these polymers 
can be toxic products, mostly weak acids, which can cause an adverse reaction if they 
accumulate locally [10]. 
Biodegradable synthetic polymers have been the primary focus for tissue 
engineered scaffolds, with most belonging to the polyester family. Some of the most 
commonly used polymers will be more specifically outlined in the following paragraphs.  
A brief overview of the polymers’ characteristics is displayed in table 1.2 [10, 11, 36, 
37]. 
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Table 1.2. Properties of degradable synthetic polymers used for tissue engineering 
scaffolds. 
 
Polymer Degradation 
method 
Degradation 
time 
Primary 
Degradation 
Products 
Bulk 
Mechanical 
Stiffness: 
E-modulus 
(GPa) 
Tissue  
Engineering 
Applications
PGA Ester 
Hydrolysis 
1 to ~12 
months 
Glycolic 
acid 
5-7 
PLA Ester 
Hydrolysis 
5 to ~60 
months 
Lactic acid 2-3 
PLGA Ester 
Hydrolysis 
1 to ~12 
months 
Lactic acid 
and glycolic 
acid 
2-7 
Skin, 
cartilage,  
bone, 
ligament, 
tendon, 
vessels, 
nerve, 
bladder,  
liver 
PDO Ester 
Hydrolysis 
3 weeks to 
6 months 
Hydroxy-
ethoxyacetic 
acid 
0.002-0.04 Orthopedics, 
drug 
delivery,  
bone, 
vessels 
PCL Ester 
hydrolysis 
1 to 3 years Caproic 
acid 
0.4 Skin, 
cartilage, 
bone, 
ligament, 
tendon, 
vessels, 
nerve 
PEG/PEO Nondegradable Not 
applicable 
Not 
applicable 
0.1-5 Drug 
delivery, 
cartilage 
 
Poly(glycolic acid).  PGA is a biodegradable, linear, aliphatic polyester that 
possesses a compact, repeating structural unit [10, 35, 38] (table 1.2, figure 1.2).  It is 
currently used in a variety of medical applications, but was initially developed as a 
commercially available suture in the 1970s because of its superior biocompatibility and 
reproducible mechanical properties [1, 39].  PGA is formed from the ring opening 
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polymerization of glycolide and produces high molecular weight materials [40].  Some 
characteristics of PGA include a high crystallinity (46-55%), a high melting point (185-
225ºC), a glass transition temperature of 35-40ºC, and a low solubility in organic solvents 
[10, 36, 38-40].  The glass transition temperature of PGA is very close to physiological 
temperature (35-40ºC), and thus, water infiltration and loss of mechanical strength may 
occur more easily after implantation.  Mechanical properties of PGA sutures include a 
tensile strength of 106 Kpsi, an elongation of 24%, and a knot retention of 65 Kpsi [1, 
35].  Due to its hydrophilic nature, PGA degrades into glycolic acid over a period of 2-4 
weeks in vivo.  The predictable bioabsorption of this polymer and the fact that its 
degradation product is metabolized in the body makes it an attractive option for many 
tissue engineering applications.  More specifically, for applications where an initially 
tough, but fast degrading material is desired, this polymer is a superior choice, as 60% of 
its strength is lost by hydrolytic degradation during the first 2 weeks.  
 PGA scaffolds have previously been formed by traditional extrusion methods 
[41], electrospinning [42], and solvent casting or particulate leaching [36].  Extrusion 
methods produce fibers with a minimum diameter above 10µm which is a highly 
unfavorable size compared to native ECM analogs.  Electrospinning methods have 
produced fibers of 200nm-1.5µm, depending upon polymer concentration.  During an in 
vitro biocompatibility study, PGA scaffolds that were pretreated with hydrochloric acid 
demonstrated the ability to increase rates of proliferation of cardiac fibroblasts (FBs) 
compared to cells on tissue culture plastic.  In vivo studies with the same scaffolds 
resulted in full incorporation of the scaffolds into the hind leg tissue of rats [38].  Freed et 
   14
al. demonstrated PGA nonwoven mesh scaffolds seeded with chondrocytes have the 
ability to aid in cellular attachment and proliferation and the regeneration of cartilaginous 
matrix [39]. 
 
Poly(lactic acid).  Another biodegradable, aliphatic polyester commonly used in 
clinical applications is PLA [1] (table 1.2, figure 1.2).  Formed from the polymerization 
of lactide, this polymer is present in two isoforms: d(-) for dexorotary, l(+) for levorotary, 
and the synthetic blend, dL for racimic [40].  P(l)LA and P(d)LA are semi-crystalline 
solids, and P(dL)LA is amorphous.  The difference in the polymer’s crystallinity has an 
effect on its clinical application.  P(dL)LA is usually used in drug delivery applications 
because of its low tensile strength, high elongation and rapid degradation time, while the 
semicrystalline PLA is preferred for load-bearing applications such as orthopedic 
fixations and sutures because of its higher tensile strength and modulus and lower 
elongation [35, 40].  Because of the extra methyl group in the monomer, PLA is more 
hydrophobic than PGA.  The chemical structure of PLA contains an ester bond, which 
makes it less likely to undergo hydrolysis.  Because of this, it degrades much slower than 
PGA (typically 30-50 weeks) and has a higher solubility in organic solvents.  Since the 
degradation of PLA yields L-lactic acid, for most tissue engineering applications, P(l)LA 
is chosen over P(d)LA because lactic acid is naturally present and metabolized in the 
body [1, 10, 35, 36].  Other characteristics of PLA include 37% crystallinity, a melting 
point of 96-185ºC, and a glass transition temperature of 57-65ºC [35, 40].  It is important 
to mention that caution should be taken when sterilizing this polymer via gamma-
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radiation because this may cause chain separation, cross-linking, and a decrease in 
crystallinity. 
 PLA scaffolds have been processed using traditional fiber extrusion methods, 
similar to PGA, and have resulted in fiber diameters on the micro-scale.  Electrospun 
PLA scaffolds produce fibers with diameters ranging from 100nm-10µm, depending 
upon solvent and concentration.  In vitro experiments done by Yang, et al. demonstrate 
neural stem cell elongation and outgrowth is parallel to the direction of P(l)LA fibers and 
higher cell differentiation for P(l)LA nanofibers versus microfibers [43].  Human 
articular chondrocytes cultured on PLA scaffolds formed from a spin-casting method 
revealed cellular attachment was increased on P(dL)LA scaffolds versus P(l)LA 
scaffolds.  In contrast, cellular proliferation was greater on P(l)LA scaffolds as compared 
to P(dL)LA scaffolds.  This is most likely due to the differences in crystallinity of the two 
polymers, which could cause a difference in the amount of serum proteins that are 
absorbed [44]. 
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Figure 1.2. Chemical structures of commonly used biodegradable synthetic polymers. 
Reprinted from [36]. 
 
Poly(lactide-co-glycolide).  PLGA (table 1.2, figure 1.2) is the copolymer formed 
by PGA and PLA.  Unlike each individual homopolymer, this copolymer is amorphous 
when either monomer is present under 70mol% because of the disruption of the regularity 
of the polymer chain by the other monomer [40].  This characteristic results in a decrease 
in degradation rates and mechanical strength [10, 35, 45].  If either homopolymer is 
present above 70mol%, the copolymer exhibits some crystallinity.  PLGA also exhibits 
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lower crystallinity and melting temperature compared to PGA or PLA.  This copolymer 
degrades in bulk by ester hydrolysis (Table 1.1), and the rate of degradation can be 
altered by adjusting the ratio of PLA/PGA. 
PLGA has been used for many medical and tissue engineering applications such 
as surgical sutures, cardiac tissue regeneration, and drug delivery because it is 
biodegradable and biocompatible [1, 45, 46].  Bone formation on PLGA foams fabricated 
by solvent casting/particulate leaching (to be discussed later) by mesenchymal stem cell 
(MSC) -derived osteoblasts has also been reported [47].  PLGA scaffolds have also been 
shown to support the cell growth and function of a variety of other cell types including 
FBs, chondrocytes, and smooth muscle cells [10, 46].  
 
Polydioxanone.  PDO is a biodegradable polyester formed from the ring opening 
polymerization of monomer paradioxanone [40, 48] (table 1.2, figure 1.2).  Originally 
this polymer was developed for use as a suture because of its superior degradation rate of 
6-12 months, falling in between PGA and PLA. PDO exhibits a high crystallinity of 55% 
and a glass transition temperature of -10-0ºC.  Another attractive property is its excellent 
flexibility because of an ester oxygen group in the backbone structure [1, 40, 48].  In 
addition, PDO has shown no acute or toxic effects upon implantation. A negative aspect 
of the polymer when used as a suture is its shape memory.  Because of the suture’s ability 
to retain its spooled shape, knot retention becomes very difficult.  Although this may 
prevent PDO from being an ideal suture material, shape memory may be a positive aspect 
for tissue engineering applications.  For example, if used in a vascular graft, it can 
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provide rebound and kink resistance [1, 40, 48].  Also, the degradation rate of PDO 
sutures can be a negative aspect because it may be too rapid to allow for a durable closure 
for wounds and may cause abnormal healing.   
Electrospinning of PDO has been performed and has resulted in fiber diameters of 
180nm-1.4µm, depending upon solution concentration, and exhibits material properties 
within the same range as the major structural components of the native vascular ECM 
(collagen and elastin).  As fiber diameter decreases, it has been shown that cell 
interaction improves and immune response is reduced [1, 48].  PDO scaffolds have also 
been used in other applications including orthopedics, plastic surgery, drug delivery, 
cardiovascular and bone repair [48]. 
 
Polycaprolactone.  PCL is another linear aliphatic polyester that has 
demonstrated good biocompatibility, favorable mechanical properties and a slow 
degradation rate of 1-3 years [1, 36, 37] (table 1.2, figure 1.2).  Prepared by the ring 
opening polymerization of the cyclic monomer ε-caprolactone, PCL is a repeating unit of 
one ester group and five methylene groups.  This semi-crystalline polymer is highly 
soluble and exhibits a low melting point of 58-64ºC and a glass transition temperature of 
-60ºC [10, 36, 40].  Degradation of PCL occurs by bulk or surface hydrolysis of the ester 
linkages, producing a byproduct of caproic acid [10].  To increase its degradation rate, 
PCL has been easily copolymerized with a variety of polymers including collagen, PGA, 
PLA, and poly(ethylene oxide) (PEO) [1, 10, 36, 40]. 
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Electrospun scaffolds of PCL that were seeded with MSC-derived osteoblasts 
promoted cellular penetration as well as ECM formation [47].  Other studies have shown 
PCL scaffolds support human osteoblast and dermal FB cell viability and the 
proliferation of human biliary epithelial cells [10].  PCL scaffolds have also been used for 
tissue engineering applications such as cartilage [49] and vascular [50].   
 
Poly(ethylene glycol)/Poly(ethylene oxide).  Poly(ethylene glycol) (PEG) is a 
linear-chained polymer consisting of an ethylene oxide repeating unit (Table 1.2).  PEO 
has the same backbone as PEG, but a higher molecular weight because of its longer chain 
length [10].  PEG and PEO are both hydrophilic and are synthesized by anionic or 
cationic polymerization of ethylene oxide [10, 51].  They have the ability to act as 
swelling polymers, which has led to their use as a hydrogel, and makes them excellent 
polymers for medical applications such as drug delivery [52].  Another attractive property 
for their use in tissue engineering is their low toxicity and biocompatibility [51].  A 
limitation of PEG and PEO is their inability to naturally degrade, but if they are 
copolymerized with a hydrolytically or enzymatically degradable polymer, they can be 
made degradable [10, 51, 53].  PEO-based copolymers, such as the triblock copolymer 
with poly(propylene oxide) (PPO), PEO-PPO-PEO, could be designed to form gels at 
body temperature by forming a liquid crystalline phase, and have been mainly used in 
drug delivery applications where they have been known to enhance drug penetration [51].  
Riley et al. cultured chondrocytes on PEG-based hydrogel scaffolds and found the 
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scaffolds supported the survival of the cells and the deposition of a cartilage-like matrix 
[54].  
 
NATURAL SCAFFOLDS 
 
To overcome the disadvantage that synthetic polymers have of lacking the 
biological component, natural polymers are widely used, either by themselves, or as a 
blend with synthetics.  Derived from renewable resources such as plants, animals and 
microorganisms, natural polymers used in scaffolds offer an advantage because of their 
excellent biocompatibility and biodegradability [55].  They are biologically similar to the 
native ECM, which allows cells to interact with these polymers in a natural manner 
through receptors and signals, and also aids in the correct functioning of cells such as 
attachment, proliferation and differentiation.  Disadvantages of natural polymers include 
variations in degradation rates, batch to batch inconsistency, and poor mechanical 
strength [1, 9, 10].  Another important disadvantage to consider is the ability of these 
polymers to induce a negative immune response due to the presence of impurities and 
endotoxins, depending on their source [55].  A detailed description of some of the most 
widely used natural polymers in tissue engineering is discussed below.   
 
Collagen.  Collagen is the most abundant protein found in the body.  It functions 
to provide the overall structure and strength to tissues and is the principal component of 
the native ECM.  In addition, the collagen structure provides cells with the appropriate 
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microenvironment for embryologic development, organogenesis, cell growth, and wound 
repair and also stores and releases important cell mediators such as growth factors [1, 55]. 
Currently, there are over 20 different kinds of collagen that have been identified, with the 
basic structure composed of three polypeptide chains, coiled around each other to form a 
triple helix (figure 1.3). 
 
 
Figure 1.3. Picture depicts triple-helical collagen structure. (A) Model of collagen 
peptide where Gly is green, Pro is grey, and Hyp is shown in magenta. (B) The schematic 
of the triple helix. Reprinted from [55]. 
 
The most common triple helix of collagen is formed by the peptides Proline, 
Hydroxyproline, and Glycine in the sequence Pro-Hyp-Gly.  The individual triple helices 
arrange to form collagen fibrils, which account for the structural integrity of the tissue.  
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Collagen fibril formation is an extracellular process, which occurs through the cleavage 
of terminal procollagen peptides by specific procollagen metalloproteinases.  The 
different types of collagen are found in different areas of the body depending upon the 
role and makeup of the tissue.  Type I collagen is the most common type, found in 
dermis, bone, tendon, fasciae, sclera, organ capsules, and fibrous cartilage, and is a major 
component of mature scar tissue.  Type II collagen is mostly found in hyaline and elastic 
cartilage, the developing cornea, and in the vitreous body of the eye.  The wall of blood 
vessels and hollow intestinal organs consist mostly of type III collagen, which also co-
polymerizes with type I.  Types V and XI are less abundant and mostly occur co-
polymerized with type V and type XI [56].  One reason for collagen’s wide use in tissue 
engineering applications is because it can be isolated from many different sources and is 
relatively non-immunogenic.  The primary sources of collagen is animal tissues (porcine 
and calf skin, bovine tendon, rat tail) in which it is purified from the tissues using an 
enzymatic treatment and salt/acid extraction.  Deriving this polymer from animals, 
although an easily accessible source, does pose some problems as its use as a scaffold 
because of the possibility of the transmission of infectious agents and of rejection from 
the host tissue.  Fortunately, many new attempts have been made to derive collagen from 
safer sources, such as jellyfish [57], and to produce human recombinant collagen [58].  
These alternatives provide a more reliable and predictable source of collagen that is free 
of animal components. 
 One feature that is necessary for all types of collagen for their use in tissue 
engineering applications is chemical cross-linking.  Although this process can be a 
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disadvantage for this natural polymer’s use in tissue engineering applications because of 
the addition of toxic solvents, this is necessary to stabilize the polymer in order to control 
the mechanical properties.  Cross-linking can be achieved in various ways, including 
chemically (glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC), genipin), physically (freeze drying, UV radiation, heating), and 
enzymatically [55, 56]. 
 Degradation of collagen is done naturally by matrix metalloproteinases, 
specifically collagenase and serine proteases [56], which also provides an advantage for 
its use in tissue engineering.  It is used in various medical applications, such as wound 
dressings and artificial skin, and collagen scaffolds have also been used in a variety of 
tissue engineering applications, such as vascular grafts [59], tendon/ligament [60, 61], 
cartilage [62], and breast tissue [63]. 
 Some drawbacks of collagen for tissue engineering applications include the 
polymer’s low mechanical properties, the need for cross-linking (mentioned above), risk 
of viral infection, increased antigenicity potential and an extremely fast biodegradation 
rate [56].  
 
Gelatin.  Gelatin is obtained by a controlled hydrolysis of collagen and is a 
natural polymer that is of interest in tissue engineering because of its excellent 
biocompatibility and biodegradability, and cost efficiency.  Generally speaking, there are 
two types of gelatin: Type A and Type B. Type A is extracted from collagens, and 
processed by an acidic pretreatment, and Type B is obtained by an alkaline pretreatment, 
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which causes it to have higher carboxylic acid content than Type A.  For many years it 
has been used as a vascular prosthetic sealant, a dressing for wounds and a carrier for 
drug delivery, and recently it has gained interest for its use as a scaffold for tissue 
engineering applications [1, 64].  One drawback of gelatin is that it dissolves as colloidal 
sol at temperatures at or above 37ºC, and gels at lower temperatures around room 
temperature.  However, when combined with other synthetic polymers, or cross-linked, 
this limitation can be reduced. 
 In a study done by Zhang et al., a mixture of gelatin and PCL solutions were 
electrospun to produce fibrous scaffolds.  These scaffolds proved to have excellent 
biocompatibility with bone marrow stromal cells and also aided in the process of cellular 
migration, proliferation, and penetration [65].  Gelatin scaffolds have also been used for 
nerve [66], hepatic [67], and cartilage [68] tissue engineering applications.    
 
Elastin.  Elastin is the most linearly elastic biosolid known and is a key structural 
protein found in the native ECM of connective tissues where elasticity and recoil are 
critical parameters (figure 1.4).  Elastin consists of several repetitive amino acid 
sequences, including VPGVG, APGVGV, VPGFGVGAG and VPGG [55].  Mature 
elastin is formed from tropoelastin, a 70-kDa protein consisting of alternating 
hydrophobic regions (responsible for the elasticity) and cross-linking domains.  
Additionally, it ends with a hydrophilic carboxy-terminal sequence containing its only 
two cysteine residues [69].  A highly insoluble protein, elastin constitutes walls of 
arteries and veins, ligaments, lung parenchyma, skin, and intestines. 
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Figure 1.4. Elastin structure reprinted from [55]. 
 
 There are some drawbacks of elastin that have limited its use as a biomaterial.  
Upon implantation, elastin preparations have a strong tendency to calcify.  This may be 
due to microfibrillar components, such as calcium-binding fibrillin, within the elastic 
fiber that are difficult to remove, although there have been studies that disprove this 
theory.  Another limitation of elastin is the complexity of its purification process [70].  
Similar to collagen, pure elastin scaffolds need to be cross-linked to improve their 
mechanical integrity, which also presents a limitation [71]. 
 Elastin scaffolds have mostly been fabricated by electrospinning [20], but others 
have used insoluble elastin in gels [72] and elastin-like polypeptide block copolymers 
[73].  In previous studies, electrospun elastin scaffolds have been shown to regulate 
proliferation, migration, and differentiation of smooth muscle cells (SMCs) as well as 
reduce the vascular proliferative response to arterial injury in vivo [59, 70].  Several other 
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studies have been performed using elastin scaffolds for cardiovascular tissue engineering 
purposes [74-76].  
 
Fibrinogen.  Fibrinogen is a naturally occurring plasma protein (340kDA) that 
plays an important role in blood clotting, fibrinolysis, cellular and matrix interactions, 
inflammation, wound healing, and neoplasia [77-79].  Fibrinogen molecules are 
elongated 45-nm structures consisting of two outer D domains, each connected by a 
coiled-coil segment to a central E domain (figure 1.5). 
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Figure 1.5.  Schematic diagram representing the major structural features of fibrinogen 
and its cleavage to fibrin. Reprinted from [79]. 
 
These molecules consist of six polypeptide chains: two Aα, two Bβ, and two γ, 
and when fibrinogen reacts with thrombin, two peptides are cleaved to produce fibrin 
monomers.  In the presence of calcium and factor XIII, fibrous clots and other fibrous 
structures are formed by the fibrin monomers.  These structures play a role in the wound 
healing process, serving as a provisional matrix on which tissues rebuild and repair 
themselves.  For this reason, fibrinogen is an attractive protein for its use in tissue 
engineering applications.  
 Another advantage of fibrinogen is that it has two integrin binding sites, RGDF 
and RGDS, in which many cellular interactions occur through binding to these sites.  
Cells that have receptors for these binding sites include platelets, endothelial cells (EC), 
melanoma cells, FBs, and monocytes, neutrophils [79].  
 Fibrin-based scaffolds have been developed previously in the form of fibrin gels 
and wet extrusion fibronectin-fibrinogen cables.  Although these gels were easily 
degradable, non-immunogenic, and promoted cell migration, they lack the structural 
integrity needed for practical use in a tissue.  The limitation of the wet extruded cables is 
their resulting large fiber size; 200-250µm in diameter is many orders of magnitude larger 
than the native fibers of the ECM, resulting in an unfavorable environment for cells to 
correctly function.  Electrospun fibrinogen has also been accomplished and has shown 
excellent cellular interaction as well as mechanical properties similar to those of native 
tissue [77, 78]. 
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Silk Fibroin.  Silk is an extremely common fibrous protein that has been used as 
a medical grade suture for centuries.  More recently silk has become a material of interest 
in the creation of tissue engineering scaffolds due to its unique blend of material 
characteristics.  Silk exhibits excellent biocompatibility with a foreign body response 
comparable to other degradable sutures, hemocompatibility, and oxygen and water 
permeability.  Although it is classified as a non-degradable suture, it has been shown that 
silk will break down through proteolytic degradation and will be slowly absorbed in vivo 
as biocompatible amino acids.  The rate of degradation varies based upon implantation 
site and the size of the implanted fibers, but has been reported to lose the majority of its 
tensile strength between 6 weeks and one year after implantation.  Silk also possesses 
remarkable mechanical properties not seen in other naturally occurring proteins [22, 80, 
81].  It has been reported that natural silk fibers have tensile strength and yield at fracture 
values comparable to synthetic fibers such as Kevlar [82].   
Silk is produced in nature by a wide variety of insects and spiders, with the silk 
from Bombyx mori silkworm cocoons being the most commonly harvested.  Natural silk 
is composed of two distinct proteins: a glue-like sericin protein, which serves to hold 
fibers together, and a fibroin filament component which acts as the mechanical backbone.  
As sericin has proven to elicit an adverse immune response inside the body, it is the 
degummed silk fibroin (SF) that is used in medical applications such as braided suture.  
This 325 kDa protein consists of repetitive hydrophobic blocks, which form crystalline β-
sheets through hydrogen bonding, and amorphous hydrophilic regions.  The β-sheets 
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provide the structure with its tensile strength, while the amorphous regions provide 
elasticity and toughness [22, 81, 82].  SF fibers have been used as both knitted constructs 
[83-85] and as electrospun scaffolds of reconstituted SF [86-94].  It has been well 
documented that reconstituted fibers of SF are almost completely amorphous in their 
structure and must be annealed in a methanol or ethanol solution to create β-sheet 
crystallization [86-88, 90, 91, 93, 95, 96].  Despite this annealing process, reconstituted 
SF scaffolds have proven to be highly conducive to cell seeding, with literature reporting 
successful proliferation of FBs [22, 84, 86, 91], osteoblast-like cells [22], keratinocytes 
[91], and bone marrow stem cells [22, 80, 81, 83, 85, 88]. 
 
Acellular Matrix and Submucosa.  Another natural-based material that has been 
used as a successful scaffold for tissue engineering applications is decellularized ECM.  
As mentioned before, nearly all tissues are comprised of ECM that consists of structural 
proteins, polysaccharides, cytokines, and growth factors. While this process of 
decellularization aims at completely removing all cellular and nuclear material from the 
tissues, the bulk composition, mechanical properties, and biological activity are still in 
tact [97].  Using this type of scaffold eliminates some of the drawbacks and limitations of 
techniques that will be mentioned later, such as insufficient mechanical strength and 
possible undesirable inflammatory responses, but still has other disadvantages, including 
rapid degradation rates and calcification production.  Native ECM structures are 
advantageous for their use as tissue engineered scaffolds because they induce a positive 
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host response that promotes cell infiltration, rapid scaffold degradation, formation of host 
derived neomatrix, and tissue remodeling with a minimum amount of scarring [98]. 
 Briefly, decellularization is the process by which cells are removed from an ECM 
through a series of mechanical, chemical or enzymatic steps, leaving an acellular matrix 
that can serve as a tissue engineering scaffold.  The main components of the native ECM 
that are left after the decellularization process are collagen and elastin [11].  ECMs that 
have been successfully processed this way include urinary bladder, the dermis of the skin, 
small intestine, pericardium, basement membrane and stroma of the decellularized liver, 
and decellularized Achilles tendon [98].  
 The submucosa is the layer of tissue beneath a mucous membrane or the layer of 
connective tissue beneath the tunica mucosa. Similar to the decellularized ECM described 
above, subintestinal submucosa (SIS) is an attractive material for tissue engineering 
scaffolds because of the structural and biological factors present in the tissue [99-102].  
In vivo studies done with a bladder submucosa confirm this tissue can contribute to 
bladder tissue regeneration.  Normal cellular organization and phenotype were 
demonstrated, along with the presence of nerve fibers [103].  Two drawbacks of both 
decellularized ECM and SIS are that they exhibit a rapid rate of degradation in vivo, and 
may elicit calcification. This former problem is especially prevalent in submucosal tissue, 
while native ECM tissue also has problems with scaffold shrinkage in vivo.  
 
OVERVIEW 
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 This study examines the tissue engineer’s ability to create tissue specific scaffolds 
through the process of electrospinning.  The inherent flexibility of the electrospinning 
process, through the use of various polymers, polymer blends, and solvents, can create 
structures that exhibit a wide array of mechanical and bioactive properties.  Altering 
process control variables such as mandrel rotational speed and charging voltage can 
dramatically change the structure of the finished fibrous scaffold.  Further modification 
of electrospun scaffolds can occur post-process through the application of a number of 
different cross-linking agents to modify scaffold mechanical properties and rates of 
degradation.  When one considers the seemingly infinite number of iterations available to 
the tissue engineer for controlling electrospun scaffold properties, it is easy to recognize 
that the electrospinning process has the potential to create tailor-made structures for 
almost any part of the human body.  The following chapters of this text provide insight 
into the alteration of scaffold properties and their use in a number of different 
applications: 
• Electrospinning of Biopolymers for Cardiovascular Applications 
(currently in press for publication in Advanced Drug Delivery Reviews, 
2009) 
• Creation of Electrospun ECM Analogues (published in Polymer 
International, 2007, volume 56, pages 1349-1360) 
• Electrospinning PDO and Elastin Blends (published in Biomedical 
Materials, 2006, volume 1, pages 72-80) 
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• Electrospinning PDO and Fibrinogen Blends (published in the Journal of 
Engineered Fibers and Fabrics, 2008, volume 3, pages 12-21) 
• Cross-linking Electrospun Fibrinogen to Tailor Scaffold Properties 
(published in Biomedical Materials, 2008, volume 3, EPUB) 
• Creation of Aligned Silk Scaffolds for Tissue Engineering (in review for 
publication in Biomedical Materials, 2009) 
• Creating Cellularized Ligament Analogues 
The first two chapters are reviews of the current use of electrospinning in tissue 
engineering; one for cardiovascular specific applications and the other providing 
information on electrospinning’s use in creating scaffolds for a number of different 
tissues in the body.   Next, two chapters detailing the use of PDO blended with the 
natural polymers elastin and fibrinogen.  These polymers were blended in a number of 
different ratios in an attempt to combine the inherent strength of the synthetic PDO 
polymer with the high level of bioactivity native to the natural polymers.  PDO and 
elastin solutions were blended together, while PDO and fibrinogen were introduced at the 
point of fiber formation through a specially designed nozzle.  The following chapter 
investigates the use of a number of different cross-linking agents to modify the 
degradation rate and mechanical properties of electrospun fibrinogen structures.  The 
subsequent chapter looks at fiber orientation in terms of its effect on scaffold mechanical 
properties when used as either ligament or vascular grafts.  Finally, the last chapter 
utilizes the method of air-gap electrospinning to create cellularized ligament analogue 
structures.  While seemingly disjoint on the surface, the results discussed in this text are 
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intended to emphasize the flexibility of the electrospinning process with regards to tissue 
engineering, and to highlight the ability of the tissue engineer to create tailor-made tissue 
specific scaffolds.   
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CHAPTER 2 Electrospinning of Biopolymers for 
Cardiovascular Applications 
 
Preface: The following manuscript is currently in press for publication in Advanced Drug 
Delivery Reviews, 2009 [104]. The work included is a review article which explores the 
process of electrospinning with an emphasis on the electrospinning of an array of 
biopolymers for cardiovascular specific applications. 
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ABSTRACT 
 
The process of electrospinning has seen a resurgence of interest in the last few 
decades which has lead to a rapid increase in the amount of research devoted to its use in 
tissue engineering applications.  Of this research, the area of cardiovascular tissue 
engineering makes up a large percentage, with substantial resources going towards the 
creation of bioresorbable vascular grafts composed of electrospun nanofibers of collagen 
and other biopolymers.  These bioresorbable grafts have compositions that allow for the 
in situ remodeling of the structure, with the eventual replacement of the graft with 
completely autologous tissue.  This review will highlight some of the work done in the 
field of electrospinning for cardiovascular applications, with an emphasis on the use of 
biopolymers such as collagens, elastin, gelatin, fibrinogen, and silk fibroin, as well as 
biopolymers used in combination with resorbable synthetic polymers. 
 
INTRODUCTION 
 
Cardiovascular disease (CVD), specifically coronary heart disease (CHD) 
resulting from arteriosclerosis, remains the leading cause of death in the United States 
and has been so virtually every year since 1900 [105].  Arteriosclerosis is a vascular 
disease characterized by thickening of the arterial wall and a subsequent decrease in the 
arterial lumen leading to an eventual decrease or loss of circulation distal to the disease 
site.  Once blood flow is compromised, vascular bypass is an option to restore blood flow 
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to tissues distal to the restriction or blockage [59].  In 2005 there were 469,000 bypass 
procedures performed due to CHD [105], which typically involve the replacement of a 
coronary artery with a patients own saphenous vein or internal mammary artery.  While 
these autologous replacement grafts have an acceptable patency rate, they are not always 
a viable option as the patient may also suffer from peripheral vascular disease; affecting 
upwards of 8 million Americans and up to 20% of those 65 years of age or older [105].  
Further complicating the use of autologous vessels is the fact that they are limited in 
number and a previous bypass operation may have already required the vessel’s use 
[106].  Currently available commercial alternatives to the autologous vessel gold standard 
are limited to synthetic vessels made of expanded polytetrafluoroethylene (e-PTFE) and 
woven or knitted polyethylene terephthalate (PET) fibers (Dacron®).  These materials 
have been used with moderate success as medium (6-10 mm internal diameter, ID) and 
large (> 10 mm ID) diameter prosthetics, but their efficacy is severely limited when used 
as small diameter vessels (< 6 mm ID).  Larger diameter vessels experience higher flows 
and less resistance than small diameter vessels, such as the popliteal or coronary arteries, 
where low blood flow and high shear makes the synthetic graft more prone to thrombus 
formation and intimal hyperplasia [59, 106-116].  Dacron® and e-PTFE grafts are non-
degradable and lack the ability to promote native tissue regeneration, making them a 
permanent fixture in the body.  As a permanent fixture, the graft is constantly threatened 
with attack from the patient’s own foreign body response as well as bacterial graft 
infection [113, 115, 117].  The electrospinning of biopolymers holds the potential to 
create bioresorbable vascular prosthetics that not only mimic the structure and function of 
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native vessel, but also have the ability to degrade over time and become replaced with 
autologous tissue. 
 
Native Vascular Physiology.  Native artery is an extremely complex multi-
layered tissue composed of a number of different proteins and cell types, which each 
plays an integral role in the mechanical behavior of the structure (figure 2.1).  In order to 
withstand the high flow rate, high pressure, and pulsatile nature of blood flow, artery is 
comprised of three distinct layers: intima, media, and adventitia.  Each of these layers has 
a different composition and plays a different physiological role.  The intimal layer is the 
innermost layer of the vessel wall and is made up of a single layer of ECs on a thin basal 
lamina and a subendothelial layer made of collagen type IV and elastin.  This layer 
contacts the bloodstream and therefore provides a critical barrier to platelet activation.  
The thick medial layer is composed of several layers of SMC in a matrix of collagen 
types I and III, elastin, and proteoglycans.  The outermost adventitial layer is made of FB 
and randomly arranged collagen type I [59, 118, 119].  The major protein components of 
native artery, collagen and elastin, provide tensile support and prevent vessel rupture, and 
confer elasticity to the vessel, providing the ability to recover from pulsatile deformation, 
respectively [120, 121].  It is the elastic nature of elastin that dominates the low-strain 
mechanical response of the vessel to blood flow and prevents pulsatile energy from being 
dissipated as heat [122, 123]. 
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Figure 2.1.  Drawing of arterial wall depicting the native tissue’s three primary layers: 
intima, media, and adventitia.  Reprinted from [111]. 
 
Bioresorbable Vascular Grafts.  Bioresorbable grafts are advantageous when 
compared to their non-resorbable counterparts due to the fact that a resorbable vascular 
prosthetic with adequate mechanical properties can be implanted and degraded gradually 
over a period of time, leaving behind no permanent synthetic materials to initiate a 
chronic foreign-body reaction [115].  Through the years, there have been many different 
approaches to the creation of a vascular graft that can be gradually degraded over time 
and replaced with native tissue.  Wesolowski et al. first introduced the concept of a 
bioresorbable vascular prosthetic in the early 1960s.  These first bioresorbable 
incarnations were composed of a variety of Dacron® yarns, collagen coatings, and 
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collagen fibers.  The permanent Dacron® provided mechanical stability, while the 
collagen added bioactivity to the structure and promoted the ingrowth of native tissue as 
it was degraded and remodeled [124, 125].  The 1970s, and ‘80s saw the advent of a 
number of different aliphatic polyesters (PLA, PGA, PDO, etc.).  These polymers 
breakdown through hydrolysis in the body, and can have their rate of degradation tailored 
by altering their structures [115, 126-130].  While this preliminary work failed to result in 
a successful commercially available graft, it laid the foundation for current research in 
bioresorbable prosthetics and demonstrated the possibilities of in situ tissue engineering.   
The creation of an off-the-shelf bioresorbable vascular graft designed to be 
remodeled in situ would use a patient’s own body as a bioreactor and the host’s own cells 
to populate and modify the scaffold.  The challenge of creating such a prosthetic is to 
tailor the graft to resorb at a rate comparable to the rate of natural tissue regeneration.  
This is necessary to prevent loss of the prosthetic mechanical backbone prior to the 
formation of autologous tissue substantial enough to withstand the rigors of the vascular 
system and prevent rupture or aneurysm formation.  The eventual absence of foreign 
material would reduce both the host’s foreign body response and the risk of graft 
infection, while increasing the patency of the prosthetic [50, 115, 131]. 
 Aside from being bioresorbable, a tissue engineered vascular graft needs to meet 
several other criteria to be considered ideal.  From an implantation standpoint, the graft 
would need to be easy for surgeons to handle with excellent suture retention, and resistant 
to kinking while remaining flexible.  The graft must be leak resistant, yet have sufficient 
porosity to allow for the ingrowth of autologous tissue.  The graft must also have 
   41
compliance similar to that of native artery to prevent intimal hyperplasia, but must be 
strong enough to prevent the formation of aneurysm.  Manufacturing concerns also play a 
role in creating an ideal vascular graft, as the structure must be easy to produce, sterilize, 
and store, as well as be economical and available off-the-shelf in a variety of sizes [50, 
113]. 
 
Electrospinning.  The resurgent interest in electrospinning in recent years has 
helped to rejuvenate the research of bioresorbable vascular grafts.  One of the main 
attractions of electrospinning is the fact that it is a simple process requiring little 
specialized equipment.  A standard electrospinning setup consists of a high voltage power 
supply, syringe pump, grounded target, and a spinneret (typically a syringe fitted with a 
blunt tip needle, figure 2.2).  The process itself can be easily performed in a laboratory 
setting or scaled up for large-scale production with little modification.  In brief, a 
polymer solution is drawn into the spinneret and charged with a large electric potential in 
the range of several kilovolts.  A grounded target is placed a set distance from the 
charged polymer solution to create a static electric field. When the electric potential 
reaches a critical level, the electrostatic repulsion of the polymer solution overcomes the 
surface tension at the tip of the spinneret, and a fine jet of entangled polymer chains is 
drawn out.  This jet whips through the air toward the grounded target, creating a dry fiber 
through the evaporation of the polymer’s solvent.  The electrospinning process has the 
capacity to produce fibers that range from 50 nm to 10 µm in diameter, collected on the 
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grounded target, dependant upon the processing conditions of the polymer 
solution/solvent used [11, 25, 48, 132-134].   
Apart from the simplicity of its setup, the versatility of the electrospinning 
process has also made it ideal for tissue engineering.  The process is compatible with a 
wide array of polymers, both natural and synthetic in origin, as well as the combination 
of any number of different polymers.  A large number of biopolymers have been 
electrospun in our lab and others, and will be discussed in detail in this manuscript: 
collagens, elastin, fibrinogen, hemoglobin and myoglobin [135], and SF.  Polymer 
solutions can be combined in a single reservoir, spun side by side from separate 
spinnerets, or layered sequentially to provide a large number of options for altering 
scaffold properties.  In addition, electrospun scaffolds can be created in nearly any shape 
required, and can consist of fibers in an assortment of orientations [132].  Electrospinning 
provides researchers with the ability to create, not only flat sheets, but also the seamless 
tubes required for vascular applications.  These tubes can be created in any diameter to fit 
the specifications of any vascular conduit. 
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Figure 2.2.  Schematic representation of a simple electrospinning setup utilizing a 
grounded rotating drum as a collection mandrel. 
 
ELECTROSPUN BIOPOLYMERS 
 
Collagen.  Collagen is the most abundant protein in the human body, a key 
element of the ECM, and imparts structural integrity and tensile strength to tissues.  
Tissue disruption following injury requires collagen for the repair and restoration of 
structure and function.  Excessive collagen deposition at a wound site results in loss of 
anatomical structure, function and fibrosis.  Conversely, if insufficient amounts of 
collagen are deposited, the wound is weak and may rupture [136]. 
The collagen super family includes over 30 different gene products that assemble 
into at least 20 genetically different collagen types, which may be homotrimeric or 
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heterotrimeric in nature.  All of the collagens share the triple helical molecular structure.  
The collagens most involved in forming fibrillar structures include types I, II, III, V and 
XI, with the fibril forming collagens type I, II, III being the most abundant [1].  The 
underlying α chains that form these polymers are arranged into a repeating motif that 
forms a coiled structure, exhibiting a 67 nm interval that imparts a characteristic banding 
pattern to the collagen structure.  The main collagens of interest to cardiovascular 
engineering are collagens I, III, and IV.  Collagen type I consists of two αI chains and 
one α2 chain forming fibrils of 50 nm in diameter, and is present in bone, skin, dentin, 
cornea, blood vessels, fibrocartilage and tendon.  Type III collagen is present in our skin 
as well as in ligaments, blood vessels and internal organs, and is composed of three 
α1(III) chains resulting in fibrils ranging from 30 to 130 nm in diameter [19].  Type III 
collagen also contributes to the flexibility of blood vessels and is expressed during the 
initial period of wound healing.  Collagen type IV, which is a major structural element of 
the basal lamina and basement membranes, is a nonfibrillar collagen.  These collagens 
associate with fibrillar collagens to form microfibrils and network structures.  
Collagen has been used in a variety of tissue engineering applications because of 
its predominance in the ECM, non-immunogenicity and available methods of isolation 
from a variety of sources.  However, the typical procedures used to isolate and reprocess 
this natural scaffolding into an engineered material may compromise many of its 
biological and structural properties [1].  Collagen fibers also possess some unique 
structural properties important for tissue engineering: they transmit forces, dissipate 
energy, prevent premature mechanical failure and provide biological signals to adjacent 
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cells that regulate functional responses.  Additionally, collagen is resorbable, has high 
water affinity, low antigenicity, very good cell compatibility and ability to promote tissue 
regeneration [19].  These factors combine to make collagen one of the most ideal 
biopolymers available for tissue engineering applications. 
 
Electrospinning of Collagen.  Collagen is one of the most plentiful proteins 
found in native blood vessel, and along with SMCs, collagen confers wall strength and 
resistance to vessel rupture in a harsh in situ environment [120].  Our laboratory has 
worked extensively on the electrospinning and characterization of many of the structural 
collagens that play significant roles in native vascular tissue: types I [19], III [137], and 
IV [1] (figure 2.3).  This work has demonstrated that the electrospinning process has the 
potential to produce collagen fibers that closely mimic, and at some point may even fully 
reproduce, the structural and biological properties of the natural collagen ECM.  
Electrospun fibers of type I collagen dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol 
(HFP) exhibited a linear relationship between polymer concentration and fiber diameter.  
Electrospun collagen solutions ranged in concentration from 0.03 to 0.10 g/ml of HFP, 
and resulted in scaffolds composed of 100 nm to 5 µm diameter fibers [19].  The 
electrospinning of collagen type III, like collagen type I, demonstrated a linear 
relationship between solution concentration and fiber diameter for collagen 
concentrations between 20 and 80 mg/ml.  Over this range of concentrations, fiber 
diameter increased from 115 to 612 nm.  It was found that for concentrations higher than 
80 mg/ml, the electrospun collagen type III resulted in small fragments of fibers as well 
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as some ribbon like fibers [137].  Our laboratory has also done some preliminary work 
with the electrospinning of the basement membrane forming collagen type IV from HFP, 
to form fibers with diameters ranging from 100 nm to 2 µm [1]. 
 
Figure 2.3.  Scanning electron micrographs of (A) electrospun type I collagen (8,000x, 
scale bar 1.0 µm), (B) electrospun type III collagen (4,300x, scale bar 1.0 µm), and (C) 
electrospun collagen type IV collagen (1,200x, scale bar 10 µm). (A) reprinted from [59].  
(B) and (C) reprinted from [1]. 
 
 
 
As HFP is a strong organic solvent, it has been suggested that electrospinning of 
collagen from HFP may result in structures composed of gelatin fibers [138].  However, 
there has been research conducted which demonstrates differences between collagen and 
gelatin electrospun from HFP [28], as well as research that demonstrates only minor 
differences between structures of collagen electrospun from HFP and structures of 
collagen electrospun from phosphate buffered saline (PBS) based solutions [139].   
Telemeco et al. [28] have shown a number of morphological characteristics which 
differ between scaffolds of electrospun collagen and gelatin.  First, the pore size of 
electrospun gelatin matrix is smaller (approx. 2000-6000 nm2) than the average pore 
dimension of electrospun collagen (approx. 1500-4000 nm2).  Second, electrophoretic 
analysis has shown that samples of electrospun gelatin are composed of fragments of type 
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I collagen. In contrast, samples of electrospun collagen appear to be composed of intact 
monomers.  Finally, fibrils of collagen exhibit a 67 nm repeat banding pattern that is 
thought to expose a binding site in the native collagen fibril that enhances cell adhesion 
and migration.  However, electrospun gelatin fibrils exhibit a non-descript amorphous 
structure and lack this 67 nm repeat pattern  
In vivo behavior of the two structures is also markedly different.  Electrospun 
cylindrical constructs of collagen type I and gelatin were implanted into the belly of the 
vastus lateralis of the rat and recovered after seven days for microscopic evaluations.  It 
was found that constructs composed of electrospun type I collagen were fully infiltrated 
with interstitial cells and were well integrated with the surrounding muscle tissue of the 
host.  The implant was free from fibrotic encapsulation and there was a smooth 
continuum of cells from the host tissue into the electrospun collagen.  Also, functional 
capillaries were present throughout the walls of these implants.  Electrospun constructs of 
gelatin on the other hand delaminated from the host tissue after seven days in vivo. It was 
revealed by microscopic examination that these implants developed fibrotic capsules, 
were poorly infiltrated with interstitial cells, and appeared to be infiltrated by 
lymphocytes [28]. 
Dong et al. [139] recently published a study on the electrospinning of collagen 
from a simple binary mixture of PBS and ethanol.  They found that pore sizes are similar 
between collagen scaffolds electrospun from either HFP or PBS/ethanol solutions.  
Fourier transform infrared spectroscopy (FTIR) data revealed that the triple helical 
structure of type I collagen remained intact after electrospinning from the PBS/ethanol 
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mixtures.  By comparison, there were only minor differences observed in the amide I and 
amide II bands of structures electrospun from HFP and the PBS/ethanol solutions. 
 
Electrospinning Collagen and Synthetic Polymer Blends.  Collagen, while a 
structural protein in vivo, lacks mechanical integrity upon hydration in an electrospun 
form.  Without sufficient cross-linking of the electrospun structure it does not have the 
strength to withstand arterial forces.  Previously established methods of cross-linking 
with glutaraldehyde (GLUT), successful in increasing the strength of the electrospun 
structures, also carry an enhanced risk of cytotoxicity and calcification when used in vivo.  
To circumvent this problem our laboratory has published a technique for the cross-linking 
of electrospun collagen with EDC in ethanol [140].  Another method for improving the 
mechanical stability of an electrospun collagen scaffold is to incorporate biodegradable 
synthetic polymers into the structure to impart immediate strength to the scaffolds while 
maintaining a high level of bioactivity through the presence of collagen. 
Blends of collagen with synthetic polymers have been used to tailor mechanical 
and bioactive properties of the electrospun scaffolds.  Collagen in the native ECM serves 
as an adhesion protein that enhances cell attachment and proliferation through specific 
interactions between RGD domains in collagen molecules and integrin receptors in the 
cell membrane.  Thus, the presence of collagen in the scaffolds would aid in increasing 
the biocompatibility of the scaffolds.  Other methods for introducing proteins into 
nanofibrous structure such as coating or grafting, lead to slow mass transfer of the 
proteins into the three dimensional porous materials.  Electrospinning of a blended 
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collagen mixture is much simpler because it avoids the slow mass transfer process and 
also uses lesser amounts of chemical reagents.  Moreover, the existence of collagen on 
the surface and inside the structure provides sustained cell recognition signals with 
polymer degradation, which is crucial for cell function and development [141]. 
Stitzel et al. [142] used a combination of collagen fibers and PLA to create a 
scaffold for vascular engineering.  Collagen fibers were wound with a novel winding 
apparatus with variable pitch to mimic the SMC structure in an artery.  Biodegradable 
PLA was spun around the collagen fibers for SMC seeding and to hold the fibers in place 
during tissue regeneration.  The collagen fiber and matrix was designed to create a 
residual stress environment similar to that found in native arteries, which encourages 
SMC orientation along the principal stress directions of an artery.  A distinct regularity in 
alignment of the SMCs along the direction of the large collagen fiber was observed, 
demonstrating that one can positively influence the alignment of SMCs before 
implantation and can thus improve the speed with which the graft can be incorporated 
into the vasculature. 
Segmented polyurethanes (SPU) have also been used to create 
synthetic/biopolymer-blended scaffolds.  A tri-layered electrospun mesh composed of 
type I collagen, styrenated gelatin (ST-gelatin), and SPU was created in which individual 
fiber meshes were deposited layer by layer by sequential electrospinning.  Confocal laser 
scanning micrographs of the scaffolds revealed the SPU, ST-gelatin, and collagen layers 
to be segregated and hierarchically positioned in the order of the vertical direction of the 
meshes.  Using this approach, a bi-layered electrospun tube composed of a collagen mesh 
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cell-adhesive inner layer and an SPU structural outer layer was constructed as a prototype 
small diameter vascular graft.  The authors speculated that such hierarchically designed 
artificial grafts may provide compliance matching that of native arteries, cell and tissue 
ingrowth, and transient antithrombogenicity in the early phase of implantation [143]. 
PCL is a bioresorbable polymer with excellent mechanical properties that has 
recently seen a marked increase in its usage as a tissue engineering scaffold.  A 
PCL/collagen type I composite scaffold with the ability to resist high degrees of 
pressurized flow over long term, while still providing a favorable environment for the 
growth of vascular cells was developed by Lee et al. [144].  The PCL/collagen composite 
scaffolds, with fiber diameters of approximately 520 nm (figure 2.4), possessed 
appropriate tensile strength (4.0 ± 0.4 MPa) and adequate elasticity (2.7 ± 1.2 MPa).  The 
burst pressure of the composite scaffolds (4912 ± 155 mmHg) was much larger than that 
of the PCL scaffolds alone (914 ± 130 mmHg), as well as exceeding the burst strength of 
native vessels.  The composite constructs were seeded with bovine ECs and SMCs, and 
showed the formation of a confluent layer of ECs on the lumen and SMCs on the outer 
surface of the scaffold.  
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Figure 2.4.  The gross appearance (a), and SEM images of electrospun PCL/collagen 
composite scaffolds: (b) entire scaffold (18x), (c) surface (6,000x), and (d) cross-
sectional (4,000x) morphologies. Reprinted from [144]. 
 
 
 
These PCL/collagen electrospun scaffolds were also investigated for their in vivo 
stability in a rabbit aortoiliac bypass model.  It was observed that endothelialized grafts 
resisted adherence of platelets when exposed to blood.  Also, it was demonstrated by 
serial ultrasonography that these scaffolds were able to retain their structural integrity 
over 1 month of implantation.  Moreover, these scaffolds continued to maintain 
biomechanical strength at retrieval that was comparable to native artery [145]. 
In a study by Venugopal et al. [146], PCL and collagen types I and III were 
blended and electrospun to create nanofibers with a diameter of 210–225 nm.  The tensile 
modulus of the structures was 18 MPa with a tensile strength of 7.79 MPa, appropriate 
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for a blood vessel conduit.  SMCs were seeded on the scaffolds and their proliferation 
was quantified.  Proliferation was significantly increased up to 63%, 73% and 82% in 
PCL/collagen nanofiber scaffolds compared to PCL nanofiber scaffolds after 2, 4 and 6 
days, respectively.  He et al. [141] fabricated collagen type I blended poly (L-lactic acid)-
co-poly(ɛ-caprolactone)  [P(LLA-CL), 70:30] biohybrid scaffolds by electrospinning, and 
tested for the growth of ECs.  Scanning electron microscopy (SEM) analysis revealed a 
smooth nanofiber surface and a narrow fiber diameter distribution between 100-200 nm.  
It was demonstrated that collagen blended polymer nanofibers could enhance the 
viability, spreading and attachment of human coronary artery endothelial cells (hCAECs) 
and preserve their phenotype. 
PDO is a polymer used commonly as a commercially available suture that has 
been shown to exhibit excellent mechanical properties, shape memory, a low 
inflammatory response, and a slower rate of degradation than other resorbable suture 
materials [48].  Electrospun scaffolds of PDO/collagen have been successfully created 
that, when hydrated, exhibited mean peak stresses between 4.6 and 6.7 MPa, mean 
tangential moduli between 7.6 and 18.0 MPa and mean strain to failure values between 
56.5% and 186.4% (table 2.1).  It is to be noted that as with other composite materials, 
these results were not just the average of the component contributions.  It has been 
speculated by the authors that an as yet unexplained interaction has taken place between 
the polymers.  These preliminary data seem to indicate that blends of PDO and collagen 
may mimic the mechanical and morphological requirements of a blood vessel's 
microenvironment [137].  
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Table 2.1.  Results of uniaxial tensile testing of electrospun blends of PDO and collagen 
types I and III compared to native saphenous vein, femoral artery, and e-PTFE (30 mm 
internodal distance).  Modified from [137] 
 
 
 
Elastin.  In vivo, elastin is a chemically inert, highly insoluble polymer composed 
of covalently cross-linked molecules of its precursor, tropoelastin, a soluble, non-
glycosylated and highly hydrophobic protein.  Tropoelastin expression and subsequent 
elastin synthesis typically occurs in FBs, vascular SMCs, ECs, and chondrocytes [147].  
During the process of elastogenesis, tropoelastin is synthesized, preventing its premature 
intracellular aggregation and protecting it from proteolytic degradation by binding a 67 
kDa galactoectin (elastin binding protein, EBP).  This association lasts until the complex 
is excreted into the extracellular space.  EBP then interacts with galactosugars of the 
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microfibrils, dramatically decreasing its own affinity for tropoelastin.  In order for proper 
elastogenesis to occur, the interaction of the N-terminal part of the microfibrillar-
associated glycoprotein with the C-terminal end of tropoelastin is required.  Once 
aligned, lysyl oxidase deaminates and oxidizes the lysyl residues to allysine following the 
action of Cu2+.  Cross-links are then formed by the reaction of the allysines with 
themselves or with an unmodified lysine [147-149].   
As a biomaterial, elastin is becoming more and more popular for tissue 
engineering applications as one of the main structural components of the vascular ECM.  
The incorporation of elastin into biomaterials has been used in several different forms, 
including insoluble elastin occurring in autografts, allografts, xenografts, decellularized 
ECM, and in purified elastin preparations where the insoluble elastin is hydrolyzed to a 
soluble form of α, β, and κ elastin [150].  Although insoluble elastin in its different graft 
forms could be considered a more “natural state,” there is an advantage to its solubility 
which makes handling and analysis of the material more straightforward.  Additionally, 
elastin peptides influence signaling, chemotaxis, proliferation, and protease release via 
the elastin receptor [151].  Daamen et al. not only found that solubilized elastin induced 
angiogenesis, but also increased elastic fiber synthesis and displayed no signs of 
calcification when compared to grafts containing its insoluble form [152].  This is one of 
many studies that have proven soluble elastin to be an advantageous biopolymer. 
 
Electrospinning of Elastin.  In low flow environments, such as small diameter 
blood vessels, it is essential to match the mechanical forces of a vascular graft with the 
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native artery for proper graft functionality.  To elicit these specific properties, the proper 
choice of polymers and fabrication must be made.  As stated previously, tropoelastin 
provides the necessary building blocks to form native elastin in vivo.  If tropoelastin were 
processed into a vascular graft this could prove to be a major advantage in cardiovascular 
tissue engineering.  Li et al. demonstrated that recombinant human tropoelastin could be 
electrospun to form both nanofibers and microfibers, depending on the delivery rate 
[153].  In their study, both tropoelastin and solubilized α-elastin were electrospun.  The 
parameters were optimized and the final products were compared through microscopy, 
mechanical tensile moduli, and cellular activity with human embryonic palatal 
mesenchymal (hEPM) cells.  Mechanically, elastin allows for distension and recoil in 
vivo.  It was determined that the elasticity of tropoelastin far exceeded that of soluble 
elastin, which could prove to be advantageous, allowing for the creation of grafts with 
compliance matching native artery.   
 
Electrospinning Elastin and Synthetic Polymer Blends.  Much like electrospun 
collagen, one of the limitations that pure electrospun soluble elastin has is its inherently 
poor mechanical properties.  It has also been shown that electrospun elastin dissolves in 
water instantaneously if uncross-linked; however, blending with synthetic polymers will 
help to maintain the structural integrity of the scaffold and thereby retain elastin.  A study 
done by McClure et al. [71] using weight sampling, SEM characterization, uniaxial 
tensile testing, and a 2,4,6-trinitrobensenesulfonic acid (TNBS) assay discovered that 
elastin, when blended with PDO, dissolved over time (figure 2.5).  As the percentage of 
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synthetic was increased, the time to dissolve elastin from the scaffold increased as well, 
likely due to more elastin becoming entrapped within the PDO fibers.  Scaffolds 
containing large amounts of elastin experienced almost instantaneous weight loss, while 
scaffolds containing larger amounts of PDO lost weight at a much slower rate with some 
elastin remaining after 1440 minutes in solution.  This weight loss was corroborated by 
uniaxial tensile testing, which revealed differences between samples of varying elastin 
percentage over the time course.  However, when the electrospun structures were cross-
linked with either EDC or genipin, elastin containing scaffolds retained their original 
weight throughout the time course, but experienced slightly altered mechanical 
properties.  Most studies involving elastin use some form of cross-linking whether it be 
GLUT, EDC, or 1,6-diisocyanatohexane (HMDI) in order to retain the electrospun 
biopolymer. 
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Figure 2.5.  Percent of scaffold weight remaining after t = 0, 15, 60, and 1440 minutes, 
respectively in PBS.  Modified from [71]. 
 
 
 
Since compliance mismatch between the graft and native artery is one of the 
major causes of graft failure, the authors of this manuscript have tested several 
combinations of PDO and elastin in order to determine its mechanical behavior in vitro 
[20].  A difference in this study, compared to other publications of vascular graft 
compliance, was that compliance was determined under dynamic conditions mimicking 
physiological parameters (figure 2.6), therefore providing a lucid interpretation as to how 
the graft should perform in the body.  In this study, it was determined that certain 
PDO/elastin blends closely matched those of native artery.   
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Figure 2.6.  Compliance determined for 120/80 mmHg pressure level for native artery 
and vein, current synthetic prosthetics, and electrospun blends of PDO and elastin 
(PDO:elastin). Modified from [20]. 
 
 
 
This led to a subsequent study performed by Smith et al. [154] in which small 
diameter grafts composed of PDO and elastin, 1.9 mm inner diameter, were electrospun 
with a double or single layer of degradable suture reinforcement.  Grafts were initially 
electrospun with a single layer of PDO/elastin and then wound with 6-0 polydioxanone 
monofilament suture (PDSTM II) to provide additional mechanical strength, maintaining a 
spacing of 1 mm and a pitch of 9o.  Four separate groups, double layered suture, single 
layered suture, and two groups containing no suture reinforcement (double layered 
polymer and single layered polymer), were mechanically characterized through dynamic 
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compliance and burst strength.  When suture was added to the scaffold structure, it 
provided higher bursting strength but lower compliance.  If suture was removed from the 
structure completely, the graft displayed higher compliance but lower burst strength, 
where double layered polymer exhibited higher mechanical strength and lower 
compliance than that of single layered polymer.  The addition or subtraction of suture 
allowed these vascular conduits to be mechanically tailored as necessary, a major benefit 
to biodegradable conduits.  These PDO/elastin grafts displayed mechanical characteristics 
within the range of native artery further proving the benefits of elastin’s use as a 
biopolymer, and demonstrated the potential of a multi-layered structure in replicating the 
mechanical properties of the native vasculature. 
Another study involving the use of a elastin/synthetic polymer multi-layered 
structure was published by Thomas et al. [155], creating a tri-layered gelatin, elastin, and 
Maxon® blended graft, with each layer containing a different blend of polymers.  The 
innermost layer contained purely gelatin and elastin, the middle layer contained gelatin, 
elastin, and Maxon, and the outer layer contained gelatin and Maxon.  Each layer 
provided the scaffold with different mechanical properties contributing to the overall 
behavior of the graft.  Slightly changing the parameters in one layer subsequently 
changed the overall material properties of the graft.  A different way of approaching this 
aspect of vascular tissue engineering has been done by El-Kurdi et al. [156].  This group 
utilized a porcine internal jugular vein with an outer electrospun polymer wrap providing 
resistance against aneurysm formation.  These outer polymer wraps contained poly(ester 
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urethane) urea (PEUU), collagen, and elastin to provide the necessary mechanical 
strength while encouraging cellular infiltration. 
There have been many studies published on the material properties and 
mechanical response of electrospun vascular grafts, which are extremely important for 
the prediction of a grafts behavior in vivo.  However, another important aspect of vascular 
regenerative medicine, which has not yet been studied extensively, is the initial host 
response produced when a graft is implanted.  One such study was done by measuring the 
immunomodulatory nature of PDO/elastin scaffolds [157].  Results indicated that both 
PDO and elastin acted as immunosuppressive agents.  The effect of these materials 
immunosuppresive nature is not yet fully understood.  This result could prove to be 
detrimental, as patients requiring a vascular graft would most likely be in poor health and 
already somewhat immunocompromised.  However, local immunosuppresion could be a 
benefit if it was required for cells to be seeded onto the graft; cells contained within the 
graft would be protected to some degree from attack by the immune system upon 
implantation.  In situ evaluation would be needed to completely evaluate the body’s 
response to the graft. 
 
Collagen and Elastin Blends.  As collagen and elastin are two of the most 
prevalent protein constituents in native vessel, it is only logical that they are often used in 
concert as tissue engineering scaffolds for vascular applications.  Boland et al. [59], in an 
attempt to create a biomimicking layered vascular structure, first electrospun an 80/20 
collagen type I/elastin tube on a 4 mm diameter mandrel.  This tube was subsequently 
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seeded with both FBs and SMCs.  Another tubular scaffold of 30/70 collagen type 
I/elastin was electrospun on a 2 mm diameter mandrel.  This electrospun scaffold was 
then inserted into the 4 mm diameter scaffold and the lumen was filled with a SMC 
suspension. After 3 days in culture, a suspension of human umbilical vascular endothelial 
cells (hUVECs) was injected into the lumen, and the entire construct was cultured for 2 
more days.  Histological examination revealed complete cellular infiltration into the 
three-layered construct after 21 days, as shown in a cross-sectional cut of the tubular 
scaffold in figure 2.7.  The artificial intima was covered by morphologically mature ECs 
and SMCs were present throughout the media, and had begun to align circumferentially 
around the axis of the scaffold.  The FBs and SMCs in the adventitia created a dense 
population throughout the outermost wall.  This study proved that an electrospun scaffold 
that mimics the native ECM is highly beneficial in the field of vascular tissue 
engineering.  However, the lack of synthetic polymers in the tubular structures did not 
allow for sustained mechanical viability.   
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Figure 2.7.  Electrospun collagen/elastin scaffold after 21 days in culture, showing 
extensive SMC infiltration, and a dense distribution of cells across the cross-section of 
the scaffold.  Reprinted with permission from [59]. 
 
 
 
In a study by Buttafoco et al. [120], soluble collagen type I from calf skin and 
soluble elastin from bovine neck ligament were electrospun from aqueous acidic 
solutions in order to avoid the use of organic solvents.  To ensure continuous and 
homogenous fibers, PEO and sodium chloride (NaCl) was added.  Meshes composed of 
fibers with diameters ranging from 220 to 600 nm were obtained by spinning the 
collagen/elastin solutions.  Scaffolds completely devoid of PEO and NaCl were obtained 
by cross-linking with EDC and N-hydroxysuccinimide (NHS).  SMCs were successfully 
cultured on cross-linked scaffolds and a confluent layer of cells was observed after 14 
days on the surface of the different scaffolds. 
Combinations of collagen and elastin with synthetic polymers have also been used 
in order to create scaffolds with desirable mechanical properties, bioactivity, and 
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sustained mechanical integrity.  Nanofiber scaffolds were fabricated using a mixture of 
40% collagen type I, 15% elastin and 45% PLGA by weight electrospun onto a 4.75 mm 
diameter cylindrical mandrel.  Collagen type I and movat staining were used to 
demonstrate a uniform distribution of collagen and elastin throughout the scaffold wall.  
Compliance testing results showed that the diameter change was approximately 9% for 
native vessels and 12–14% for electrospun scaffolds under a physiologic pressure range.  
In vitro cell proliferation of SMCs and ECs was determined by mitochondrial metabolic 
activity assay (MTT) and showed an average of 82% of SMCs and 72% of ECs survived 
on the scaffolds.  Scaffolds were also implanted subcutaneously in mice to demonstrate 
the biocompatibility of the electrospun vascular scaffolds in vivo.  No behavioral or 
visible changes of physical impairment indicating systemic or neurological toxicity were 
observed during the post-operative examinations or at the time of sacrifice.  During the 
entire study period, complete blood count of the implanted animals was within normal 
limits.  No significant lesions or evidence of particle migration in any of the major organs 
was observed.  Histology revealed an initial minimal inflammatory response, which 
subsided over time [158]. 
In a similar study, an array of synthetic materials with 45% collagen, 15 % 
elastin, and 40% biodegradable synthetic (PLGA, PLLA, PCL, and poly(D,L-lactide-co-ε-
caprolactone) (PLCL)) were electrospun.  Tubular scaffolds were characterized through 
SEM, uniaxial tensile testing, and biocompatibility.  Once again it was demonstrated that 
scaffold mechanical properties were improved with the addition of synthetic polymers.  
An interesting result of this study was the dimensional stability of the synthetic 
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containing scaffolds after 56 days in culture medium at 37oC, where collagen/elastin 
blends were completely dissolved after 28 days in medium.  This demonstrated that in 
order for a graft to remain patent when using biopolymers such as collagen and elastin, 
the addition of a synthetic is necessary for sustained stability [159].   
 
Gelatin.  Gelatin is a derivative of collagen, acquired by denaturing the triple-
helix structure [1, 10].  There are two types of gelatin extracted from collagenous tissue: 
type A, processed by an acidic pretreatment, and type B, processed by an alkaline 
pretreatment.  The main difference between the two is that type B has higher carboxylic 
acid content than type A.  Due to the similarities between gelatin and collagen and its 
natural origin, it has become an attractive polymer for tissue engineering applications.  Li 
et al. [160] have demonstrated that the average diameter of electrospun gelatin and 
collagen fibers were similar, and could be scaled down to 200–500 nm.  The mechanical 
properties of the two were also similar, with tensile strengths of 8–12 MPa, and ultimate 
elongations of 0.08–0.1 mm/mm.  However, gelatin exhibited a higher tensile modulus 
than collagen fibers.  In addition to similar mechanical properties to collagen, gelatin 
exhibits excellent biodegradability, non-antigenicity, and cost efficiency [1, 64, 65, 75].  
One drawback of gelatin is that it dissolves as a colloidal sol at temperatures at or above 
37ºC, and gels at lower temperatures around room temperature.  However, when cross-
linked, or combined with synthetic polymers, this limitation can be significantly reduced 
[65].   
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Gelatin nanofibers have been electrospun from the organic solvents HFP and 
trifluoroethanol (TFE), as well as formic acid, acetic acid, and water.  Gelatin scaffolds, 
as well as gelatin/synthetic polymer scaffolds, have been gaining interest as a tissue 
engineering scaffold, and there have been several studies detailing their efficacy [64, 65, 
67, 75, 153, 161-163].  Electrospun gelatin scaffolds have been used for applications such 
as wound healing [164], nerve [66], cartilage, bone [165], and dermal tissue engineering 
applications [166].  For vascular applications, much of the work with gelatin has been 
centered around its use as sealant or coating to enhance the biological properties of 
synthetic scaffolds.  Gelatin containing grafts have displayed better biointegration than 
non-coated grafts, as well as excellent cellular biocompatibility and antithrombogenicity 
[167-170].   
Much of the work published on gelatin scaffolds has been directed towards use in 
cardiac tissue engineering applications.  Li et al. [171] electrospun gelatin with a 
conductive polymer, polyanaline.  Pure gelatin scaffolds (8% w/v) were fabricated with 
fiber diameters of 800 nm, tensile strength of 5.7 MPa, modulus of 499 MPa, and an 
elongation of 96%. The addition of polyanaline (3% w/v at ratios of 15:85, 30:70, 45:55, 
and 60:40 polyanaline:gelatin) at increasing concentrations caused a decrease in the fiber 
diameter and an increase in the mechanical integrity of the scaffolds.  Cell culture 
analysis done with H9c2 rat cardiac myoblasts resulted in attachment, spreading, 
migration and proliferation to confluence on the scaffolds.  In a similar study, PLGA, 
gelatin, and elastin were co-electrospun at 10%, 8%, and 20% (w/v) respectively at ratios 
of 3:1:2 and 2:2:2 (PLGA:gelatin:elastin).  These scaffolds exhibited high mechanical 
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properties, with moduli of 254 MPa (3:1:2 ratio) and 122 MPa (2:2:2 ratio).  These 
scaffolds also facilitated excellent cell proliferation, morphology and penetration of H9c2 
rat cardiac myoblasts and neonatal rat bone marrow stromal cells showing their ability to 
be used in cardiovascular tissue engineering applications [172]. 
Gelatin (5%, 7% and 10% w/v) has also been electrospun with PCL (1%, 7%, 5%, 
and 10% w/v) to create scaffolds that avoid the need for post-fabrication cross-linking.  
Fiber sizes were recorded at diameters ranging from 640 nm to 880 nm depending on the 
amount of gelatin and PCL, where an increase in the percentage of gelatin and PCL 
resulted in higher fiber diameters.  Pore sizes of the scaffolds were measured to be 24-79 
µm2 with a tensile strength of 6.14-11.17 MPa, and a Young’s modulus of 57-138 MPa.  
Human adipose derived stem cells were cultured on the electrospun gelatin/PCL scaffolds 
and demonstrated extensive cell attachment, excellent cell migration, and confluent 
coverage over the entire scaffold [75].  In a study done by Zhang et al. [65], a mixture of 
gelatin (10% w/v) and PCL (10% w/v) solutions (50:50 ratio) were electrospun to 
produce fibrous scaffolds with fiber diameters that ranged from 10 nm to 1 µm (figure 
2.8).  Mechanical testing of the gelatin/PCL scaffolds resulted in tensile strengths of 1.29 
MPa, a Young’s modulus of 30.8 MPa, and an elongation of 138%.  These scaffolds 
proved to have excellent biocompatibility with bone marrow stromal cells and also aided 
in the process of cellular migration, proliferation, and penetration. 
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Figure 2.8.  Optical microscope images of electrospun gelatin at different concentrations.  
Reprinted from [65]. 
 
 
 
Heydarkhan-Hagvall et al. [75] blended PCL with collagen, elastin, and gelatin 
biopolymers.  It was observed that with increasing protein and polymer concentrations, 
fiber size increased proportionally but pore size decreased.  In terms of mechanical 
properties, electrospun gelatin/PCL scaffolds displayed a higher tensile strength when 
compared to collagen/elastin/PCL scaffolds.  All hybrid scaffolds were seeded with 
adipose-derived stem cells.  SEM and nuclei staining of cell-seeded scaffolds showed 
complete cell attachment to the surfaces of both hybrid scaffolds, but cell migration into 
the scaffold was mainly seen in the gelatin/PCL hybrid scaffold. 
An interesting alternative to bovine and porcine derived gelatin has also recently 
been published by Songchotikunpan et al. [163] which may prove to be beneficial as a 
scaffolding material for tissue engineering.  Gelatin extracted from Nile tilapia was 
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electrospun from an acetic acid solvent or a formic acid solvent and resulted in fiber 
diameters ranging from 161 to 761 nm for acetic acid and 109 to 302 nm for formic acid.  
Mechanical properties for the pure gelatin fiber mats included a tensile strength of 2.4-4.2 
MPa, Young’s modulus in the range of 118-194 MPa, and the elongation of 3.3-37.6%.  
Gelatin scaffolds were cross-linked, which caused the mats to become stiffer, with tensile 
strength increasing to 4.9-10.6 MPa, Young’s modulus being 366-570 MPa, and the 
elongation ranging from 3.3-25.7%. 
 
Fibrinogen .  Fibrinogen is a 340 kDa glycoprotein, synthesized by the liver and 
found freely circulating in the bloodstream which plays a major role in clotting.  During 
the coagulation cascade, more specifically the common pathway, fibrinogen is cleaved by 
thrombin to cause spontaneous polymerization of fibrin monomers.  Fibrin then forms 
lateral protofibril associations, which result in the formation of a loosely assembled clot, 
subsequently stabilized by covalent cross-links created by plasma transglutaminase 
(factor XIIIa).  This stable clot not only plays a haemostatic role, but also acts as an 
initial scaffold for tissue regeneration, serving as a platform for cell migration and 
proliferation [79, 173-175].   
As a protein critical to the coagulation of blood, fibrinogen is not generally 
thought about as a scaffold for cardiovascular engineering, but more commonly as a 
haemostatic agent or wound dressing.  However, the effectiveness of fibrinogen as a 
tissue engineering scaffold has the potential to extend beyond its primary role in clotting; 
it is a protein with the capacity to bind a wide array of molecules that could be beneficial 
   69
from a vascular prosthetic engineering standpoint.  Fibrinogen has been shown to contain 
RGD integrin binding sites which commonly bind FBs and ECs.  Additionally, fibrinogen 
has demonstrated the ability to bind with high affinity to functional vascular endothelial 
growth factor (VEGF), fibroblast growth factor (FGF), and a number of other cytokines 
[79, 176-178]. 
 The electrospinning of fibrinogen nanofibers was first published by Wnek et al. 
[21], and has since been demonstrated as a tissue engineering scaffold with great 
potential.  Preliminary in vitro cell culture with neonatal rat cardiac FBs proved the 
electrospun fibrinogen scaffolds to be extremely bioactive, with cardiac FBs readily 
migrating through the scaffolds and depositing native collagen [78].  A similar study 
done with human bladder smooth muscle cells (hBSMs) also demonstrated the ability of 
electrospun fibrinogen scaffolds to be degraded and remodeled over a short time course, 
with nearly complete remodeling taking place by day 14 (figure 2.9) [179].  Similar to 
electrospun collagen, electrospun fibrinogen lacks the mechanical integrity to serve as a 
tissue engineering scaffold on its own for long periods of time [77].  However, its 
mechanical properties can be altered by combining fibrinogen with synthetic polymers 
such as PDO [180], as well as cross-linking of the scaffolds with EDC and genipin [181].  
Due to the important part fibrinogen plays in the clotting cascade, its role in 
cardiovascular tissue engineering has yet to be determined; blood material interaction 
studies are needed to establish how electrospun fibrinogen scaffolds behave in contact 
with blood, with in situ evaluation required to fully understand their interaction. 
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Figure 2.9.  Histological evaluation of electrospun fibrinogen scaffolds seeded with 
hBSMs and stained with Masson’s Trichrome to demonstrate the production of new 
collagen matrix (blue) and remodeling of fibrinogen (red).  Scaffolds contained 
increasing amounts of aprotinin from left to right.  Images at 20x.  Reproduced from 
[179]. 
 
 
 
Silk Fibroin.  Silk is an intriguing natural protein, used for centuries as a medical 
grade suture, which is gaining momentum as a tissue engineering scaffold due to its 
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unique blend of material characteristics and bioactivity.  Silk exhibits excellent 
biocompatibility with a foreign body response comparable to other degradable sutures, 
hemocompatibility, and oxygen and water permeability.  Silk has also been shown to 
break down through proteolytic degradation and be slowly absorbed in vivo as 
biocompatible amino acids, despite the fact it is listed as a non-degradable suture due to 
the length of time over which it degrades.  The rate of degradation varies based upon 
implantation site and the size of the implanted fibers, but has been reported to lose the 
majority of its tensile strength between 6 weeks and one year after implantation.  Silk 
also possesses remarkable mechanical properties not seen in other naturally occurring 
proteins [22, 80, 81].  It has been reported that natural silk fibers have tensile strength and 
yield at fracture values comparable to synthetic fibers such as Kevlar [82].   
The use of silk fibers in tissue engineering typically refers to the use of SF.  Silk, 
which is produced in nature by a wide variety of insects and spiders, is composed of two 
distinct proteins: a glue-like sericin protein, which serves to hold fibers together, and a 
325 kDa fibroin filament component which acts as the mechanical backbone.  The sericin 
protein has proven to elicit an adverse immune response inside the body, making its 
removal necessary for tissue engineering applications [22, 81, 82]. 
Historically, tissue engineering with SF has been reserved for ligament 
engineering applications, as both knitted constructs [83-85] and as electrospun scaffolds 
of reconstituted SF [86, 88-94].  These studies have demonstrated the bioactivity of SF 
when seeded with FBs [22, 84, 86, 91], osteoblast-like cells [22], keratinocytes [91], and 
bone marrow stem cells [22, 80, 81, 83, 85, 88]. However, SF has also been recently 
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utilized in the creation of electrospun bioresorbable vascular grafts with promising 
results.  Zhang et al. successfully seeded electrospun SF with both human aortic 
endothelial cells (hAEC) and human coronary artery smooth muscle cells (hCASMC) 
[182].  Both hAECs and hCASMCs demonstrated an affinity for the electrospun SF.  
hCASMCs were shown to elongate and align themselves with SF fibers as well as 
produce native collagen ECM.  By 7 days in cultures hAECs exhibited an interconnecting 
network of capillary tubes with an identifiable lumen (figure 2.10 C, D).  Soffer et al. 
electrospun tubular SF constructs and performed tensile, creep, and burst strength studies 
to determine their mechanical properties [183].  SF vascular grafts demonstrated the 
ability to withstand native arterial pressures while behaving in a similar manner to native 
vessels during creep testing.  While much is yet to be determined with electrospun SF 
vascular grafts, these two studies reveal great potential for the use of SF in the future of 
cardiovascular engineering. 
 
Figure 2.10.  hAECs seeded on electrospun SF scaffolds.  Cell viability was determined 
through live/dead assay at days 1, 4, 7, and 14 (A, B, C, and D, respectively). Scale bar is 
50 µm.  Reprinted from [182]. 
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CHALLENGES TO BE MET 
 
There are still many challenges that have to be met prior to the creation of an ideal 
vascular substitute.  To date, there has not been an ideal electrospun scaffold created for 
use as a bioresorbable vascular substitute.  Electrospinning, which does an excellent job 
of mimicking the architecture of the native ECM, retains many aspects that make it more 
of an art than a science when it comes to creating tissue engineering structures.  While 
there is much potential in the electrospinning of biopolymers, researchers need to fine-
tune the process to create reproducible scaffolds with ideal fiber and pore sizes.  Our 
knowledge of polymers has allowed us to create electrospun structures that can be both 
bioactive and display sufficient mechanical properties for vascular success in a laboratory 
setting.  However, more research is necessary to understand the in vivo behavior of these 
materials; their rate of degradation and remodeling in situ, as well as their inflammatory 
and immune responses need to be understood before they make the leap from benchtop to 
bedside.  Finally, while our knowledge of vascular biology is growing on an almost daily 
basis, there is still much that needs to be done with respect to regulating the remodeling 
that takes place in vivo.  We have to promote remodeling and integration of an 
electrospun graft at an accelerated pace, while preventing fibrosis or a chronic 
inflammatory response, or the premature degradation of the electrospun structure. 
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CONCLUSION 
 
Despite the fact that there are still many obstacles that must be overcome in the 
creation of a successful electrospun biopolymer vascular graft, research from the last ten 
years has exponentially increased our knowledge and understanding of what is required 
of a vascular substitute.  A decade ago the biopolymers that constitute native vessel, such 
as collagen and elastin, had yet to be electrospun, limiting vascular prosthetics to 
synthetic polymers that failed to replicate the structure or function of the native 
vasculature.  The creation of structures made from these nanofiber biopolymers has the 
potential to not only mimic the structure of native artery, but also mimic the mechanical 
properties and behavior of native artery, thereby enhancing the success of vascular 
prosthetics as a whole. 
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CHAPTER 3 Creation of Electrospun ECM Analogues 
 
Preface: The following manuscript appeared in Polymer International, 2007, volume 56, 
pages 1349-1360 [24]. The work included is a review article which provides insight into 
the versatility of the electrospinning process, allowing it to create ECM analogues made 
from a wide range of natural and synthetic polymers that have applications in nearly 
every part of the human body. 
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ABSTRACT 
 
While electrospinning had seen intermittent use in the textile industry since the early 
twentieth century, it took the explosion of the field of tissue engineering, and its pursuit 
of biomimetic ECM structures, to create an electrospinning renaissance.  Over the past 
decade, a growing number of researchers in the tissue engineering community have 
embraced electrospinning as a polymer processing technique that effectively and 
routinely produces non-woven structures of nano-scale fibers (sizes of 80 nm to 1.5 
microns).  These nano-fibers are of physiological significance as they closely resemble 
the structure and size scale of the native ECM (fiber diameters of 50 to 500 nm).  
Attempts to replicate the many roles of the native ECM have led to the electrospinning of 
a wide array of polymers, both synthetic (poly(glycolic acid), poly(lactic acid), 
polydioxanone, polycaprolactone, etc.) and natural (collagen, fibrinogen, elastin, etc.) in 
origin, for a multitude of different tissue applications.  With various compositions, fiber 
dimensions, and fiber orientations, the biological, chemical, and mechanical properties of 
the electrospun materials can be tailored.  In this review we highlight the role of 
electrospinning in the engineering of different tissues and applications (skin/wound 
healing, cartilage, bone, vascular tissue, urological tissues, nerve, and ligament), as well 
as discuss its potential role in future work.  
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INTRODUCTION 
 
Significant tissue engineering research is based on the creation of scaffolds that 
simulate the body’s native ECM. [184, 185]  The ECM is a complex arrangement of 
proteins and polysaccharides such as collagen, hyaluronic acid, proteoglycans, 
glycosaminoglycans, and elastin.  These ECM components are constantly synthesized, 
secreted, oriented, and modified by the cellular components that they support.  
Classically, the function of native ECM was only believed to be as a structural 
framework for tissues.  However the ECM, through interaction with receptors on the 
surfaces of cells, directly takes part in promoting cell adhesion, migration, growth, 
differentiation, and apoptosis.  The ECM also plays a role in cytokine activity and 
intracellular signaling, both of which serve numerous functions in cell regulation and 
activation. [5, 16] 
 Ideally, to create a tissue engineered scaffold capable of the regeneration of fully 
functional tissue, one would like to mimic both the fibrillar form and the complex 
function of the native ECM. [11, 17, 18]  To attain a successful ECM analogue scaffold, 
there are several design and material criteria that must be met.  First and foremost, the 
scaffolding material should be subjected to the same standards as any other biomaterial 
implanted in the body, namely, the scaffold should not initiate any adverse tissue or 
immune reactions.  For many applications, scaffolding materials should be biodegradable 
or bioabsorbable at a rate that will allow for their gradual incorporation into the 
surrounding tissue without any fibrous encapsulation or residual evidence of their 
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presence. [11, 17]  To be ideal, this ECM analogue would need to mimic the 
topographical features and geometry on the macro-, micro-, and even nano-scale levels, 
as each influences cell response to the scaffold. [25]  Native ECM is composed of nano-
scale fibers that offer structural integrity to tissues.  Electrospinning (figure 3.1) allows 
for the creation of ECM analogue scaffolds composed of nano-scale fibers, which creates 
a very high surface area to volume ratio to support cell growth and infiltration. [18, 186]  
In addition, the morphological similarities between the nanofibrous structures and the 
native ECM are believed to improve cellular response and overall biocompatibility. [16, 
18]  A study by Sanders et al. showed that electrospun scaffolds composed of micro-scale 
and smaller diameter fibers resulted in little to no fibrous encapsulation when compared 
to larger diameter fibers. [187] 
 
Figure 3.1.  Generic electrospinning setup depicting the major components of the 
electrospinning process, including a high voltage power supply, polymer solution, and 
grounded collection target. 
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APPLICATIONS FOR ELECTROSPINNING IN TISSUE ENGINEERING 
 
Skin / Wound Healing.  Skin is the body’s largest organ, and functions foremost 
as a barrier, preventing pathogens from entering the body.  It is also a sensory organ and 
a regulator, gauging water retention and heat loss.  Skin is composed of two layers, the 
epidermis and dermis (figure 3.2). [188]  The epidermis is composed of five strata, with 
the most proximal layer, the strata germinativum, providing germinal cells for 
regeneration of the four other layers.  The regeneration of this layer is of extreme 
importance in understanding and promoting wound healing.  The underlying dermis is 
composed of two regions, the papillary dermis and the deeper reticular dermis.  These 
layers are composed primarily of FBs, which secrete ECM proteins such as collagen and 
elastin, however macrophages and lymphocytes are also present. [189, 190]  It is this 
unique structure that gives skin its distinctive biomechanical properties.  
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Figure 3.2.  Picture of histology demonstrating the main layers of skin, the dermis and 
epidermis.  Reprinted from [191]. 
 
 
 
 Severe burns, pressure ulcers, and other chronic ulcerations pose hurdles to 
caregivers and are costly to treat.  Healing tissue undergoes several stages: hemostasis, 
inflammation, proliferation, and remodeling. [192]  Although tissue engineered aids to 
wound healing can be applied to a variety of dermal maladies, they do not replace the 
stages of wound healing.  Rather, they aid endogenous wound healing, and are ultimately 
replaced by native tissue. [193] 
 Tissue engineering of skin poses many challenges to researchers.  Autografts and 
allografts are effective, but their use is limited due to their inherent limited supply and 
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cost.  Current wound dressings use material from a variety of natural and synthetic 
sources.  Many successful skin grafts utilize natural ECM proteins.  Collagen, in 
particular, has been used extensively in many successful wound dressings.  Alloderm™ is 
an  autograft that uses acellular matrix cultivated from cadavers.  Integra™ is a temporary 
dressing composed of type I collagen and glycosaminoglycans (chondroitin-6-sulfate).  
Dermagraft™ and TransCyte™ both use cultured neonatal foreskin FBs on synthetic 
polyglactin and nylon fiber, respectively.  Apligraft™ and Orcel™ are both skin 
equivalents made from bovine collagen.  Despite their successes, many of these 
treatments are still expensive, and they do not fully replace damaged skin, thus new 
inroads to the resolution of these problems must be made [188, 190, 194]. 
Electrospinning has great potential for contributing to the field of skin tissue 
engineering.  This process produces scaffolds that are highly conducive to cell 
infiltration, attachment, and activity while also providing structural support for 
regenerating tissues. [185]  Electrospinning allows for the control of pore size and 
polymer diameter and thus provides a greater degree of control over cell infiltration. [28, 
195]  This makes electrospinning relevant to wound healing, as these properties are 
highly desirable in the development of wound dressings. [190]  Electrospun synthetic 
materials, such as polyurethane membranes, already demonstrate effectiveness as wound 
dressings [21].  In addition, electrospun polystyrene scaffolds were found to promote 
natural FB and keratinocyte self-organization in the absence of any external cues. [196] 
Several natural polymers that are important considerations for inclusion in wound 
dressings have been electrospun, including collagen, fibrinogen, and hemoglobin. [19, 21, 
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135]  Recently in our laboratory, the globular proteins hemoglobin and myoglobin were 
successfully electrospun into fibrous mats (figure 3.3).  The significance of this 
achievement, with regard to wound dressings and skin regeneration, is that the inclusion 
of hemoglobin in wound dressings may help to deliver oxygen directly to the healing 
tissues.  Made possible by the high surface area-to-volume ratio of electrospun scaffolds, 
electrospun hemoglobin contains approximately the same number of hemoglobin 
molecules per unit volume as a red blood cell (based on the concentrations of hemoglobin 
electrospun, i.e. 150 mg/mL and 225 mg/mL); thus electrospun hemoglobin mats have 
the potential to supply approximately the same oxygen per unit volume as a functional 
red blood cell. [135] 
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Figure 3.3.  Photograph (top) and scanning electron micrograph (bottom) of a 
hemoglobin scaffold electrospun from a 175 mg/ml solution. 
 
 
 
Blends of natural and synthetic polymers have also been successfully electrospun 
and proven applicable for use in dermal substitutes. [197]  Additionally, electrospun 
materials offer added benefits of drug delivery and controlled release. [198]  Future work 
in this area should focus on combinations of these desirable components into 
multifunctional scaffolds, including incorporation of analgesics for pain relief, 
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hemoglobin for increasing oxygen delivery to healing tissues, and fibrinogen for 
hemostasis and adhesion, and synthetic materials for additional mechanical integrity. 
 
Cartilage.  Articular cartilage is a thin layer of connective tissue covering 
synovial joint surfaces.  In normal physiologic conditions, articular cartilage is porous 
and highly hydrated.  Articular cartilage functions to absorb energy, distribute loads 
uniformly between bones, and provide low-friction articulation. [199]  Cartilage can be 
considered a fiber-reinforced composite material, that is both non-homogeneous and 
anisotropic, consisting of two major structural macromolecules (collagen, mainly type II, 
and proteoglycans), cells, water, and solutes including ions and nutrients. [200, 201]  
Collagen and proteoglycan macromolecules are intertwined to form a solid structure that 
is anchored to the subchondral bone and through which water and solutes move freely in 
and out of the tissue to provide nourishment to the thinly dispersed cells (known as 
chondrocytes) as well as mechanical support and lubrication to the joint.  For normal 
human articular cartilage the compressive modulus is 0.79 MPa and the tensile modulus 
ranges from 0.32 to 10.2 MPa depending upon direction and location (i.e. depth) of 
testing. [200, 202, 203] 
 Mature articular cartilage is aneural, avascular, and alymphatic. [204]  Hence, 
articular cartilage has a limited capacity for repair and regeneration, and in situations of 
trauma, overuse, or misuse, degenerative changes may occur that can eventually lead to 
the development of osteoarthritis (OA). [205]  Early changes seen in OA include a 
disruption in the collagen fiber network (such as loosening), changes in proteoglycan 
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properties (such as disaggregation or swelling), and changes in the collagen-proteoglycan 
interactions. [200]  There are numerous autologous and allogeneic therapies and tissue 
grafts/transplantations that have been investigated for the therapeutic treatment of 
articular cartilage defects, all of which have had varying results. [201, 205-213] 
 Because of the inability of cartilage to regenerate when injured, tissue engineering 
holds much promise in the repair of larger cartilage defects.  The tissue engineering of 
articular cartilage commonly involves using a three-dimensional scaffold onto which 
articular chondrocytes or their precursor cells are seeded (sometimes with the addition of 
growth factors) in order to grow a three-dimensional tissue that can be implanted into the 
joint defect.  The goal is in vitro chondrogenesis within the cell-electrospun scaffold 
construct that matches native in vivo chondrogenesis.  Such in vitro chondrogenesis is 
dependent upon cell type, initial cell density, scaffold characteristics, and culture 
conditions. 
 There are a number of natural materials utilized in scaffold materials to fill 
cartilage defects, including fibrin, agarose and alginate hydrogels, collagen (gels, 
sponges, and fibrous scaffolds), chitosan hydrogels and molded porous structures, and 
hyaluronan. [206, 208-210, 214]  Of the synthetic materials utilized as scaffolds for 
articular cartilage tissue engineering, the most widely used are PLA, PGA, and their 
copolymers. [202, 206, 208-210, 213, 214]  These scaffolds can be produced in the forms 
of foams, hydrogels, woven and nonwoven fiber meshes, or multi-phase structures. [206, 
215]  Though the choice of scaffold has not been agreed upon, there is consensus that 
mechanical stimuli are necessary in the tissue engineering of articular cartilage. [208, 
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216, 217]  Bioreactors have become quite popular since they allow the control of in vitro 
culture conditions (including biochemical factors in the growth medium) and provide 
low-shear mechanical stimuli to cells (figure 3.4). [201, 208, 213, 218]   
 
 
Figure 3.4.  Articular cartilage sample developed from normal human chondrocytes and 
electrospun collagen type II in a slow turning lateral vessel bioreactor. 
 
 
 
 Thus far, many scaffolds tested have not resulted in regenerated tissue with the 
biomechanical or morphological properties native to that of normal articular cartilage. 
[206]  Due to limited availability of suitable donor tissue and the desire to match the 
mechanical properties of the implant with the mechanical requirements in vivo, 
investigators have recently become interested in designing electrospun scaffolds for the 
tissue engineering of articular cartilage.  Type II collagen was first electrospun for 
potential use in cartilage tissue engineering by Matthews et al. using HFP as the solvent 
to produce fibrous scaffolds (with mean fiber diameters of 110 and 1750 nm).  Following 
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cross-linking in GLUT vapors, seeding with normal human articular chondrocytes, and 
two weeks in a rotary cell culture system, there was a nearly confluent layer of cells on 
the external seeded surface with some observable degree of remodeling of the matrix. 
[219]  Shields et al. electrospun type II collagen in HFP; the scaffolds were cross-linked 
with GLUT vapor and seeded with adult human articular chondrocytes (statically 
cultured for 7 days).  Chondrocytes adhere and proliferate throughout the thickness of the 
scaffolds [220].  Our laboratory has recently electrospun type II collagen (extracted from 
fetal bovine articular cartilage) at concentrations between 60 mg/ml and 120 mg/ml in 
HFP resulting in mean fiber diameters ranging from 107 to 446 nm (unpublished data), as 
shown in figure 3.5.  The lower end of these average fiber diameters approach the 80 nm 
fibers that make up native articular cartilage. 
 
    
(b) (c)(a) (d)  
Figure 3.5.  Scanning electron micrographs of electrospun type II collagen at (a) 60 
mg/ml, (b) 80 mg/ml, (c) 100 mg/ml, and (d) 120 mg/ml (1 µm scale bar, 4300X 
magnification). 
 
 
 
Several other materials have also been electrospun for the tissue engineering of 
cartilage.  Bhattatai et al. electrospun alginate-PEO in water solutions to create scaffolds 
with mechanical properties within the range of articular cartilage following cross-linking 
with calcium chloride.  Cellular compatibility was investigated (3 days) with 
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chondrocytes and resulted in the cells attaching well, forming clusters, and maintaining 
their round morphology. [221]  Li et al. electrospun PCL in tetrahydrofuran (THF) and 
dimethylformamide (DMF) (producing 700 nm diameter fibers) to investigate the 
responses of fetal bovine chondrocytes in vitro; the cells appeared round, adhered to and 
extended along the fibers, and expressed cartilage-associated ECM genes. [109]  In 
another study, Li et al. seeded electrospun PCL scaffolds with human bone marrow 
derived MSCs and maintained these in medium supplemented with recombinant human 
transforming growth factor-β1 (TGF-β1) prepared to promote chondrogenesis.  In the 
presence of TGF-β1, the PCL scaffold induced greater expression of sulfated 
glycosaminoglycan synthesis and collagen types II and IX were up-regulated; the cell 
count remained constant after 21 days. [108]  Recently, Li et al. electrospun different 
poly(α-hydroxy ester) polymers, including PGA, PLA, copolymers of the two, and PCL.  
For the PLLA and PCL scaffolds, which had the lowest Young's moduli (uniaxial tensile 
testing) of the polymers investigated and maintained their fibrous structure following a 42 
day degradation analysis, the seeded chondrocytes adhered to the fibers and began 
migrating through pores during the 7 days of incubation. [222]  Shin et al. electrospun the 
copolymer PLGA in DMF and THF (producing a mean fiber diameter of 550 nm and a 
porosity of 81 %).  Tensile testing of dry samples revealed a mean tensile modulus of 
95.5 MPa, a mean ultimate tensile stress of 3.1 MPa, and a mean ultimate tensile strain of 
79 %; there was little degradation of this scaffold even after 7 weeks of incubation. [223]  
Chitosan was mixed with a small amount of PEO in an undisclosed solvent and 
electrospun by Subramanian et al.  Tensile testing of wet samples gave results of 2.3 MPa 
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for the modulus and 0.6 MPa for the ultimate tensile strength.  Following cell seeding, 
canine chondrocytes attached to the fibers of the scaffold; cell growth was not inhibited 
by the electrospinning reagents or process. [224] 
 
Bone.  The skeletal system provides structure to the body, protects internal organs 
and acts as a reservoir of calcium and phosphate.  In spite of its perceived inert role of 
providing rigid structural support, it is extremely plastic in its ability to adapt to ever 
changing loading conditions, and its remarkable ability to regenerate without scar 
formation in adults following injury makes it unique.  However, the intrinsic ability of 
bone to regenerate is limited by the size of the defect.  Early studies established a 
threshold-critical sized defect, beyond which regeneration is limited and fibrous ingrowth 
occurs.  Numerous instances (birth defects, comminuted and non-union fractures, tumor 
resections) occur in clinical practice when the threshold is surpassed and external 
intervention in some form becomes necessary. [225-227] 
The replacement of lost bone tissue has taken a variety of forms: metals, 
ceramics, polymers and bone itself, none of which has proven to be ideal.  Inadequate 
supply and risk of disease transmission limits the use of autografts and allografts.  Metals 
and ceramics replace only the structural function of the lost bone tissue and lack the 
ability to be resorbed, therefore needing to be removed at a later date.  Tissue engineered 
solutions containing cellular components and resorbable electrospun scaffolds offers 
enormous promise to restore tissue function without a need for removal.  Electrospun 
scaffolds are economical, easy to produce and can be fabricated into highly 
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interconnected porous scaffolds that permit cellular infiltration and vascular ingrowth.  
The diversity electrospinning affords has resulted in scaffolds created from both ceramics 
and polymers, and various composites of the two. [228] 
Bioactive glasses are an interesting class of ceramics that can form chemical 
bonds with the host bone at the interface.  Such materials are used in bone replacement 
therapies; predominantly in bulk form.  In one study, a precursor solution containing 
calcium and phosphate was mixed with a high molecular weight polymer (undefined by 
author) and electrospun.  Subsequent heat treatment and calcination decomposed the 
polymer to yield pure HA fibers. [229]  Kim et al., electrospun sol-gel precursor solution 
mixed with polyvinyl butyral to generate nanofibers of HA and fluoridated apatite (fHA).  
The fibers were heated to remove any polymer components and to induce crystallization 
of HA and fHA. [230]  Subsequently, they developed a novel composite by hybridizing 
heat treated electrospun bioactive glass nanofibers with reconstituted type I collagen 
solution.  The sol was processed differently and lyophilized to yield either membranes or 
thick scaffolds.  Incubation of these scaffolds in simulated body fluid for 7 days resulted 
in formation of nanocrystalline carbonated apatites (CA) that were chemically bonded to 
the scaffolds.  Osteoblasts cultured on bioactive scaffolds showed enhanced function 
(alkaline phosphatase assay) compared to those cultured on collagen scaffolds. [231]  
Other ceramics with potential for tissue engineering are the bioinert Alumina and 
stabilized Zirconia, which have been used for total hip replacements because of their 
superior mechanical properties and excellent biocompatibility.  A recent study proved the 
possibility of electrospinning zirconia (2-30 wt%) from an aqueous based suspension of 
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PEO:PEG (1:2 weight ratio), and it would be interesting to observe if the results could be 
exploited in tissue engineering. [232] 
 A number of different polymers have been electrospun for use in bone 
engineering, both synthetic and natural in origin.  PCL has been one of the most popular 
synthetic polymers used for bone engineering scaffolds because of its biocompatibility, 
slow degradation, and the ease of electrospinning from a variety of solvents.  MSCs from 
rats cultured on electrospun PCL scaffolds, supplemented with osteogenic media for 4 
weeks, showed complete penetration of the scaffolds with the formation of multilayers.  
Mineralization and type I collagen were detected by the von Kossa protocol and 
immunostaining, respectively. [47]  Incorporation of calcium carbonate and HA powders 
to the polymer solution have resulted in slight increases in the mechanical properties and 
fiber diameters but have not affected the biocompatibility. [233] 
Another class of synthetic polymers recently electrospun is phosphazenes, which 
were first introduced for tissue engineering applications in the early nineties. [234]  
Laurencin et al., successfully electrospun a solution of polyphosphazene that was loaded 
50-90% w/w with nano-crystalline HA and concluded that incorporation of nano HA 
(nHA) was maximal with a theoretical loading of 50%. [235] 
Chitin is the planet’s second most abundant carbohydrate; chitin and its 
deacetylated product chitosan have been long recognized for their antifungal properties 
and ability to induce protease inhibitors in plants.[236]  Recent evidence points to the 
role of chitin in the induction of interleukins (IL), FBs, and angiogenesis, [237] 
suggesting a role in immunity.  Blends of chitosan and PEO from acetic acid solutions 
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have been successfully electrospun. [238, 239]  A preliminary investigation into a 90:10 
PEO:chitosan blend showed that the scaffold was non-toxic and osteoblast spreading in 
culture was optimal, as evaluated by SEM after 5 days.  The cells developed discrete 
filopodia and exhibited long microvilli on their surfaces, which attached to and grew 
along the polymer nanofibers.  The authors concluded that the cells adhered to and 
maintained characteristic morphology indicative of phenotype. [240] 
Electrospinning of SF solutions blended with PEO was first reported by Jin et al., 
for the generation of submicron sized fibers. [88, 89]  In a later study, SF-PEO based 
blends were electrospun with or without bone morphogenetic protein 2 (BMP-2) and 
nHA, seeded with human MSCs, and cultured for 4 weeks.  Significantly higher levels of 
calcium deposition, DNA content, and elevated levels of mRNA bone marker transcripts 
were observed in silk:PEO scaffolds functionalized with BMP-2 and HA.  These findings 
suggest electrospun silk-based scaffolds can be used as delivery systems for cytokines 
and growth factors. [241] 
 
Vascular Tissue.  The capabilities of electrospinning to mimic the 
microenvironment of a cell are especially important when dealing with vascular grafts.  
The dynamic situation of a blood vessel creates a complicated sequence of events in 
which the walls are stretched and the inner lumen is sheared.  A microenvironment 
capable of withstanding these forces with minimal energy loss is essential for proper 
blood vessel functioning.  Electrospinning of polymer fibers into a vascular conduit has 
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been demonstrated to be a potential technique that not only creates scaffolds simulating 
the ECM, but also contributes tailorable mechanical properties (figure 3.6). 
 
 
Figure 3.6.  1.8 mm I.D. reinforced PDO-elastin tube with imbedded PDS-II suture 
windings for possible use as a small-diameter vascular graft. 
 
 
 
Currently, the most common vascular materials are Dacron (PET) and e-PTFE.  
Dacron is widely known for its use in aortic and iliac grafts.  Its success in these areas of 
the body is due mainly to larger diameters and flow rates, which are not conducive to 
thrombus formation and the subsequent decrease in luminal diameter.  However, for a 
small diameter graft of 5 mm or less, the following properties must be attained for 
successful grafting to occur: biocompatibility, lack of chemical reactivity, very low 
thrombogenicity, porosity, and mechanical strength, including compliance matching that 
of native artery and resistance to aneurysm formation. [59, 242, 243] 
Inner luminal wall thickening and subsequent occlusion and loss of blood flow in 
vascular grafts is one of the most critical concerns when designing a vascular prosthetic.  
Mechanical problems such as compliance mismatch between the natural vessel and 
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prosthetic contribute to this effect, and are a key component to the creation of a 
successful vascular graft.  Recently, our laboratory performed compliance testing of 
electrospun PDO and elastin in an effort to match natural arterial compliance.  Various 
ratios of PDO:Elastin were electrospun and tested in a bioreactor with internal pressures 
changing cyclically from 120 mmHg to 80 mmHg at 60 Hz, where a blend of 50:50 
showed particular promise (figure 3.7) [20].  Vaz et al. selected two different polymers to 
be electrospun together, PCL and PLA, and characterized their properties through 
uniaxial tensile testing. [244]  Testing of the circumferential dilation of electrospun 
segmented polyurethane (SPU) scaffolds by Matsuda et al. demonstrated the dependence 
of scaffold compliance on mandrel rotation, as scaffolds created with a high degree of 
rotation were less compliant. [245]  Enhancement of the mechanical properties of 
electrospun PLLA was demonstrated by Lee et al.  This unique approach to biomaterial 
production involved adding a small quantity of nano-sized montmorillonite (MMT) 
platelets to increase mechanical and physical properties. [246] 
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Figure 3.7.  Compliance determined for a 120/80 mmHg cyclic internal pressure change 
(93.33 mmHg Mean Arterial Pressure (MAP)) for various vascular graft compositions.  
Reprinted from [20]. 
 
 
 
Immunogenicity of the materials must also be taken into consideration so as to 
decrease polymer degradation and protein encapsulation.  A commonly used commercial 
suture, PDS, with good immunological properties was electrospun by Boland et al. [48] 
and mechanically tested at different concentrations.  Others, however, have examined 
scaffold interaction on cell morphology with FBs, SMCs, or ECs. [142] 
Biodegradable nanofiber mesh polymers were developed in one instance to 
maintain the phenotype and functions of hCAECs.  The study found that ECs seeded onto 
electrospun poly(L-lactic acid)-co-poly(epsilon-caprolactone) (P(LLA-CL)) grew in the 
direction of the fiber itself, indicating a potential material for effective endothelialization. 
[247]  PCL and polyurethane (PU) fibers were electrospun on a mandrel and tested for 
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EC attachment; ECs formed monolayers and expressed PECAM-1, a cellular adhesion 
molecule. [248]  However, excessive cellular proliferation can also cause occlusion and 
graft failure.  Mitigation of this aspect was studied by Luong-Van et al. where they used 
PCL fiber mats for controlled delivery of heparin.  It has been suggested that a controlled 
release of heparin to the local adventitial surface of a graft could reduce the severity of 
intimal hyperplasia. [249]  Surface properties of biomaterials, such as surface roughness, 
affect cell behavior and may induce thrombotic clots in some cases.  Researchers have 
found that rough and smooth surfaces will encourage different types of cell adhesion. 
[250]  Xu et al. electrospun PLLA and compared its surface roughness characteristics to a 
solvent cast PLLA scaffold.  The results demonstrated that electrospun PLLA had a 
higher surface roughness than the solvent cast and cell number and attachment was 
greater on solvent cast PLLA than on electrospun PLLA. [250]  This demonstrates that 
through electrospinning and the creation of non-woven fibers, surface roughness and 
cellular adhesion can be significantly altered.   
In addition to using biodegradable and synthetic polymers, vascular graft 
development has incorporated the addition of natural polymers such as collagen (types I 
and III) and elastin, the major components of the native vascular ECM.  Matthews et al. 
successfully electrospun collagen types I, II, and III out of HFP and demonstrated that 
cells seeded onto the scaffolds were viable. [19, 219]  Others have taken this technology 
a step further, combining all ECM components of a blood vessel to create a graft 
material.  Both Boland et al. [59] and Buttafoco et al. [120] electrospun soluble collagen 
and soluble elastin together to form a fibrous vascular graft material  Buttafoco et al. 
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demonstrated that the combination of soluble collagen type I and elastin with a high 
molecular weight polymer such as PEO could allow native polymers to be electrospun 
from non-organic solvents.  Boland et al. investigated soluble collagen types I and III and 
elastin  and the effects of the electrospun structure on cellular culture in a rotary 
bioreactor.  Both studies examined cross-linking methods: GLUT vapor, which can 
sometimes be problematic because of its cytotoxicity [59] and EDC in the presence of 
NHS, which is known to be non-cytotoxic. [120] 
 The chemical composition, construction parameters and biomechanics of a 
vascular graft influence its interaction with its host.  The differences of graft materials, 
porosity, compliance, electrical charge, and surface texture all contribute to the 
magnitude and characteristics of the body’s inevitable “foreign body” reaction. [251]  
The site of anastomosis between relatively compliant arteries and noncompliant grafts 
represents sites of flow disruption and complications with graft construction.  New 
theories on ways to alleviate the problems are being tested, but so far nothing has arisen 
as an efficient replacement. 
 
Urological Tissue.  The need for urinary tract reconstruction can result from a 
large variety of urologic disorders such as stricture disease, cancer, trauma and congenial 
anomalies that may affect the ureters, bladder or urethra.  Complications from inserting 
autologous tissue, such as enteric segments, into the urinary tract are well known and 
often manifest as metabolic and histopathologic abnormalities. These sequelae have 
motivated investigators to search for tissue-engineered alternatives. 
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The first use of electrospun scaffolds in urologic tissue engineering was reported 
in 2004 using a blend of elastin and PLA. [11]  This feasibility study demonstrated that 
electrospun elastin:PLA scaffolds would support the growth of seeded neonatal rat 
BSMs.  BSMs formed single to multiple cell layers with some areas of penetration 
through the scaffold surface. Histological evaluation also demonstrated intense staining 
concentrated beneath the cell-scaffold interface suggesting cellular production of ECM. 
After the initial description of electrospinning fibrinogen [21], preliminary cell 
culture work was done with neonatal rat cardiac FBs (CFB) [78].  In comparison to the 
elastin culture, the CFB migrated into the fibrinogen scaffold more readily.  More 
complete feasibility studies confirmed these preliminary results and demonstrated that 
neonatal rat BSMs (unpublished data) and cardiac FBs rapidly migrated into and 
remodeled electrospun fibrinogen scaffolds with deposition of native collagen fibrils.  
Follow-up studies demonstrated similar results when electrospun fibrinogen scaffolds 
were seeded with human BSMs (unpublished data).  The caveat to these studies was that 
aprotinin, a protease inhibitor, was required to inhibit scaffold degradation during cell 
culture. [77] 
In an effort to develop a scaffold for direct implantation and tissue regeneration, 
rather than in vitro cell culture, composite fibrinogen-PDO electrospun scaffolds were 
investigated (unpublished data).  Blending natural and synthetic polymers has been used 
previously to add structural integrity to electrospun natural polymer scaffolds.  This study 
was able to demonstrate that an electrospun fibrinogen-PDO composite scaffold could 
retain the superior cellular interaction of fibrinogen while producing a product with 
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functional strength for direct implantation.  Uniaxial mechanical testing further 
demonstrated that stress-strain properties could be controlled in a predictable fashion by 
adjusting the polymer concentration ratio.  Animal implantation studies are planned, but 
results are not yet available. 
An acellular urinary bladder matrix has also been described utilizing electrospun 
cellulose. [252]  Electrospinning conditions (solution flow rate and electric field strength) 
were varied to create multilayered scaffolds in a single-step production technique.  
Evaluation by SEM demonstrated a multi-layered scaffold that closely resembled porcine 
bladder ECM (figure 3.8). 
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Figure 3.8.  Cross sectional views of a porcine urinary bladder matrix (top) and an 
electrospun urinary bladder matrix mimicking scaffold composed of cellulose acetate 
(bottom).  Reprinted from [252]. 
 
 
 
Electrospun polystyrene scaffolds have also been evaluated utilizing BSMs. [253]  
These scaffolds were not specifically studied for urologic tissue engineering purposes, 
but they were shown to support BSM growth, and argon plasma treatment resulted in a 
significant improvement in cell attachment after seeding. 
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There is only one report of electrospinning scaffolds for renal tissue engineering. 
[254]  Polyamide was electrospun onto glass coverslips and seeded with normal rat 
kidney (NRK) cells.  NRK cells grown on the electrospun polyamide demonstrated 
increased actin and vinculin fiber formation compared to NRK cells grown on a glass 
coverslip alone.  The NRK cells grown on electrospun polyamide also produced long, 
slender aggregates of beta-1 integrin compared to the classical punctuate, focal adhesions 
seen when cultured on two-dimensional substrates. 
 
Nerve.  The tissue engineering of nerve represents a significant challenge to the 
field of tissue engineering.  Research into understanding and controlling nerve 
regeneration is one of the most urgently needed areas of modern medicine.  The solution 
may lie in the ability of the peripheral nerve to regenerate, or why olfactory neurons are 
the only type of neuron to undergo neogenesis every few weeks.  Either way, perhaps one 
day there will be some breakthrough, and those with nerve injury (including such central 
nervous system injuries as spinal cord) will have some hope at restoring normal function. 
Among the main components of peripheral nerve tissue are unmyelinated or 
myelinated axons, Schwann cells, capillary wall ECs, and connective tissue made up of 
collagen fibers. [255]  It has been suggested that there are four essential components to 
the effective regeneration of peripheral nerve: the use of growth permissive scaffolds, 
stimulatory ECM proteins, the incorporation of growth factors (such as nerve growth 
factor, NGF) and the presence of Schwann cells or glial cells. [256]  Of these, the major 
focus recently has been on scaffold development.   
   103
A vast majority of the focus in nerve regeneration has centered on the creation of 
nerve guidance conduits of various compositions. [257-261]  The use of nerve guides to 
aid nerve regeneration extends back to the late 1800s, when arteries and veins were used 
in nerve repair applications, but these were met with little or no success. [262]  Advances 
in the 1960s led to the use of silicone elastomer tubing, which was able to support 
regeneration in several mammalian species.  Current investigations into the use of 
biodegradable polymers for guidance conduits may offer alternatives to current treatment 
options.  Surprisingly, the application of electrospinning to this field is relatively new.  
Yang, et al. [43] reported in 2005 on the potential of electrospun PLLA in neural 
tissue engineering applications.  This work was expanded upon by Bini et al., [263] who 
reported the use of electrospun PLGA structures that encouraged nerve stem cell 
attachment and differentiation.  They compared cell adhesion and differentiation between 
electrospun, microbraided, and polymer film scaffolds, and they found that cells appeared 
to adhere to the electrospun scaffolds better than the film.  Furthermore, they found that 
micron-sized scaffolds (microbraided, not electrospun) that demonstrated a high degree 
of alignment encouraged the stem cells to grow in the direction of the fiber alignment, 
whereas on the electrospun nano-scale fibers, a more random orientation was noted.  In a 
separate manuscript, Bini et al. [264] reported on the use of electrospun PLGA guidance 
conduits in a rat sciatic nerve model.  However, results were not highly encouraging, with 
successful regeneration occurring in less than 50% of the animals. 
The most effective efforts in nerve tissue engineering may be due to the 
mimicking of the ECM through the use of natural materials and electrospinning.  
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Recently, Schnell et al. reported on the ability of electrospun PCL and Collagen-PCL 
fibers to promote peripheral nerve regeneration. [265]  They demonstrated that, while 
both groups promoted neurite outgrowth and glial migration, the blended collagen-PCL 
constructs improved Schwann cell migration and neurite orientation, providing further 
evidence that bioactivity improves cell-matrix interaction. 
Finally, another consideration is the potential use of electrospun fibers for 
sustained release of NGF, which may offer additional help to the regenerating peripheral 
nerve. [198, 266]  Perhaps the combination of electrospinning natural and synthetic 
polymer blends with the controlled addition of growth factors would be a well-advised 
change in focus for this area of tissue engineering. 
 
Ligament.  Native human ligament, due to its extremely limited repair capacity, 
and high occurrence of injury, has a large need for a tissue-engineered solution.  It is 
estimated that more than 100,000 anterior cruciate ligament (ACL) reconstruction 
surgeries are performed each year in the United States, with the current options being 
cadaver allografts, autografts (patellar tendon, hamstring tendon), and synthetic grafts 
(Gore-Tex, Stryker-Dacron, etc.).  However, none of these are ideal, and each has its own 
set of limitations: allografts are limited in number, and have the potential for infectious 
disease transfer, autografts are limited by donor site morbidity, and synthetic grafts 
exhibit poor long-term outcomes due to mechanical mismatch, poor abrasion resistance, 
and limited natural tissue integration. [267-271] 
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From a compositional standpoint, ligament is essentially a grouping of cross-
linked collagen fibrils (70-80% type I by dry weight) bundled together with an 
orientation parallel to the direction of loading.  It also contains some elastin, 
proteoglycans, and FBs. [268, 271-273]  These components come together to form an 
extremely durable, anisotropic tissue essential for joint stabilization and the limitation of 
abnormal motion of the joint.  Ideal tissue engineered grafts would have the ability to 
match the mechanical durability of native ACL, which on average will undergo a cyclic 
load of 300 N, nearly 1.5 million times a year. [268]  In addition to mechanical durability, 
the graft would need to be porous to allow for cellular penetration and native tissue 
integration, critical to in situ repair and maintenance.  It would also need to be 
bioresorbable at a rate which prevents stress shielding of surrounding tissues, eventually 
giving way to complete load bearing by native ligamentous tissue. [267, 269, 272] 
There have been several preliminary attempts at creating fibrous tissue engineered 
ACL grafts utilizing electrospinning due to its high surface area to volume ratio, which is 
preferable for cellular infiltration.  Bashur et al. [274] used electrospun PLGA fibers of 
various diameters and orientations to investigate the regulation of cell morphology.  They 
determined that cells aligned themselves along the direction of fiber orientation.  
Additionally, cell spreading increased with increased fiber orientation.  These findings 
show that electrospinning can effectively create an organized matrix for cellular 
infiltration, and bodes well for ligament engineering as poor mechanical properties of 
repaired ligament tissue are often associated with a disorganized ECM.  Lee et al. [275] 
electrospun PU nanofibers and demonstrated that the morphology of human ligament 
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fibroblasts (hLF) has a direct impact on the amount of ECM they produce, with spindle 
shaped, oriented cells producing more collagen than randomly oriented cells.  In an 
attempt to recreate their in vivo environment they also cyclically strained the hLF seeded 
scaffolds in the direction of their alignment, revealing that strained scaffolds produced 
150% more collagen than unstrained scaffolds.  Sahoo et al. [276] electrospun PLGA 
nanofibers onto a microfibrous knit PLGA scaffold, acting as a mechanical backbone, in 
order to create a strong structure with the potential for rapid cellular infiltration.  Using 
bone marrow stromal cells they were able to demonstrate that the nanofibrous coating 
promoted cell attachment and proliferation.  The cells on these nano-microfibrous 
scaffolds produced more collagen than an equivalent number of cells cultured on a 
knitted microfibrous scaffold without an electrospun coating.  
 
CONCLUSION 
 
While there is still much work to be done in electrospinning tissue scaffolds, 
preliminary results have been promising, especially from the standpoint of cell 
morphology and ECM production.  There are still questions about the ability of 
electrospinning to produce scaffolds that can withstand the mechanical rigors inherent to 
tissue grafts, however the process’s compatibility with a wide array of polymers and the 
potential to create nano-microfibrous constructs allows for a large number of different 
mechanically viable possibilities.  The potential of electrospinning as a means to create 
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effective ECM analogue scaffolds is not limited to the select tissues listed here, and there 
are numerous other possibilities, including cardiac, corneal, and esophageal tissues. 
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CHAPTER 4 Electrospinning PDO and Elastin Blends 
 
Preface: The following manuscript appeared in Biomedical Materials, 2006, volume 1, 
pages 72-80 [20].  The work included demonstrates the potential of combining PDO and 
elastin to produce a structure that could be used as a vascular grafting material. 
Scaffolds were created by mixing solutions of PDO and elastin prior to electrospinning in 
a number of different v/v ratios.  Electrospun tubular scaffolds were then evaluated using 
a number of different vascular specific mechanical tests, exhibiting tailorable mechanical 
properties similar to those of native vessel. 
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ABSTRACT 
 
An electrospun cardiovascular graft composed of polydioxanone (PDO) and elastin has 
been designed and fabricated with mechanical properties to more closely match those of 
native arterial tissue, while remaining conducive to tissue regeneration.  PDO was chosen 
to provide mechanical integrity to the prosthetic, while elastin provides elasticity and 
bioactivity (to promote regeneration in vitro/in situ).  It is the elastic nature of elastin that 
dominates the low-strain mechanical response of the vessel to blood flow and prevents 
pulsatile energy from being dissipated as heat.  Uniaxial tensile and suture retention tests 
were performed on the electrospun grafts to demonstrate the similarities of the 
mechanical properties between the grafts and native vessel.  Dynamic compliance 
measurements produced values that ranged from 1.2 to 5.6 %/100 mmHg for a set of 
three different MAPs.  Results showed the 50:50 ratio to closely mimic the compliance of 
native femoral artery, while grafts that contained less elastin exceeded the suture 
retention strength of native vessel.  Preliminary cell culture studies showed the elastin-
containing grafts to be bioactive as cells migrated through their full thickness within 
seven days, but failed to migrate into pure PDO scaffolds.  The electrospinning of the 
PDO and elastin blended composite into a conduit for use as a small diameter vascular 
graft has extreme potential and warrants further investigation as it thus far compares 
favorably to native vessel. 
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INTRODUCTION 
 
CVD, specifically coronary artery disease resulting from arteriosclerosis, remains 
one of the leading causes of death in the United States.  Arteriosclerosis is a vascular 
disease that is characterized by thickening of the arterial wall and the subsequent 
decrease in the arterial lumen leading to eventual decrease or loss of circulation distal to 
the disease site.  Once blood flow is compromised, vascular bypass is an option to restore 
blood flow to tissues distal to the restriction or blockage.  In 2000 there were an 
estimated 519,000 coronary bypass surgeries performed [59], which typically involve the 
replacement of a coronary artery with an autologous saphenous vein or internal mammary 
artery.  While these autologous alternatives perform at an acceptable patency level, they 
are not always a viable option as the vessels may themselves be diseased if the patient 
suffers from peripheral vascular disease, which in its own right affects upwards of 12 
million Americans with significant associated mortality, or a previous bypass operation 
may have already required their use [106].  Synthetic vessels made of expanded e-PTFE 
and woven or knitted PET fibers (Dacron®) have been utilized as bypass grafts for 
peripheral arteries for quite some time.  These graft materials function adequately as 
medium (6-10 mm internal diameter, ID) and large (> 10 mm ID) prosthetics in areas 
where there is high flow and low resistance.  The functionality of these synthetic 
polymers as small diameter vessels (< 6 mm ID), such as the popliteal arteries, leaves 
much to be desired.  In these low flow situations, synthetics have proven to be much 
more prone to thrombus formation and intimal hyperplasia [59, 106-110]. 
   112
 A synthetic vascular prosthetic would need to meet several performance criteria 
requisite to being considered ideal.  These include ease of handling, suture retention, ease 
of suture placement, flexibility with kink resistance, biocompatibility, non-
thrombogenicity, maintained durability post implantation and incorporation into 
surrounding tissue, compliance matching that of native artery, and resistance to aneurysm 
formation.  From a production standpoint, the prosthetic must be easy to manufacture in a 
variety of different lengths and diameters, and must not require any complex storage 
protocol.  This must all be accomplished while keeping the prosthetic economical and 
affordable [59, 107, 277]. 
 The authors believe that electrospinning is a viable option for the fabrication of 
tissue engineered vascular grafts.  Through electrospinning, our lab has successfully 
created seamless, non-woven fibrous structures of various geometries and sizes from an 
assortment of natural and synthetic polymers.  The process used in this study has been 
previously described in detail in prior publications [19, 42, 48, 59, 77, 142, 219, 278].  
Briefly, electrospinning requires a large electric potential to be applied to a polymer 
solution.  An oppositely charged target is placed a set distance (air gap) from the charged 
polymer solution to create a static electric field.  When the electric potential reaches a 
critical level, and the electrostatic forces within the solution overcome the surface tension 
of the solution, a fine jet of entangled polymer chains is drawn from the solution.  As this 
jet travels through the air gap towards the target, solvent evaporation occurs, leaving a 
dry fiber.  This fiber is then collected by the target, the translation/rotation of which 
controls the structural characteristics of the scaffold. 
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 Native artery is an extremely complex tissue with unique biomechanical 
characteristics.  In order to withstand the high flow rate, high pressure, and pulsatile 
nature of blood flow, artery is comprised of three distinct layers with three distinct 
compositions.  The innermost layer, immediately surrounding the lumen, is known as the 
intima and is made of a single layer of ECs on a basement membrane composed of 
collagen type IV and elastin.  This layer contacts the bloodstream and therefore provides 
a critical barrier to platelet activation.  The thick middle layer, the media, is composed of 
several layers of MCs in a matrix of collagen types I and III, elastin, and proteoglycans.  
The outermost adventitial layer is made of FBs and randomly arranged collagen type I 
[59, 118].  Throughout the artery, SMC’s maintain vascular tone, while the collagens 
provide tensile support and prevent vessel rupture, and elastin fibers confer elasticity to 
the vessel and provide the ability to recover from pulsatile deformations [120, 121].  It is 
the elastic nature of elastin that dominates the low-strain mechanical response of the 
vessel to blood flow and prevents pulsatile energy from being dissipated as heat [122]. 
 With mechanical integrity being paramount to vascular graft success, it is obvious 
that an electrospun tissue engineered prosthesis would need to include a component 
capable of withstanding the rigors of circulation.  While collagen fills this role in native 
vessel, its electrospun form lacks the strength and durability required [19, 219].  For this 
reason, PDO was chosen to be the major mechanical backbone of our tissue engineered 
vessel.  PDO (Ethicon, Inc.) is a colorless, crystalline, bioabsorbable polymer that is 
currently in use as a commercially available wound closure suture.  As a suture, PDO is 
highly flexible with excellent strength retention and shape memory, and a lower 
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inflammatory response and slower absorption rates than sutures composed of PGA and 
PGLA.  Successful electrospinning of PDO has been performed in our lab previously, 
with promising mechanical results [48].  Elastin was incorporated into the graft to 
provide elasticity and bioactivity (i.e. to promote regeneration in vitro/in situ). 
 While mechanical integrity is of utmost importance, particularly in high pressure 
vessels to maintain suture placement and prevent aneurysm, compliance is of equal or 
greater importance in small diameter vessels, where diminished pulsatile flow can lead to 
flow stagnation and graft thrombosis.  The compliant nature of native vessel actually 
assists in pushing blood through the circulation.  In addition, the occurrence of intimal 
hyperplasia has been closely tied to the mismatch of graft and adjacent arterial 
compliance [107-109, 279].  This mismatch creates abnormal cyclical strains which trap 
activated platelets through anastomotic flow disturbance.  These activated platelets 
release mitogens that stimulate perianastomotic SMCs, leading to a thickening of the 
arterial wall at the anastomosis (typically at the distal end) and a narrowing of the lumen 
[279]. 
 This study created a non-woven scaffold for potential use as a vascular graft 
composed of electrospun blended nanofibrous PDO and elastin.  A number of mechanical 
tests were performed to demonstrate the material to have sufficient mechanical integrity 
to resist aneurysm and compliance matching that of native artery.  In vitro cell culture 
studies were performed to evaluate cell affinity towards the elastin containing scaffolds, 
and the potential for in vivo tissue regeneration. 
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MATERIALS AND METHODS 
 
Electrospinning.  Concentrations of 100 mg/mL of PDO (Ethicon, Inc.) and 200 
mg/mL of elastin from bovine neck ligament (Elastin Products Co., Inc.) were dissolved 
in HFP (Sigma Aldrich Co.) and blended in ratios of 100:0, 90:10, 80:20, 70:30, 60:40, 
and 50:50 (PDO:Elastin).  These solutions were then loaded into a Becton Dickinson 
syringe (either 3.0 or 5.0 mL) with an 18 gauge blunt tip needle and placed in a KD 
Scientific syringe pump to be dispensed at a rate between 4 and 8 mL/h, depending on the 
amount of elastin included in the solution (higher elastin equates to lower rate).  
Solutions were then electrospun onto a rotating flat mandrel (2.5 cm wide x 10.2 cm long 
x 0.3 cm thick) to produce a flat sheet with a random fiber orientation for scaffold 
characterization, uniaxial tensile testing, and preliminary cell culture.  The same solutions 
were also electrospun on a rotating tubular mandrel to produce a seamless vascular graft 
with an internal diameter of 6 mm and a wall thickness of approximately 350 microns for 
suture retention testing and compliance measurement.  All electrospinning was performed 
with an applied voltage of 22 kV, while the mandrel was rotated at a rate of 500 
revolutions per minute (RPM) and placed 12 cm away from the needle tip. 
 
Scaffold Characterization.  Scaffold characterization was performed using SEM 
on small pieces cut from the electrospun mats (SEM, JEOL JSM-820 JE Electron 
Microscope).  SEM images were digitized with a Hewlett-Packard Scanjet 5550c flatbed 
scanner and analyzed with ImageTool 3.0 software (Shareware provided by UTHSCSA).  
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Characterization included determining the average fiber diameter for the electrospun 
structure by taking the average of 60 measurements chosen randomly from across the 
image.  In addition, the average pore area, which at this point is still a rather subjective 
measurement, was taken by measuring the circumference of 60 different pores from 
across the image.  For all of the measurements made from the SEM images, calibration of 
the ImageTool software was done with the scale bar on each image. 
 
Uniaxial Tensile Testing.  Uniaxial tensile testing was performed to failure on 
dry samples, to determine handling characteristics, and hydrated samples (soaked in PBS 
for 24 hours at 37°C), to mimic physiological conditions.  “Dog-bone” shaped samples 
were cut from the electrospun mat (2.75mm wide at their narrowest point with a gage 
length of 7.5 mm) and tested on a MTS Bionix 200 testing system with a 50 N load cell 
(MTS Systems Corp.) and an extension rate of 10.0 mm/min.  Elastic modulus, peak 
stress, and strain at failure were calculated by the MTS software TestWorks 4.0 and 
recorded. 
 
Preliminary Cell Culture.  To evaluate preliminary cell interaction, three 
circular discs (5.9 mm in diameter) were punched from scaffolds of four different 
electrospun ratios (100:0, 90:10, 70:30, and 50:50), disinfected (by soaking in ethanol for 
10 minutes followed by repeated rinses in PBS), and placed in a 96-well plate.  Each disc 
was then seeded with human dermal FBs at a concentration of 50,000 cells/mL.  
Dulbecco’s Modified Eagle Medium with Nutrient Mixture F-12 (Invitrogen Corp.) 
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supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomyocin 
(10,000 Units/ml each, Gibco BRL Life Technologies) was added in the center of each 
scaffold (100 µL of cells in media incubated for 45 minutes and followed by 100 µL of 
media).  The scaffolds were then statically cultured under standard culture conditions 
(37°C and 5% CO2) in an incubator.  One disc of each ratio was removed after 24 hours 
for SEM analysis, while the others were left in culture for seven days, fixed in 10% 
formalin, and processed for histology (Hematoxylin and Eosin staining, H&E). 
 
Suture Retention Testing.  Suture retention testing was performed on 6 mm 
inner diameter tubular specimens, both dry and soaked in PBS for 24 hours at 37°C, on a 
MTS Bionix 200 testing system with a 50 N load cell (MTS Systems Corp.) and an 
extension rate of 150.0 mm/min in accordance with the straight across procedure 
described in section 8.8 of the American National Standards Institute (ANSI)/Association 
for the Advancement of Medical Instrumentation (AAMI) ANSI/AAMI VP20:1994 
entitled “Cardiovascular Implants – Vascular Graft Prostheses” [280].  5.0 commercial 
PDS™ II violet monofilament suture (Ethicon, Inc.) was placed 2 mm from the end of the 
sample and extended until the suture had pulled through the graft 
 
Compliance Measurement.  Dynamic compliance was determined for 6 mm 
inner diameter tubular grafts under simulated physiological conditions in accordance with 
section 8.10 of ANSI/AAMI VP20:1994 [280].  The specimens were tested in an 
Intelligent Tissue Engineering via Mechanical Stimulation (ITEMS™) Bioreactor 
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developed by Tissue Growth Technologies (Minnetonka, MN) filled with PBS at 37°C.  
The bioreactor provided a cyclic (1 Hz, representing 60 beats per minute) pressure 
change to the inside of the graft; three different pressure levels (90/50, 120/80, and 
150/110 mmHg) were investigated to produce a range of MAPs.  MAP is defined as 
)(
3
1
DSD PPPMAP −+=       (4.1) 
where PD is the diastolic pressure and PS is the systolic pressure [281].  The MAPs tested 
in this experiment ranged from 63.33 mmHg to 123.33 mmHg (in accordance with 
section 8.10 of ANSI/AAMI VP20:1994 [280]), while physiological values for MAP are 
typically between 50 and 150 mmHg [282]. 
Grafts were also subjected to a pressure change of 80-120 mmHg for two hours to 
observe any change in compliance over that time.  Internal pressure was measured with a 
pressure transducer capable of measuring dynamic pressure up to 200 ± 2 mmHg, while 
the external diameter was recorded with a laser micrometer system with an accuracy of ± 
0.001 mm.  Prior to insertion into the bioreactor, the grafts were soaked in PBS at 37°C 
for 24 hours, after which time their average wall thickness was measured.  From this the 
internal radii of the graft was determined and used in the following equation to calculate 
compliance for each specimen: 
( ) 412
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Compliance PPP      (4.2) 
Where R is the internal radius, P1 is the lower internal pressure, and P2 is the higher 
internal pressure [280].  It was found that the pure PDO graft leaked through the pores 
under pressure, resulting in an inaccurate negative compliance.  To counteract 
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phenomenon, the graft was lined with a latex balloon far more compliant than the graft 
itself, as recommended in section 8.10.2 of ANSI/AAMI VP20:1994 [280]  Under 
pressure the balloon expanded and mated tightly to the internal surface of the graft to 
prevent leakage. 
 
Statistical Analysis.  Unless otherwise stated, all statistical analysis was based on 
a Kruskal-Wallis one way analysis of variance (ANOVA) on ranks and a Tukey-Kramer 
pair-wise multiple comparison procedure (α=0.05) performed with the JMP®IN 4.0.3 
statistical software package (SAS Institute, Inc). 
 
RESULTS AND DISCUSSION 
 
Scaffold Characterization.  Analysis via SEM revealed that all ratios of PDO to 
elastin were successfully electrospun into thin scaffolds composed of small diameter 
fibers (figure 4.1).  It should be noted that the elastin forms ribbon-like (flat and thin) 
fibers while the PDO forms more typical round fibers.  This is most evident in the 50:50 
ratio, where a large number of ribbon-like fibers are clearly seen.  This unique 
electrospun elastin characteristic may have led to some skewing of the measured average 
fiber diameter values (figure 4.2) depending on the orientation of the fiber.  As the graph 
shows, fiber diameter decreases a statistically significant amount from the maximum at 
the 100:0 ratio to a minimum value for the 80:20 ratio.  The diameter then increases an 
insignificant amount over the 100:0 ratio for the 70:30, and 60:40 ratios, with a 
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statistically significant increase for the 50:50 ratio over the previous ratios.  This may be 
caused by a decrease in the amount of large, round PDO fibers and a transition to more 
flat, wide elastin fibers.  As was expected, the pure PDO scaffold having the largest fiber 
diameter had the largest mean pore area, with the other ratios all having significantly 
smaller pores.   
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C D
  
E F 
Figure 4.1.  Scanning electron micrographs of electrospun PDO and elastin with ratios of 
100:0 (A), 90:10 (B), 80:20 (C), 70:30 (D), 60:40 (E), and 50:50 (F).  All micrographs 
were taken at x2000 magnification, and the scale bar is equivalent to 10 microns. 
 
   122
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
100:0 90:10 80:20 70:30 60:40 50:50
PDO:Elastin Ratio
Av
er
ag
e 
Fi
be
r 
Di
am
et
er
 (m
ic
ro
ns
)
0
1
2
3
4
5
6
7
8
9
10
100:0 90:10 80:20 70:30 60:40 50:50
PDO:Elastin Ratio
Av
er
ag
e 
P
or
e 
Ar
ea
 (S
q.
 M
ic
ro
ns
)
 
Figure 4.2.  Graphs depicting the average fiber diameter (top) and pore area (bottom) for 
electrospun PDO:Elastin scaffolds. 
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Uniaxial Tensile Testing.  The results of the mechanical testing of the 
electrospun PDO:elastin specimens can be seen in figure 4.3.  Statistical analysis showed 
that the only significant difference between dry and hydrated peak stresses within a single 
ratio was with the 80:20 ratio, as all other ratios experienced insignificant differences 
going from the dry state to a hydrated one.  The hydrated pure PDO scaffold experienced 
significantly higher peak stress than the three ratios with the lowest amounts of PDO, and 
the 60:40 and 50:50 ratios were significantly lower than the other four scaffolds.  The 
70:30 ratio stood alone, and was significantly different from all others.  As the amount of 
PDO within a scaffold decreased the overall strength of the scaffold decreased.  This 
result was expected because of the excellent strength of PDO and its inclusion as the 
mechanical backbone of the scaffold. 
The trend seen in the dry moduli was rather surprising as there was a sudden 
significant decrease in modulus with the inclusion of elastin into the scaffold, followed 
by a steady significant increase of modulus as the amount of elastin was increased to the 
60:40 ratio.  The dry 50:50 ratio was not significantly different from the pure electrospun 
PDO scaffold.  It is hypothesized that the initial decrease in modulus may have been 
caused by the inclusion of elastin fibers that were too few in number to contribute to the 
scaffold’s overall elasticity and actually decreased the elastic integrity of the scaffold.  
The gradual increase represents some sort of transition from the highly elastic, strong 
PDO fibers to the highly elastic, but overall weaker elastin fibers dominating the 
mechanical characteristics of the scaffold.  This will need to be investigated further in 
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future work.  Soaking of the scaffolds had a significant negative effect on the modulus of 
the hydrated samples as, unlike the peak stress values, there were significant differences 
in the modulus of elasticity for all ratios between dry and hydrated specimens, with the 
dry specimens exhibiting a much higher modulus than their hydrated counterparts.  The 
hydrated pure PDO scaffold exhibited a significantly reduced modulus compared to the 
dry scaffold; however it remained significantly larger than all of the hydrated elastin-
containing specimens.  The trend seen in the dry specimens was upheld in the hydrated 
specimens albeit with reduced values, as the modulus of the 50:50 ratio was significantly 
greater than those of the other scaffolds where elastin was present.  However, unlike the 
dry specimens, the hydrated 50:50 ratio was significantly different from the pure PDO.  
The strain at break trends were consistent with previous uniaxial testing performed on 
PDO scaffolds [48].  Pure PDO scaffolds had the highest mean strain at break values for 
both the dry and hydrated specimens.  This value then decreased with decreasing amounts 
of PDO contained in the scaffold.  Strain at break values of the hydrated samples of the 
90:10, 80:20, and 70:30 ratios were significantly higher than the corresponding dry 
samples, and there was an overall trend of hydrated values being larger than those of dry 
scaffolds that contained elastin.  
While the peak stress and strain at break of the pure PDO scaffolds were 
significantly reduced with the addition of elastin, this reduction may actually enhance the 
attractiveness of PDO:Elastin blends for use in vascular applications.  Table 4.1 shows 
the mechanical properties of hydrated PDO:Elastin scaffolds of various ratios compared 
to the mechanical properties of native femoral artery.  Note that the pure electrospun 
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PDO scaffold had larger values than the femoral artery for all parameters investigated 
(modulus, ultimate stress, and strain at failure).  It is also of interest that the more elastin 
present in the scaffold, the closer the values come to that of native artery.  The 
mechanical properties of the 50:50 ratio fell within the range of the femoral artery values 
in nearly every instance, the only exception being that the electrospun scaffold exhibited 
higher ultimate stresses than the native vessel.  This matching of mechanical properties 
may aid in reducing compliance mismatch between an electrospun graft and the native 
vasculature. 
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Figure 4.3.  Mechanical properties for dry and hydrated samples of electrospun 
PDO:Elastin scaffolds of various ratios. 
 
   127
Table 4.1.  Mechanical properties of hydrated electrospun scaffolds of various 
PDO:Elastin ratios compared to native femoral artery [283, 284] and e-PTFE [285]. 
 
Graft Material Elastic Modulus (MPa) 
Ultimate Stress 
(MPa) 
Strain at Failure 
(%) 
Femoral Artery 9 – 12 1 - 2 63 – 76 
e-PTFE (30 micron 
internodal distance) 42 – 60 6 - 15 20 - 30 
PDO (100:0) 19.98 ± 0.74 5.57 ± 0.7 206.33 ± 38.96 
90:10 5.2 ± 0.35 5.1 ± 0.34 193.75 ± 12.48 
80:20 5.73 ± 0.77 5.3 ± 0.76 126.7 ± 15.05 
70:30 4.89 ± 0.59 4.17 ± 0.45 114.45 ± 4.37 
60:40 6.0 ± 0.87 3.22 ± 0.42 77.95 ± 7.01 
50:50 9.64 ± 0.66 3.25 ± 0.24 64.93 ± 3.97 
 
 
Preliminary Cell Culture.  Micrographs of scaffolds that had been cultured for 
24 hours (figure 4.4) revealed that cells migrated into the fibrous networks of the 90:10, 
70:30, and 50:50 ratios, while the human dermal FBs remained on the surface of the pure 
PDO scaffold after 24 hours.  Histology performed at seven days in culture (figure 4.4) 
showed that the cells penetrated the full thickness of the elastin containing scaffolds, with 
no penetration of the pure PDO scaffold.  This finding suggests that the inclusion of 
elastin into the electrospun scaffolds does in fact improve the in vitro bioactivity of the 
matrix through either chemical (cells recognizing elastin as a native ECM material) or 
mechanical (cells sense desirable, native-like mechanical properties of fibrous ECM) 
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signaling, or a combination of the two.  This will have to be investigated further in future 
studies.  At this point it does appear that elastin serves as a stimulus for the transduction 
of cellular signals to enhance the migration of the cells.  
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Figure 4.4.  (Left) Scanning electron micrographs of electrospun scaffolds after one day 
in culture of pure PDO (A), 90:10 ratio of PDO to elastin (B), 70:30 ratio (C), and 50:50 
ratio (D).  (Right) Histology performed after seven days in culture for corresponding 
ratios (20x). 
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Suture Retention Testing.  Suture retention testing on both dry and hydrated 
specimens resulted in retention strengths between those of saphenous vein [286] and e-
PTFE, two of the most common vascular grafting materials in clinical use today (figure 
4.5).  For all ratios except the 50:50, the retention strengths of the hydrated samples were 
significantly less than the retention strengths of the dry samples.  This was somewhat 
surprising as the differences in peak stress between dry and hydrated samples were, for 
the most part, insignificant during uniaxial tensile tests.  While there was no significant 
difference between the hydrated and dry 50:50 ratio, this particular ratio experienced 
suture retention strengths that were overall significantly less than the other ratios, as well 
as that of the saphenous vein.  Overall, three of the ratios (100:0, 90:10, and 80:20) tested 
in a hydrated state surpassed the requisite 375 gram force needed for suture pullout of 
native arterial structures utilizing 5-0 suture [287], i.e. native tissue at the anastomosis 
would fail before the electrospun graft at these ratios.   
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Figure 4.5.  Suture retention strengths for electrospun PDO:Elastin ratios, e-PTFE 
vascular graft, and native saphenous vein.  Saphenous vein data from [286]. 
 
 
 
Compliance Measurement.  Testing graft compliance at three different pressure 
levels produced the data found in figure 4.6.  As stated previously, this data was recorded 
after the graft had been subjected to each pressure level for 30 minutes to allow for 
equilibrium to be achieved.  As expected, pure PDO grafts had the lowest compliance, 
while those grafts that contained elastin exhibited significantly greater compliance, with 
the 50:50 ratio being the most compliant.  Interestingly, as the MAP was increased the 
compliance of the elastin containing grafts decreased.  However, this trend is concurrent 
with the behavior of native arteries, particularly the large elastic arteries, where 
compliance decreases with increasing blood pressure [288].   
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Figure 4.6.  Compliance determined from internal radii at three different MAPs (90/50, 
120/80, and 150/110 mmHg).  All measurements were taken after the graft had been 
subjected to the target pressure for 30 minutes to allow for stabilization. 
 
 
 
Compliance of the electrospun grafts was also determined for the 120/80 mmHg 
(93.33 mmHg MAP) pressure level at a time of 0 hours, 1 hour, and 2 hours (figure 4.7).  
Again, the pure PDO grafts had the lowest compliance, with the elastin containing ratios 
being significantly greater.  There was a general trend of compliance increasing as the 
amount of elastin contained in the graft increased.  The exception to this was the 60:40 
ratio, where compliance values do not follow the same trend.  This is unexplainable at 
this time, but may have simply been an aberration.  There was also a trend of compliance 
falling off a significant amount after the initial measurement was taken at time zero for 
the elastin containing grafts.  The 60:40, 70:30, and 90:10 all experienced a significant 
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decrease in compliance between the 0 hour and 1 hour measurements.  This may be due 
to some amount of stiffening of the elastin fibers as they adjusted to being subjected to a 
sustained cyclic load.  Of note is the behavior of the pure PDO graft, which actually 
became more compliant as time progressed.  This may be due to the polymer fibers 
plasticizing under loading. 
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Figure 4.7.  Compliance calculated from the graft’s internal radius at internal pressures 
of 120/80 mmHg at times of 0, 1, and 2 hours. 
 
 
 
Figure 4.8 compares the compliance values determined for the electrospun 
PDO:Elastin grafts to the compliance values of native artery and vein, as well as the 
common vascular graft materials Dacron® and e-PTFE.  The range of compliances 
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achieved for the elastin containing grafts included the values for both artery and vein, 
with the 50:50 ratio significantly exceeding that of native artery.   
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Figure 4.8.  Compliance determined for 120/80 mmHg pressure level (93.33 mmHg 
MAP) for various vascular graft compositions.  Values for artery, vein, Dacron®, and e-
PTFE were obtained from [279]. 
 
 
 
CONCLUSION 
 
In conclusion, an electrospun cardiovascular graft composed of non-woven, sub-
micron scale PDO and elastin fibers was successfully designed and fabricated with a 
range of mechanical properties that included those of native arterial tissue.  These 
   135
properties proved to be easily tailorable by varying the amount of elastin.  These 
scaffolds hold the potential to be conducive to tissue regeneration based on the results of 
the in vitro cell culture study.  While many researchers have published promising in vitro 
results on numerous vascular graft materials, what sets this study apart is the 
incorporation of the native-like elastin nanofibers.  This study has shown that the 
presence of elastin not only vastly improves cellular response to the graft, but also 
positively contributes to the mechanical behavior of the graft through the same 
mechanisms as in native vessel.  We believe that the promising results obtained herein 
will have successfully laid the groundwork for future in vivo testing of these grafts.
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CHAPTER 5 Electrospinning PDO and Fibrinogen Blends 
 
Preface: The following manuscript appeared in the Journal of Engineered Fibers and 
Fabrics, 2008, volume 3, pages 12-21 [180]. The work included demonstrates the 
efficacy of combining natural (fibrinogen) and synthetic (PDO) polymers together in the 
same scaffold to produce a structure with both tailorable mechanical properties and 
bioactivity. Scaffolds were created through the use of a 2-1 nozzle rather than mixing 
solutions together in the same syringe prior to electrospinning.  The author’s role in this 
work included the design of the nozzle and the fabrication and mechanical evaluation of 
the scaffolds. 
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ABSTRACT 
 
Our objective is to demonstrate an electrospun fibrinogen-PDO composite scaffold will 
retain the superior cellular interaction of fibrinogen while producing a product with the 
functional strength needed for direct implantation.  Fibrinogen-PDO composite scaffolds 
were electrospun with PDO ratios of 0% (pure fibrinogen), 10%, 20%, 30%, 40%, 50% 
and 100% (pure PDO) and disinfected using standard methods.  Scaffolds were seeded 
with human BSM per scaffold and incubated with twice weekly media changes.  Samples 
were removed at 7, 14 and 21 days for evaluation by collagen assay, SEM and histology.  
Cell seeding and culture demonstrated human BSM readily migrate throughout and 
remodel electrospun fibrinogen-PDO composite scaffolds with deposition of native 
collagen.  Cell migration and collagen deposition increased with increasing fibrinogen 
concentration while scaffold integrity increased with increasing PDO concentration.  
Electrospun fibrinogen-PDO composite structures promote rapid cellular in-growth by 
human BSM while maintaining structural integrity.  The fibrinogen to PDO ratio can be 
adjusted to achieve the desired properties required for a specific tissue engineering 
application.  Our ultimate objective is to utilize this innovative biomaterial technology to 
produce an acellular, bioresorbable product that enables in situ tissue regeneration.  
While there is still much work to be done, these initial findings indicate fibrinogen-PDO 
composite scaffolds deserve further investigation. 
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INTRODUCTION 
 
The need for urinary tract reconstruction can result from a large variety of 
urologic disorders such as congenital hypospadias, stricture disease, cancer and trauma.  
These disorders may affect the ureters, bladder or urethra, decreasing the availability of 
adequate autologous tissue.  Moreover, complications from inserting autologous tissue, 
such as enteric segments, into the urinary tract are well known and often manifests 
metabolic and histopathologic abnormalities.  These sequelae have motivated 
investigators to search for tissue-engineered alternatives.   
Ideally, a tissue-engineered scaffold should mimic the structural and functional 
profile of the native ECM.  To achieve this objective, the “ideal” scaffold has been 
described as having the following characteristics: 1) a three-dimensional structure with a 
surface chemistry that promotes cell attachment, proliferation and differentiation [289], 
2) that does not induce adverse immune responses from the surrounding tissues [289], 3) 
mechanical properties to withstand organ-specific in vivo forces while being completely 
resorbable [290], and 4) a feasible production process that allows for various shapes and 
sizes [291].  Despite many recent advances, none of the scaffolds in use today meet all of 
the above mentioned criteria completely. 
Fibrinogen is a naturally occurring soluble blood protein that functions as a major 
structural element in the coagulation cascade, clot formation and wound healing [292, 
293].  The reaction of fibrinogen with thrombin produces fibrin.  This exposes regions of 
opposite charge leading to the assembly of fibrous clots and/or other fibrous structures.  
   140
These fibrous structures function as nature’s provisional matrix, on which tissues rebuild 
and repair themselves, making this type of structure an attractive scaffold for tissue 
engineering and regeneration [294-296].  
Fibrin and fibrinogen have a well established track record in tissue engineering, 
due to their innate ability to induce cellular interaction and subsequent scaffold 
remodeling.  Fibrinogen based scaffolds have previously been developed in the form of  
fibrin gels [295-302] and wet extrusion fibronectin-fibrinogen cables [303-305].  These 
studies demonstrated fibrinogen based scaffolds were easily degradable, nonimunogenic 
[297] and promoted increased cell migration [303, 305]. 
Electrospinning is a technology with the potential to fulfill the requirements of an 
ideal scaffold.  Briefly, electrospinning is accomplished by inducing a large electric 
potential (15 to 30 kilovolts DC) in a polymer solution and separating that polymer from 
an oppositely charged target.  This charge separation creates a static electric field.  As the 
field strength grows, the charge separation overcomes the surface tension of the solution 
and a thin jet of entangled polymer chains is ejected from the polymer reservoir.  As this 
jet travels toward the target, instabilities within the charged jet define its orientation in 
space (condition previously described as whipping).  By the time the jet reaches the 
target, the solvent has evaporated and a dry fiber is collected in the form of a non-woven 
scaffold (figure 5.1).  
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Figure 5.1.  Scanning electron micrographs of electrospun fibrinogen-PDO composite 
scaffolds at 2000x magnification.  10% PDO composite (top) has a scale bar of 10 µm, 
while 40% PDO composite (bottom) has a scale bar of 5 µm. 
 
 
METHODS 
 
Electrospinning.  For this study, fibrinogen (Bovine soluble fraction 1, Sigma 
Aldrich Chemical Co.) was dissolved in 9 parts HFP (Sigma Aldrich Chemical Co.) and 1 
part 10X minimal essential medium (MEM) at a concentration of 110 mg/mL.  PDO 
(Ethicon) was dissolved in HFP at a concentration of 100 mg/mL.  These ratios were 
chosen based on previous work conducted by the authors that demonstrated the best 
mechanical and cellular interaction characteristics for further investigation.  The solutions 
were then loaded into separate Becton Dickinson 5.0-mL syringes and placed in a KD 
Scientific syringe pump.  The fibrinogen solution was dispensed at a rate of 1.8 mL/hr.  
The dispensing rate of the PDO solution was varied to produce scaffolds with PDO ratios 
of 0%, 10%, 20%, 30%, 40%, 50% and 100% by volume.  The positive output lead of a 
high voltage power supply (Spellman CZE1000R; Spellman High Voltage Electronics 
Corp.), set to 22 kV, was attached to a custom designed 2 input - 1 output nozzle as 
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depicted in figure 5.2.  This nozzle had an estimated component mixing length of 15 mm 
prior to exiting the nozzle.  A grounded target (2.5 cm Wide × 10 cm Long × 0.3 cm 
Thick; 303 stainless steel) was placed 10 cm from the nozzle tip and rotated at 500 RPM 
to evenly coat the mandrel, but not impart a large degree of alignment to the deposited 
fibers.   
 
 
Figure 5.2.  Diagrammatic representation of the custom designed nozzle in a typical 
electrospinning setup, attached to syringes with 18 gauge Tygon® tubing (top) and 
section view of the 2 input - 1 output nozzle (bottom).  
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Mechanical Evaluation.  For determining the bulk mechanical properties, 
samples were incubated at 37ºC for 24 hours in complete culture media containing 
DMEM:F12 supplemented with 5% FBS and 1.2% penicillin-streptomycin antibiotic 
(10,000 I.U. penicillin/mL, 10,000 µg/mL streptomycin, Mediatech, Inc.).  Uniaxial 
tensile testing was performed on a MTS Bionix 200 (MTS Systems Corp.) mechanical 
testing system incorporating a 50 N load cell with an extension rate of 10 mm/min to 
failure.  A total of six test specimens (n=6) were tested for each study group.  Specimens 
were punched from the scaffolds using a “dog-bone” shaped template to assure 
uniformity and isolate the failure point away from the grips.  The specimens had a width 
of 2.67 mm and a gauge length of 11.25 mm.  Specimen thickness was measured on a 
Mitutoyo IP54 digital micrometer (Mitutoyo American Corp.) and ranged from 0.03 to 
0.20 mm.  Tangent modulus (tangential method automatically selected by the MTS 
TestWorks 4.0 software), peak stress (engineering stress based on the initial cross-
sectional area), and strain to failure (also calculated automatically by the software) were 
determined. 
 
Cell Culture.  Experiments were designed to evaluate cell proliferation and cell 
migration into the scaffolds at varying fibrinogen and PDO concentrations.  Scaffolds 
were electrospun with PDO as previously described.  Seventy-five 15 mm diameter die-
cut scaffold specimens, five scaffolds at each concentration at each time point, were 
placed in separate wells of 24 well culture plates.  All scaffolds were sanitized in 100% 
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ethanol for ten minutes then rinsed four times with sterile PBS for three minutes per 
rinse.  Human BSM (Cambrex) were expanded utilizing standard cell culture protocol in 
complete culture media containing DMEM:F12 supplemented with the Cambrex 
BulletKit (hEGF, hFGF-B, insulin, gentamicin, amphotericin-B, 5% FBS).  Scaffolds 
were seeded with 2x104 cells per scaffold.  Culture media was aspirated from the scaffold 
containing test wells and 500 µl of fresh media was added to each culture well and 
changed twice per week.  Cultures were incubated at 37ºC in 5% CO2 and removed for 
testing at 7, 14 and 21 days.   
 
Collagen Assay.  Collagen deposition by cultured cells was measured using the 
Sircol Collagen Assay (Biocolor).  This is a colorimetric assay for the quantification of 
acid-soluble and pepsin-soluble collagens (Types I to IV) extracted from mammalian 
tissues.  The Sircol dye reagent contains Sirius Red, which is an anionic dye with 
sulphonic acid side chain groups that react with the side chain groups of the basic amino 
acids present in collagen.  The specific affinity of the dye for collagen, under the assay 
conditions, is due to the elongated dye molecules becoming aligned parallel to the long, 
rigid structure of native collagens that have intact triple helix organization.  Increased 
collagen content leads to an increase in the amount of Sircol dye bound, which is 
measured with a spectrophotometer.   
After the 7 and 14 day incubation periods, scaffolds were removed from the 
culture wells and placed in separate 1.5 mL centrifuge tubes.  One milliliter of 0.5 M 
acetic acid solution containing 1 mg of pepsin was added to each centrifuge tube and 
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samples were placed on an orbital mixer overnight.  The tubes were gently mixed and 
100 µL of solution from each tube was transferred to a new centrifuge tube.  To develop 
a standard curve, four control solutions were prepared by combining 5, 10, 25 and 50 µL 
(1µg/µL) of reference collagen standard with distilled water to total 100 µL.  Four tubes 
were filled with 100 µL of distilled water to serve as background controls.  One milliliter 
of Sircol dye was added to all tubes, mixed by inversion and then placed on an orbital 
mixer for thirty minutes.  Tubes were then centrifuged at 10,000 times gravity for 10 
minutes, the supernatant drained and 1.0 mL alkali reagent added.  After mixing, 200 µL 
of solution from each tube was transferred into wells on a new 96 well microtiter plate 
where the absorbance of the samples was measured, against the background control, on a 
microtiter plate reader (SpectraMax Plus, Molecular Devices Corporation) at a 
wavelength of 540 nm. 
 
Microscopy Evaluations.  Scaffolds were fixed in 10% formalin solution for 
evaluation by SEM and histology.  Samples to be evaluated by SEM were dehydrated; a 
representative sample from each scaffold was sputter coated in gold (Electron 
Microscope Sciences model 550) for SEM (JEOL JSM-820 JE Electron Microscope) and 
evaluated at 350 to 1500 times magnification.  Samples for histologic evaluation were 
cross-sectioned for slide mounting and H&E staining (Harris Histology Relief Services).  
H&E slides were evaluated by optical light microscopy (Eclipse TE300, Nikon). 
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Statistics.  All statistical analyses were performed utilizing Sigma Stat (Version 
2.03; SPSS, Inc).  For the data collected, normality and equal variance tests were set to 
reject for P ≤ 0.01.  All samples passed normality and equal variance tests and were 
evaluated using a one-way ANOVA and then subjected to a pair-wise multiple 
comparison procedure (Tukey Test).  The a priori alpha value was set at 0.05. 
 
RESULTS 
 
Mechanical Evaluation of Electrospun Scaffolds.  Results of mechanical testing 
of the various electrospun fibrinogen-PDO composite structures are presented in figures 
5.3-5.5.  Properties of pure fibrinogen scaffolds (no PDO) were similar to those 
previously reported [77].  In general, values for modulus and peak stress increased as 
PDO concentration increased (figure 5.3).  Values for strain at failure varied from 84% to 
130%, but differences were not statistically significant (figure 5.4). 
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Figure 5.3.  Results of mechanical testing of electrospun fibrinogen-PDO composite 
structures are illustrated in terms of modulus of elasticity (dark bars) and peak stress 
(white bars) verses the PDO concentrations in the solution from which structures were 
electrospun. 
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Figure 5.4.  Results of mechanical testing of electrospun fibrinogen-PDO composite 
structures are illustrated in terms of percent strain at failure verses the PDO 
concentrations in the solution from which structures were electrospun. 
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Figure 5.5.  Modulus of elasticity and peak stress data demonstrate the linearity of these 
values from 0-50% PDO concentration.  The R2 value for the linear fit of the curve was 
0.977 for modulus and 0.945 for peak stress. 
 
 
 
Analysis of modulus of elasticity and peak stress data demonstrate the linearity of 
these values from 0-50% PDO concentration (figure 5.5) indicating a predictable increase 
in modulus of elasticity and peak stress as PDO concentration increases.  The R2 value 
for the linear fit of the curve was 0.977 for modulus and 0.945 for peak stress.  An 
increase in PDO concentration of 20% and 30% was required to achieve a statistically 
significant increase in peak stress and modulus, respectively. 
 
Collagen Assay.  The controls in figure 5.6 demonstrate the linearity of the assay 
results from 5 µg to 50 µg.  The R2 value for the linear fit of the standard curve was 0.926 
at 7 days and 0.991 at 14 days.  Collagen content (figure 5.7) was calculated from the 
standard curve in figure 5.6.  Comparison of collagen content at different PDO 
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concentrations demonstrated statistically significant differences at 7 and 14 days.  
Comparison between individual groups at day 7 only demonstrated statistical significance 
between the 0% PDO group and the 10% and 100% PDO groups.  At 14 days, statistical 
significance was demonstrated between all individual groups except between the 10% 
and 100% PDO groups.  Comparison of mean collagen content revealed two trends.  
First, there was a decrease in collagen content as PDO concentration increased up to 40% 
PDO, with an increase in collagen content in the 100% PDO group.  Second, there was a 
higher collagen content at 7 days than at 14 days.  These trends did not hold true for the 
0% PDO concentration at 7 days which had a lower than expected collagen content.   
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Figure 5.6.  Collagen assay controls demonstrating the linearity of the assay results from 
5 µg to 50 µg.  The R2 value for the linear fit of the standard curve was 0.926 at 7 days 
and 0.991 at 14 days. 
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Figure 5.7.  Bar graph depicting the collagen assay in terms of collagen content (based 
on the standard curve) for each scaffold condition. 
 
 
 
Microscopy Evaluations.  SEM analysis of post-cell culture electrospun 
scaffolds demonstrated evidence of cellular activity.  This evidence is seen as areas of 
partial scaffold degradation and individual fibers having been pulled out of their expected 
orientation.  Cells were not visible on the surface of the scaffolds.   
Samples from the H&E stained histological sections are presented in figure 5.8.  
Histological evaluations of internal domains of the scaffolds revealed BSM cells had 
migrated into, and appear to be evenly distributed throughout, the scaffold thickness in 
fibrinogen containing groups at 7 days, indicating a substantial degree of cell migration 
transpired early in the study period.  Further comparison of histologic samples revealed 
two trends.  First, there was an increase in the structural integrity of scaffolds as PDO 
concentrations increased.  Second, there was an increase in cell layering and cell 
spreading as PDO concentrations increased.  These trends did not hold true for the 100% 
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PDO samples where no cells were identified on histological examination at any time 
point. 
  All PDO containing scaffolds remained structurally intact at 7 days, but areas of 
broken fibers were observed in the 0% PDO group demonstrating some early loss of 
structural integrity.  Varying degrees of scaffold fragmentation and fusing of fibers with 
loss of the fibrous architecture were seen in the 0%, 10% and 20% PDO groups at 14 and 
21 days.  All samples in these groups were significantly fragmented by 21 days.  The 
40% PDO group maintained its structural integrity and fibrous structure throughout the 
study period. 
Cell layering is an indicator of the extent to which a scaffold is directing cell 
growth and migration.  Some degree of cell layering can be seen in all groups at 7 days, 
but it is most pronounced in the 40% PDO group.  In the 0%, 10% and 20% PDO groups, 
cell layering is substantially decreased at 14 days and almost nonexistent at 21 days.  Cell 
layering remains consistent throughout the study period in the 40% PDO group.   
Cell spreading is an indicator of the degree to which a scaffold supports BSM 
cells assuming their natural morphology.  At 7 days, there is an increase in cell spreading 
in the PDO containing groups compared to the 0% PDO group.  This spreading is most 
pronounced in the 40% PDO group.  There is a significant decrease in the amount of cell 
spreading in all groups, except the 40% PDO group, at 14 days and 21 days. 
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Figure 5.8.  Optical micrographs of H&E stained electrospun fibrinogen-PDO composite 
scaffolds at 20 times magnification.  BSM cells migrated through the full thickness of the 
scaffolds by day 7 (left column).  Structural integrity of the scaffolds increased as PDO 
concentration increased (top to bottom).  Cell layering and cell spreading also increased 
as PDO concentration increased. 
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DISCUSSION 
 
The use of fibrinogen in tissue engineering applications is not new.  Fibrinogen 
hydrogels have received much attention because they possess the benefits of 
homogeneous cell distribution and collagen deposition [297, 304, 306].  The use of 
hydrogels for tissue engineering requires mixing cells into the fibrinogen solution prior to 
forming the hydrogel.  Electrospun fibrinogen scaffolds promote rapid cell migration into 
the scaffolds [78] allowing for cell seeding after scaffold production.  However, these 
structures do not possess the structural integrity needed for direct implantation.  
Electrospun PDO structures have greater initial structural integrity and take longer to be 
degraded.  The objective of this study was to demonstrate that an electrospun fibrinogen-
PDO composite scaffold would retain the superior cellular interaction of fibrinogen while 
producing a product with functional strength for direct implantation. 
In this study, mechanical testing data demonstrated that increasing the PDO 
concentration in electrospun fibrinogen-PDO composite scaffolds increased strength 
(peak stress) and stiffness (modulus) in a predictable fashion. All composite scaffolds 
maintained similar elasticity profiles, indicating composite scaffolds could be tailored to 
meet specific tissue engineering mechanical requirements.   
The cell culture data demonstrated several trends related to scaffold composition.  
First, collagen deposition decreased as PDO concentration increased, with the exception 
of the 100% PDO group.  Collagen deposition is an indication of the extent to which cells 
are remodeling a scaffold [78].  Second, there was increased cell spreading and cell 
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layering at higher PDO concentrations.  Cell spreading demonstrates the scaffold 
supports cells assuming their natural morphology while cell layering within a scaffold 
demonstrates the scaffold is directing cell growth and migration.  Third, higher PDO 
concentrations produced scaffolds with greater structural integrity and stability.  In 
general, the higher PDO concentrations produced more stable scaffolds that allowed for 
slower scaffold remodeling and stimulated cells to assume a morphology closer to their 
native state.   
One of the most attractive aspects of the electrospinning process is that scaffolds 
of various shapes and sizes can be constructed while at the same time precisely 
controlling fiber orientation, composition (blended fibers), and dimensions.  Complex 
constructs can be fabricated to closely replicate the structural and chemical composition 
of the native structures.  For example, flat sheets for on-lay grafts, seamless tubes, or any 
three dimensional shape in which a mandrel can be fabricated could be produced.  Also, 
the ability to co-spin polymers with various additives (e.g. growth factors) offers the 
possibility of tailoring the scaffold to a specific site and application.  Thus, with 
electrospinning, it may be possible to create ideal scaffolding for a wide array of tissue 
engineering applications.  
Previous tissue engineered products for urinary tract reconstruction have been 
described utilizing decellularized submucosa, natural polymer hydrogels and synthetic 
polymer scaffolds created from a variety of production techniques [307-309].  Recent 
work by Atala et al. [310] has even demonstrated the feasibility of bladder augmentation 
with tissue engineered products using in vitro cell culture.  This process is labor and 
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resource intensive with multiple procedures required to harvest cells for in vitro cell 
culture followed by later implantation.  Electrospun scaffolds produced from other 
polymers have also been described for non-urologic applications [38, 59], but have failed 
to promote the rapid cellular in-growth demonstrated in this study.  
While an electrospun PDO-elastin composite scaffold has been described [20], 
this is the first report of an electrospun fibrinogen-PDO scaffold and the first report 
utilizing an electrospun synthetic and natural polymer composite structure for urologic 
tissue engineering.  
 
CONCLUSION 
 
This study demonstrates human BSM cells rapidly migrate into and remodel an 
electrospun fibrinogen-PDO composite scaffold with deposition of native collagen.  
While there is still much work to be done, these initial findings indicate there is 
tremendous potential for electrospun fibrinogen-PDO composite structures as urologic 
tissue engineering scaffolds with the ultimate goal of producing an implantable acellular 
product that would promote cellular in-growth and in situ tissue regeneration. 
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CHAPTER 6 Cross-linking Electrospun Fibrinogen to Tailor 
Scaffold Properties 
 
Preface: The following manuscript appeared in Biomedical Materials, 2008, volume 3, 
EPUB [181]. The work included demonstrates how the treatment of electrospun 
fibrinogen structures with two different cross-linkers, EDC and genipin, can affect the 
tensile strength, degradation rate, and bioactivity of the scaffold.  Treatment with EDC 
and genipin enhanced scaffold mechanical properties and degradation time, making the 
normally insufficient fibrinogen structures mechanically stable as useful tissue 
engineering scaffolds. 
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ABSTRACT 
 
The purpose of this study was to enhance the mechanical properties and slow the 
degradation of an electrospun fibrinogen scaffold, while maintaining the scaffolds high 
level of bioactivity.  Three different cross-linkers were used to achieve this goal: GLUT 
vapor, EDC in ethanol, and genipin in ethanol.  Scaffolds with a fibrinogen concentration 
of 120 mg/mL were electrospun and cross-linked with one of the aforementioned cross-
linkers.  Mechanical properties were determined through uniaxial tensile testing 
performed on scaffolds incubated under standard culture conditions for 24 hours, 7 days 
and 14 days.  Cross-linked scaffolds were seeded with human foreskin FBs (BJ-GFP-
hTERT) and cultured for 7, 14, and 21 days, with histology and SEM performed upon 
completion of the time course.  Mechanical testing revealed significantly increased peak 
stress and modulus values for the EDC and genipin cross-linked scaffolds, with 
significantly slowed degradation.  However, cross-linking with EDC and genipin was 
shown to have some negative affect on the bioactivity of the scaffolds as cell migration 
throughout the thickness of the scaffold was slowed. 
 
INTRODUCTION 
 
The interdisciplinary field of tissue engineering has blossomed in the brief two 
decades since the term was coined [2, 5].   While extensive research has been done in 
many areas that would fall under the umbrella name of tissue engineering, of particular 
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interest to this study is the research done on the creation of tissue engineering scaffolds 
that mimic the native ECM.  A countless number of materials, both natural and synthetic 
in origin, and processing techniques have been used to engineer these ECM analogues, 
with varying degrees of success.  While scaffolds may be designed and created to fit a 
specific application, ultimately all scaffolds regardless of application must meet a number 
of basic criteria to be successful.  At its most fundamental, the scaffold should not elicit 
an immune response while remaining a viable framework for cellular 
infiltration/proliferation, ultimately mimicking both the fibrillar form and the complex 
function of the native ECM [11, 17-19, 27-29].  This requires the scaffold to have an 
idealized combination of mechanical properties, geometry, and surface chemistry [18, 25, 
26].   
Fibrinogen is a 340 kDa glycoprotein, synthesized by the liver and found freely 
circulating in the bloodstream, composed of three pairs of polypeptide chains: Aα, Bβ, 
and γ.  During the coagulation cascade, more specifically the common pathway, 
fibrinopeptides A and B are cleaved from fibrinogen by thrombin to cause spontaneous 
polymerization of fibrin monomers.  Fibrin then forms lateral protofibril associations, 
which result in the formation of a loosely assembled clot, subsequently stabilized by 
covalent cross-links created by plasma transglutaminase (factor XIIIa).  This stable clot 
not only plays a haemostatic role, but also acts as an initial scaffold for tissue 
regeneration, serving as a platform for cell migration and proliferation [79, 173-175].   
 The effectiveness of fibrinogen in wound healing extends beyond its role in 
clotting; it is a protein with the capacity to bind a wide array of molecules that could be 
   160
beneficial from a tissue engineering standpoint.  Fibrinogen contains two RGD integrin 
binding sites, located on the Aα chain, which commonly bind FBs and ECs.  
Additionally, fibrinogen has demonstrated the ability to bind with high affinity to 
functional VEGF and FGF.  Fibrinogen also binds plasma fibronectin to its Aα chain, as 
well as insulin-like growth factor-binding protein-3 (IGFBP-3), which in turn binds 
insulin-like growth factor (IGF-1) [79, 176-178].  
Our lab has previously reported on the electrospinning of fibrinogen scaffolds 
composed of nano-scale fibres for use as tissue engineering ECM analogues [21, 77, 78, 
179, 180, 311].  Electrospinning is a simple process requiring little specialized equipment 
in order to create sub-micron scale, fibrous ECM analogues from a wide array of 
polymers.  In brief, a polymer is placed in solution and drawn into a syringe fitted with a 
blunt tip needle.  The surface tension of the polymer solution at the tip of the needle is 
overcome through the application of a large electric potential.  A grounded target is 
placed a set distance from the charged polymer solution to create a static electric field. 
When the electric potential reaches a critical level, the electrostatic forces overcome the 
surface tension at the needle tip, and a fine jet of entangled polymer chains are drawn out.  
This jet whips through the air toward the grounded target, creating a dry fibre through the 
evaporation of the polymers solvent [11, 25, 48, 133, 134].  The electrospinning of 
fibrinogen produces scaffolds composed of fibres between 80 and 700 nm in diameter, 
dependant upon the starting concentration of the fibrinogen solution [21].  
Fibrinogen has proven to be an intriguing polymer for use as a tissue engineering 
scaffold as it has consistently demonstrated excellent bioactivity, albeit with limited 
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mechanical integrity after several days in culture [77, 78, 179, 180].  As fibrinogen is 
readily broken down by thrombin and other serum proteases, it was determined that 
electrospun fibrinogen scaffolds needed to be successfully cross-linked in order to 
increase their lifespan both in vivo and in vitro.  An ideal cross-linking agent would slow 
the rate of fibrinogen degradation, while having no negative impact on the bioactivity of 
the scaffold itself.  Fibrin clots are cross-linked naturally through the inclusion of 
activated factor XIII (transglutaminase), which forms covalent bonds between glutamyl 
and lysyl residues of adjacent fibrin molecules [312-314].  However transglutaminase is 
expensive, and there are other cross-linking agents available that may prove to be more 
efficient and cost effective. 
GLUT is the most common cross-linking agent in clinical use today for fixing 
collagenous tissues [315, 316].  GLUT is fairly inexpensive and has the ability to cross-
link quickly over large distances with a wide array of amino groups [317].  However, 
GLUT has also been associated with increased cytotoxicity and material calcification 
[315, 316].  Heterobifunctional carbodiimides, more specifically EDC, have been gaining 
in popularity as tissue engineering cross-linkers and have recently been used in our 
laboratory to successfully cross-link both electrospun collagen [140] and elastin [71].  
EDC is a zero-length cross-linker, as it does not become incorporated into the 
macromolecule, thereby decreasing the potential for cytotoxic effects [315, 316].  
Genipin is a naturally occurring cross-linking agent that is derived from the fruits of 
Geinpa Americana and Gardenia jasminoides Ellis.  It has been used mainly in herbal 
medicine, as well as in the creation of heat, pH, and light resistant food dyes as its 
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reaction with primary amines results in dark blue pigmentation [318].  There have been 
several publications reporting on the use of genipin to cross-link collagenous tissues, 
[316, 319, 320] polyethylene glycol hydrogels, [321] gelatin, [322] and chitosan [318].  
Genipin has proven to be an effective cross-linker that increases a materials ultimate 
tensile strength and toughness, yet exhibits significantly less cytotoxicity than GLUT 
[323].  
The purpose of this study was to determine an effective cross-linker for 
electrospun fibrinogen scaffolds; one that would ideally increase their mechanical 
properties and slow their degradation, while maintaining a high level of bioactivity.  
Uniaxial tensile testing over a two week period, in vitro cell culture, and scaffold porosity 
calculation results were compared to the results of uncross-linked scaffolds to determine 
the efficacy of the cross-linkers. 
 
MATERIALS AND METHODS 
 
Electrospinning.  Solutions of 120 mg/mL of fibrinogen (Fraction 1, Type 1-S 
from bovine plasma, Sigma Aldrich, Co.) were made with a 90% by volume solution of 
HFP (TCI America Inc.) and 10% by volume 10x MEM (Sigma Aldrich, Co.).  Solutions 
were left overnight on a shaker plate to ensure that all fibrinogen had dissolved and 
formed a homogenous solution.  5 mL of polymer solution were then drawn into a plastic 
Beckton Dickinson syringe and placed in a KD Scientific syringe pump (Model 100) to 
be dispensed at a rate of 3.5 ml/h.  A high voltage power supply (Spellman CZE1000R; 
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Spellman High Voltage Electronics Corporation) was used to apply a voltage of 25 kV to 
a blunt tip 18 gauge needle fixed to the solution containing syringe.  Solutions were 
electrospun onto a flat, stainless steel, grounded mandrel (2.5 cm wide × 10.2 cm long × 
0.3 cm thick) placed 12 cm from the needle tip and rotating at a rate of ~500 rpm to 
produce a scaffold of randomly oriented fibers.  Immediately after electrospinning, 
scaffolds were cut from the mandrel and placed in a fume hood for 30 minutes for 
degassing and removal of any residual HFP. 
 
Glutaraldehyde Cross-linking.  Scaffolds to be cross-linked with GLUT (Fisher 
Scientific Inc.) were placed in a 50% GLUT vapor chamber at room temperature for 1 
hour.  To construct the vapor chamber, 2 mL of GLUT were placed in a small (35 mm 
diameter) uncapped Petri dish, which was then placed inside of a large (100 mm 
diameter) Petri dish.  The fibrinogen scaffold was also placed within the large Petri dish; 
the large dish was then covered and sealed with parafilm.  After the 1 hour time period, 
the cover was removed and the scaffold was allowed to degas for 1 hour.   
 
EDC Cross-linking.  The EDC (Sigma-Aldrich Chemical Co.) cross-linking 
protocol used in this study was modified from a similar protocol used to cross-link 
electrospun type II collagen [140].  Based on the molecular weight of fibrinogen (340 
kDa), the molarity of the electrospun fibrinogen solution was determined to be 0.35 mM.  
From this, an EDC solution at a 50 fold molar excess (17.6 mM) was created by 
dissolving the cross-linker in pure ethanol (Fisher Scientific Inc.).  Electrospun scaffolds 
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were placed in 50 mL of cross-linking solution for 18 hours at room temperature, 
followed by a 2 hour rinse in 0.1 M sodium phosphate to hydrolyze any unreacted O-
isoacylurea intermediates. 
 
Genipin Cross-linking.  The genipin cross-linking protocol used was similar to 
that of the EDC cross-linking protocol and was modified from a published protocol to 
cross-link porcine pericardia [320].  Genipin powder (Wako Pure Chemical Industries, 
Ltd.) was dissolved in pure ethanol to a molarity of 30 mM (determined by unpublished 
lab results).  Fibrinogen scaffolds were placed in 50 mL of cross-linking solution for 72 
hours at room temperature.  It has been reported [321] that when the genipin cross-
linking process is complete the cross-linked material will become dark blue in color.  As 
such, it was noted that the electrospun fibrinogen scaffolds gradually changed color over 
the 3 day period, eventually reaching a dark blue near the end of day 3.  Scaffolds were 
removed from the cross-linker solution at the completion of the time course. 
 
Controls.  As both the EDC and genipin cross-linkers were dissolved in ethanol, 
it was decided that a pure ethanol solution should be used as a control to ensure that the 
cross-linking effects were a result of the cross-linkers rather than the ethanol.  
Electrospun scaffolds were placed in an ethanol solution for 72 hours to mimic the 72 
hour exposure time of the genipin cross-linked scaffolds. 
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Scaffold Porosity Measurement.  Previous research has shown that electrospun 
fibrinogen scaffolds densify and contract when placed in an aqueous solution [311].  To 
determine what, if any, effect cross-linking had on scaffold densification, porosity was 
determined for uncross-linked, GLUT cross-linked, ethanol soaked, EDC cross-linked, 
and genipin cross-linked samples.  Disks 21 mm in diameter were punched from dry, 
uncross-linked electrospun fibrinogen scaffolds.  Each disk’s dry mass and thickness was 
recorded, and the dry void fraction (porosity) of each disk was determined using the 
following equation: 
⎥⎦
⎤⎢⎣
⎡−= 1001 x
DensityMaterialKnown
DensityScaffoldCalculatedFractionVoid                                (6.1) 
The calculated scaffold density was determined by dividing the mass of the disk by the 
total volume of the disk, while the dry density of fibrinogen was known to be 1.38 g/cm3 
[77].  
Disks were then cross-linked according to protocols described previously.  Once 
cross-linking had been completed, samples were rinsed 3 times in PBS to remove any 
residual cross-linker.  Samples were then soaked for 24 hours in PBS at room 
temperature.  The diameter and thickness of the samples were measured to determine 
their wet total volume after both the ethanol rinses and the PBS soak.  Hydrated void 
fraction was calculated using equation (6.1) in the same way as the dry void fraction.  
The hydrated calculated scaffold density was determined by dividing the previously 
measured dry mass of the disks by the altered total volume of the hydrated disks, which 
was then divided by the dry density of fibrinogen.  The dry mass and density were used 
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because it was assumed that the only difference in mass would be due to the presence of 
ethanol/water molecules in void spaces and not the actual electrospun fibers gaining or 
losing mass. 
 
Uniaxial Tensile Testing.  For uniaxial tensile testing, “dog-bone” shaped 
samples (2.75mm wide at their narrowest point with a gage length of 7.5 mm) were 
punched from each of the electrospun mats following cross-linking.  These samples were 
then soaked in ethanol for 10 minutes, followed by 3 rinses in sterile PBS for 
disinfecting.  These samples were soaked in DMEM-F12 (Invitrogen Corp.) 
supplemented with 10% FBS and 2% penicillin-streptomyocin (10,000 Units/mL each, 
Gibco BRL Life Technologies) under standard culture conditions (37°C and 5% CO2) in 
an incubator for 1, 7, and 14 days. At the end of each time course, samples were tested to 
failure on a MTS Bionix 200 testing system with a 50 N load cell (MTS Systems Corp.) 
at an extension rate of 10.0 mm/min.  Elastic modulus, peak stress, and strain at break 
were calculated by the MTS software TestWorks 4.0 and recorded. 
 
In Vitro Cell Culture.  To evaluate the effect of cross-linking on cell-scaffold 
interaction, circular disks (10 mm in diameter) were punched from each of the cross-
linked scaffolds, disinfected (by soaking in ethanol for 10 minutes followed by 3 rinses in 
PBS), and placed in a 48-well plate.  Each disk was then seeded in its center with 
immortalized human foreskin FBs (BJ-GFP-hTERT), containing a retroviral transduced 
human telomerase reverse transcriptase (hTERT) element and green fluorescent protein 
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(GFP), at a concentration of 16,500 cells / 100 µL.  DMEM-F12 supplemented with 10% 
FBS and 1% penicillin-streptomyocin was added to each scaffold (100 µL of cells in 
media incubated for 45 minutes, followed by 200 µL of media).  The scaffolds were then 
statically cultured under standard culture conditions (37°C and 5% CO2) in an incubator.  
One disk of each sample was removed after 7, 14, and 21 days.  Removed disks were 
fixed in 10% formalin and processed for SEM and histology.  Samples for SEM were 
dehydrated and sputter coated in gold (Electron Microscope Sciences model 550).  
Micrographs were taken on a Zeiss EVO 50 XVP scanning electron microscope and 
evaluated between 500 and 5000 times magnification.  Samples for histologic evaluation 
(H&E and Masons Trichrome) were cross-sectioned for slide mounting and stained by 
Harris Histology Relief Services.  Slides were then evaluated by optical light microscopy 
(Eclipse TE300, Nikon). 
 
Statistical Analysis.  Statistical analysis was performed on mean scaffold 
porosities (n=6), as well as mean uniaxial tensile testing values (n=6).  All statistical 
analysis was based on a Kruskal–Wallis one-way ANOVA on ranks and a Tukey–Kramer 
pairwise multiple comparison procedure (α = 0.05) performed with the JMP®IN 4.0.3 
statistical software package (SAS Institute, Inc.).  Graphical depictions of mean data were 
constructed with Microsoft Excel 2000, with error bars representing standard deviations.  
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RESULTS 
 
Electrospinning.  Electrospinning of 120 mg/ml fibrinogen solutions from HFP 
resulted in formation of non-woven fibrous scaffolds.  Fibrinogen fibers were randomly 
oriented and had a mean fiber diameter of 710 + 220 nm (figure 6.1).  The scaffolds 
appeared to be highly porous, with a large amount of void space. 
 
 
Figure 6.1.  Scanning electron micrograph of electrospun fibrinogen at 2050x. 
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Cross-linking.  Scanning electron micrographs of electrospun fibrinogen 
scaffolds taken before and after the various cross-linking methods were taken to provide 
insight into the fibers morphology (figure 6.2).  Scaffolds were dipped in ethanol and 
dehydrated prior to sputter coating and SEM. 
 
 
Figure 6.2.  Scanning electron micrograph of electrospun fibrinogen scaffolds after 
treatment with GLUT (A), ethanol (B), EDC (C), and genipin (D).  All images were 
taken at 8000x. 
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Scaffold Porosity Measurement.  Mean scaffold porosity measurements are 
shown in figure 6.3.  While all scaffolds tested maintained a high percentage of void 
space, significant decreases in porosity occurred in a number of samples after they were 
placed in PBS.  The control scaffolds (no fixation and ethanol soaked) exhibited the 
largest amount of densification, while the GLUT cross-linked specimens also exhibited a 
significant decrease in mean scaffold porosity.  EDC cross-linked specimens did not 
experience significant densification, while genipin cross-linked scaffolds exhibited a 
small significant difference between the dry and PBS soaked samples.  There was no 
significant difference between PBS soaked samples cross-linked with EDC and genipin, 
which may indicate that a larger sample size would have reduced the standard deviation 
and eliminated the difference seen in the genipin specimens. 
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Figure 6.3.  Mean scaffold porosities for different cross-linking groups. 
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Uniaxial Tensile Testing.  The results of the uniaxial tensile testing 2 week 
degradation study are presented in figure 6.4.  After 1 day in solution under standard 
culture conditions, peak stress values were significantly higher for the EDC and genipin 
cross-linked scaffolds when compared to the uncross-linked, GLUT, and ethanol soaked 
samples.  Modulus values mirrored these results, while strain at break values were 
significantly reduced for the EDC and genipin cross-linked scaffolds.  This reduced 
straining of cross-linked samples is consistent with prior results, and is believed to be due 
to the stiffening of the scaffold fibers through the cross-linking procedure. 
By day 7 the uncross-linked and GLUT cross-linked scaffolds lacked the 
mechanical integrity needed to undergo mechanical testing.  While these scaffolds 
maintained their “dog-bone” shape and were able to be placed in the grips of the MTS, 
their extension resulted in an extremely noisy stress-strain curve of low value that did not 
allow for the extraction of results.  Surprisingly, the ethanol soaked samples were still 
mechanically viable, albeit with significantly reduced mechanical properties.  The EDC 
and genipin cross-linked scaffolds maintained their original mechanical properties with 
no significant differences. 
By day 14 the only surviving samples were those that had been cross-linked with 
EDC and genipin.  For these scaffolds, there was no significant difference between the 
mechanical properties achieved on day 14 when compared to day 1.  The other scaffolds, 
while appearing to maintain their “dog-bone” shape, immediately fell apart when they 
were removed from solution, making mechanical evaluation impossible.   
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Figure 6.4.  Peak stress (top), modulus (middle), and strain at break (bottom) values for 
cross-linked scaffolds achieved through uniaxial tensile testing over a 2 week degradation 
period. 
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In Vitro Cell Culture.  Results of the SEM analysis and histological evaluation 
are shown in figures 6.5, 6.6, and 6.7.  The SEM analysis provided qualitative 
information on cell proliferation as well as cell migration across the scaffolds’ surface, 
while histology provided an indication of cellular migration into the scaffold as well as 
the degree to which collagen was produced and the scaffold was remodeled.  Cell 
proliferation was evident in each of the scaffolds seeded with FBs as there is a definite 
increase in the number of cells seen on the surface of the scaffolds at the end of the time 
course.  Surface migration of cells was also apparent for all scaffolds regardless of cross-
linking as FBs were seen on almost all areas of the scaffolds surface by day 21, as 
opposed to cells being present in only localized areas for day 7.  However, cross-linking 
appeared to play a major role in the ability for cells to migrate into the thickness of the 
scaffold.  As evidenced clearly by the trichrome stained samples taken at day 21, the 
uncross-linked and ethanol soaked fibrinogen scaffolds (red) were almost entirely 
replaced by newly produced collagen (blue).  The GLUT cross-linked scaffold showed a 
gradual transition from electrospun fibrinogen to newly produced collagen, while both 
the EDC and genipin cross-linked scaffolds exhibited very little remodeling 
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Figure 6.5.  SEM analysis of electrospun scaffolds seeded with FBs.  All micrographs 
were taken at 498x. 
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Figure 6.6.  Histological evaluation of cross-linked scaffolds observed under an optical 
light microscope at 40x magnification.  For trichrome stained samples fibrinogen appears 
red while collagen is blue. 
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Figure 6.7.  High magnification (100x) images of H&E stained cells (*) on electrospun 
fibrinogen scaffolds treated with ethanol (A) and EDC (B) after 21 days in culture. 
 
 
 
DISCUSSION 
 
Scaffold Porosity Measurement.  The scaffold porosity measurement results 
demonstrated that fibrinogen scaffolds electrospun from HFP were highly porous.  
However, this porosity changes when the scaffolds become hydrated in an aqueous 
environment.  This densification may be due in part to some short term ultra-
hydrophobicity caused by residual solvent left within the scaffold.  The sub-micron scale 
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roughness of the scaffolds may also contribute, however further investigation is necessary 
before any concrete explanation can be provided.  Regardless of the reason for the 
densification, it was shown that cross-linking of the fibrinogen scaffolds could 
significantly reduce the degree to which the scaffold contracted.  GLUT cross-linking 
resulted in a significant increase in hydrated scaffold porosity (74%) over uncross-linked 
scaffold porosity (66%), while EDC and genipin cross-linking resulted in even larger 
sustained porosities (roughly 78% for both).  Interestingly, soaking the scaffolds in 
ethanol as a control had no effect on hydrated scaffold porosity.  This would indicate that 
the ethanol itself played no role in altering the scaffolds hydrophobicity, rather it was the 
cross-linkers themselves which enhanced the mechanical properties of the scaffold, 
which in turn hindered densification.  The sustainability of a highly porous scaffold 
would be of great benefit in a tissue engineering application as this high porosity would 
in turn enhance scaffold permeability, making cell migration and nutrient/waste transport 
more feasible over longer distances. 
 
Uniaxial Tensile Testing.  The uniaxial tensile testing results achieved over the 
14 day time course of this study provided data that definitively shows fibrinogen scaffold 
mechanical enhancement through the use of EDC and genipin cross-linkers.  Electrospun 
fibrinogen, while highly bioactive, lacked the mechanical integrity needed to become a 
reliable tissue engineering scaffold.  Clearly, the total loss of mechanical properties after 
one week in solution demonstrates the purely short term possibilities of a tissue 
engineering scaffold made of uncross-linked fibrinogen for use in vivo.  While the 
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uncross-linked scaffolds retained their shape at one week, they lacked any significant 
mechanical properties and would surely have failed in the more rigorous in vivo setting.  
By the second week of the test, breakdown of the uncross-linked scaffolds was visually 
evident, as the original “dog bone” shaped specimens had begun to break apart.   
GLUT cross-linking failed to produce any significant improvement.  This was 
somewhat surprising as GLUT is one of the most commonly used fixatives available.  
The poor performance of the GLUT in this study may have been improved by utilizing an 
alternate form of GLUT cross-linking.  The gas vapor method was used here, rather than 
an immersion technique, to prevent large quantities of residual GLUT from becoming 
trapped within the scaffold, as GLUT has been proven to be highly cytotoxic.  Increasing 
the contact between GLUT and the fibrinogen scaffolds may have enhanced the amount 
of cross-linking that occurred, but would have also run the risk of making the scaffold 
uninhabitable and prone to calcification. 
The use of both the EDC and genipin cross-linkers in ethanol proved to be highly 
effective in enhancing the mechanical properties of the electrospun scaffolds, opening the 
door for fibrinogen to be used as a scaffolding material in more tissue engineering 
applications where mechanical stability is paramount (haemostatic patches, skin grafts, 
tubes and conduits, etc).  Peak stress and modulus values for the EDC and genipin cross-
linked scaffolds were significantly improved over the remaining groups, while strain at 
break values were significantly reduced.  Yet, there was little difference between the 
samples cross-linked with EDC and the samples cross-linked with genipin.  This was 
somewhat surprising as, at least in collagenous structures, the two cross-linkers act 
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through different mechanisms [316].  Further testing is necessary to quantify the amount 
of cross-linking that each cross-linker produces, using a ninhydrin assay [324] to measure 
free amine groups.  
Not only did the EDC and genipin cross-linking improve the mechanical 
properties of the electrospun scaffolds, but it was also effective in slowing the rate of 
fibrinogen degradation.  Scaffolds cross-linked with EDC and genipin retained their 
shape and remained mechanically viable during the 14 day course of the study with no 
significant decrease in mechanical properties.  More long term studies are required to 
determine just how long the cross-linked scaffolds remain viable in solution; the ultimate 
test being implantation in vivo.  However, from these preliminary results it certainly 
seems feasible to tailor the rate of scaffold degradation, at least to some extent, by 
altering the amount of cross-linking that takes place.  By reducing the concentration of 
the cross-linkers in ethanol, or reducing the exposure time of the scaffolds to the cross-
linking solutions, one could alter the amount of cross-linking that occurs.  A reduction in 
the degree to which the fibers are cross-linked would lead to a reduction in their 
degradation time.  As a nano-fibrous bioactive scaffold, with a controllable rate of 
degradation, electrospun fibrinogen could have potential as a slow release drug delivery 
vehicle. 
 
In Vitro Cell Culture.  The results of the SEM and histological evaluation 
demonstrated that while cross-linking with EDC and genipin positively enhanced 
electrospun fibrinogens’ mechanical properties, it also played a role in altering the 
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scaffolds previously excellent bioactivity.    Uncross-linked and ethanol soaked scaffolds 
showed nearly complete scaffold remodeling by 21 days, while the scaffolds cross-linked 
with EDC and genipin resulted in very little collagen deposition.  Samples cross-linked 
with the cytotoxic GLUT exhibited a gradual top down remodeling of the scaffold.  This 
was quite surprising as the EDC and genipin cross-linked scaffolds maintained the 
highest porosity, as shown previously.  However it was the scaffolds that experienced the 
most densification and had the lowest porosities that had the best cell migration.  This 
may be due to the fact that cells have shown the ability to move electrospun fibers to 
create pores as large or small as they require for migration [28], and require the 
transduction of certain chemical or mechanical signaling to occur between cells and 
matrix for subsurface migration to occur.  As shown previously, the modulus of the 
scaffolds was significantly increased when cross-linked with EDC and genipin.  These 
altered fibers may have then been too stiff to allow for subsurface cell migration to occur.  
Additionally, the cross-linking process may have masked the integrin binding sites that 
are normally exposed on fibrinogen, causing the cells to no longer recognize the matrix 
as an ECM analogue.  Further testing will need to be done to determine exactly what 
caused the reduction in scaffold bioactivity. 
 
CONCLUSION 
 
This preliminary investigation into the cross-linking of electrospun fibrinogen 
scaffolds for tissue engineering applications yielded mixed results.  Of the cross-linking 
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methods tested, EDC and genipin in ethanol proved to be highly effective in enhancing 
scaffold mechanical properties, with significant increases seen over uncross-linked 
samples.  Moreover, these cross-linkers were successful in retarding the rate of scaffold 
degradation in culture media under standard culture conditions over a period of 14 days.  
While these cross-linkers strengthened the electrospun scaffolds, they also had a negative 
impact on the ability for FBs to migrate below the surface of the scaffold and remodel it 
with collagen.  Further investigation is needed to determine what mechanisms were 
affected by cross-linking to reduce scaffold bioactivity; whether it was plasticizing of the 
fibrinogen fibers which ultimately led to loss of inherent cell binding sites, or alteration 
of individual fiber mechanical properties.  It will also be necessary to perform a more in-
depth analysis of the degree to which cross-linking is controllable by altering the 
exposure time and concentration of the EDC and genipin cross-linkers.  Regardless, the 
enhanced mechanical properties and degradation time were seen as positive results that 
may outweigh the reduced subsurface migration when placed in vivo.  The use of these 
cross-linkers could open doors for further use of electrospun fibrinogen ECM analogue 
scaffolds to be used in more applications that require tailorable degradation rates and 
long term mechanical stability, such as a steady state drug release vehicle. 
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CHAPTER 7 Creation of Aligned Silk Scaffolds for Tissue 
Engineering 
Preface: The following manuscript has been submitted for review to Biomedical 
Materials at the time this document was prepared. The included work investigates 
differences in anisotropy of electrospun silk-based scaffolds for potential use as both 
ligament and vascular grafts.  A number of different silk-based structures were created 
with varying degrees of fiber alignment, and were subsequently evaluated through 
mechanical testing and FFT.  The author’s role in this work was silk fibroin extraction 
and the creation, imaging, and mechanical testing of structures intended for use as 
ligament analogues. 
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ABSTRACT 
 
Extracellular matrices are arranged with a specific geometry based on tissue type and 
mechanical stimulus.  For ligaments and blood vessels in the body, preferential alignment 
of fibers is in the direction of repetitive force.  Electrospinning is a controllable process 
which can result in fiber alignment and randomization depending on the parameters 
utilized.  In this study, both ACL and arterial scaffolds were studied to determine if fibers 
could be controllably aligned in the circumferential direction of a large 80 mm diameter 
mandrel for ACL and a small 4 mm diameter mandrel for blood vessel applications.  
Results revealed that large and small diameter mandrels produced different degrees of 
fiber alignment based on the analysis of SEM images.  Uniaxial tensile testing further 
demonstrated scaffold anisotropy through changes in peak stress, modulus, and strain at 
break at mandrel rotational speeds of 500 and 8000 RPM.  Additional mechanical testing 
was performed on vascular grafts using dynamic compliance, burst strength, and 
longitudinal strength displaying that grafts electrospun at higher rotational rates produced 
stiffer conduits which had lower compliance and higher burst strength compared to the 
lower mandrel rotational rate.  Scaffold properties were found to depend on several 
parameters in the electrospinning process: mandrel rotational rate, polymer type, and 
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mandrel size.  The electrospinning of PCL, PDO, and silk together in different polymer 
blends demonstrates promise for both ACL and artery and warrants further investigation 
into parameter optimization. 
 
INTRODUCTION 
 
Anterior Cruciate Ligament.  Ligament injury, particularly injury to the ACL, is 
becoming extremely common in our society due to our desire to perform physical 
activities.  These injuries to ligaments residing inside the knee capsule (cruciate 
ligaments) lack the ability to heal spontaneously and must be repaired surgically [271].  
In 2002, more than 5 billion dollars were spent to reconstruct 200,000 ligaments in the 
United States [268]. In the short term, ligament damage can result in severe pain and 
discomfort as well as limitations in mobility and the ability to participate in athletics and 
exercise [80].  Prolonged joint use without the benefit of the ACL will lead to joint 
instability, altered load bearing, articular cartilage damage, and ultimately OA [325].  
Currently there is no clinical graft material to replace a damaged ligament that would be 
considered ideal. 
There have been many different approaches taken to tissue engineering ligament 
replacements.  Most involve the use of bioresorbable synthetic polymers such as PLA  
[268, 269, 273, 326, 327], PLGA [267, 269, 276, 328, 329], PCL [80, 268], and PDO [22, 
80, 83-85, 268, 270, 273, 330].  Natural biopolymers such as silk, and collagen [61, 268, 
270, 273, 326] have also been used extensively.  These materials have been used almost 
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exclusively as braided, knitted, or extruded micron scale fibers, with no evidence of a 
ligament analogue composed entirely of electrospun nanofibers in the literature. 
The creation of an ideal tissue engineered ligament replacement requires a 
structural scaffold (ECM analogue) that can support cell activity, host reparative cells 
with the ability to produce ECM, and have an overall structure conducive to the repair 
process with appropriate nutrient supply.  The engineered ECM analogue should ideally 
have mechanical properties similar to those of native ACL; for a complex load bearing 
structure, this is no small feat and as such there are several major hurdles.  Foremost, the 
initial mechanical properties of the structure (i.e. ultimate stress, modulus, and strain at 
break) need to replicate those of ACL.  To prevent catastrophic failure, the mechanical 
properties of the implanted structure need to remain high in vivo as the material degrades 
and cells infiltrate and remodel the scaffold. 
 
Artery.  CVD, specifically CHD resulting from arteriosclerosis, remains the 
leading cause of death in the United States and has been so virtually every year since 
1900 [105].  Arteriosclerosis is a vascular disease characterized by thickening of the 
arterial wall and a subsequent decrease in the arterial lumen leading to an eventual 
decrease or loss of circulation distal to the disease site.  Once blood flow is compromised, 
vascular bypass is an option to restore blood flow to tissues distal to the restriction or 
blockage [59].  In 2005 there were 469,000 bypass procedures performed due to CHD 
[105], which typically involve the replacement of a coronary artery with a patients own 
saphenous vein, the gold standard.  Synthetic alternatives include e-PTFE and woven or 
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knitted PET fibers (Dacron®).  However, at the small diameter level, in low flow 
environments, these grafts are prone to thrombus formation and intimal hyperplasia. 
Developments of vascular graft materials have undergone several pathways.  
Bioresorbable scaffolds such as PLA [331-333], PGA [334, 335], PDO [48, 154], PCL 
[145, 248, 336, 337], in addition to natural polymers such as collagen [19, 59, 87, 120, 
338] and elastin [20, 71], have been at the top the list.  Electrospinning has provided a 
possible key to unlocking the synthetic graft bypass mystery, where synthetic polymers 
and biopolymers can be blended together with tunable mechanical properties.  However, 
tuning these mechanical properties can be a difficult task when attempting to mimic the 
arterial wall. 
The arterial wall is composed of three separate layers: the intima, media, and 
adventitia, each imparting its own biomechanical function, while being subjected to both 
axial, circumferential, and torsional forces.  The most intricately arranged layer of the 
three is the media, whereby elastic fenestrae, specific smooth muscle orientation, and 
ECM proteins such as elastin and collagen provide a network that is both highly elastic 
and strong.  Several studies have found the medial layer in both elastic arteries (i.e. aorta) 
and muscular arteries (facial, brachial, femoral) to be arranged with specific pitch 
geometry, composed of SMCs and their matrix [339].   
The natural geometry of native human ECM provides a mechanical advantage for 
tissues which undergo constant deformation and stress.  In particular, both ACL and 
arteries are continuously loaded and unloaded.  Ligaments, like the ACL, are composed 
of closely packed collagen fiber bundles oriented in a parallel fashion to provide for 
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stability of joints in the musculoskeletal system, creating a structure that is best suited for 
the longitudinal direction.  Arteries are composed of a combination of mainly collagen 
and elastin, where collagen fibers are positioned specifically to provide maximum 
resistance to the three dimensional stress variables while elastin generates elastic recoil 
and minimizes energy loss. 
Synthetics such as PDO and PCL have displayed strong mechanical properties 
while remaining flexible, properties that are conducive to both ligament and arterial 
tissue engineering.  Silk, as a suture, has been used for centuries, however, it is relatively 
new to the field of tissue engineering and has demonstrated promise in several ligament 
and vascular studies [80, 84, 86, 183, 340-342].  This study focuses on the generation of 
either aligned or random electrospun fiber matrices using combinations of PDO, PCL, 
and silk.  These polymer blends were analyzed for fiber alignment on small, 4 mm 
diameter, and large, 80 mm diameter, mandrels using fast Fourier transform (FFT) and 
mechanical characterization. 
 
MATERIALS AND METHODS 
 
Silk Fibroin Extraction.  SF was extracted from the cocoons of Bombyx mori 
silkworms (The Yarn Tree) through an established protocol [88].  Briefly, silk cocoons 
were cut into pieces and boiled in a 0.02 M Na2CO3 (Sigma Aldrich) solution for 30 
minutes to remove the sericin gum, followed by thorough rinsing in de-ionized water 
(DI), and drying in a fume hood.  The SF is then dissolved in a LiBr (Fisher Scientific) 
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solution at 60°C for 4 hours.  This solution is then dialyzed against DI water for 3 days 
using 3500 MWCO dialysis tubing (Fisher Scientific).  The SF solution is then frozen 
and lyophilized to provide a pure SF powder for electrospinning. 
 
 Scaffold Preparation.  PCL:Silk and PDO:Silk scaffolds were prepared in ratios 
of 100:0 and 50:50 (v:v) by volume dissolved in HFP (TCI America).  PCL (MW 65,000 
kDa Sigma) and PDO (Ethicon, Inc.) were dissolved at a concentration of 100 mg/ml.  SF 
was dissolved at a concentration of 70 mg/ml.  These solutions were then inserted into a 
plastic 5 ml Becton Dickinson syringe with a blunt tip 18 gauge Becton Dickinson 
PrecisionGlide® needle.  The syringe and needle were placed in a KD Scientific syringe 
pump to be dispensed at rates of 6 ml/hr for 100:0 PDO:Silk and PCL:Silk and at 4 ml/hr 
for 50:50 PDO:Silk and PCL:Silk.  For vascular applications, the solutions were 
electrospun onto a cylindrical rotating mandrel with a 4 mm diameter with a 12 cm length 
at both 500 RPM and 8000 RPM with a translational speed of 6 cm/s over a distance of 
12 cm to produce a cylindrical tube with either random or aligned fiber orientation, 
respectively.  For ACL applications, the solutions were electrospun onto a cylindrical 
rotating mandrel with an 80 mm diameter at both 1000 RPM and 8000 RPM and a 
translational speed of 0 cm/s to determine degree of alignment between the two groups, 
and the solutions were electrospun onto a rectangular mandrel (2.5 cm wide x 10.2 cm 
long x 0.3 cm thick) at 500 RPM with a translational speed of 6 cm/s over a distance of 
12 cm to produce random fiber orientation.  PDO:Silk and PCL:Silk 100:0 blends were 
electrospun with an applied voltage of 22 kV to the needle tip and -8 kV on a round, 15 
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cm diameter aluminum target placed behind the mandrel, while PDO:Silk and PCL:Silk 
50:50 blends had an applied voltage of 25 kV and a grounded, round, 15 cm diameter 
aluminum target placed behind the mandrel.  After electrospinning was complete, the 
scaffolds were dipped in methanol for 30 minutes to force β-sheet formation in silk fibers 
[22]. 
 
 Scanning Electron Microscopy.  Scaffold characterization was performed using 
SEM of the electrospun mats (Zeiss EV050).  SEM micrographs were analyzed with 
ImageTool 3.0 software (Shareware provided by UTHSCSA).  Characterization included 
determining the average fiber diameter for the electrospun structure by taking the average 
of 60 measurements chosen randomly from across the image.  Calibration of the 
ImageTool software was done with the scale bar on each image.  
 
Fast Fourier Transform.  As described in [343], an FFT method was used to 
evaluate relative fiber alignment in electrospun scaffolds.  The FFT function converts 
information present in an optical data image from a ‘‘real’’ domain into a mathematically 
defined ‘‘frequency’’ domain. The resulting FFT output image contains grayscale pixels 
that are distributed in a pattern that reflects the degree of fiber alignment present in the 
original data image. A graphical depiction of the FFT frequency distribution is generated 
by placing an oval projection on the FFT output image and conducting a radial 
summation of the pixel intensities for each angle between 0 and 360o, in 1o increments. 
The pixel intensities are summed along each radius and then plotted as a function of the 
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angle of acquisition (position of the radial projection on the oval profile), usually between 
0 and 180o (FFT data are symmetric so a pixel summation to 360o is unnecessary). The 
degree of alignment present in the original data image is reflected by the height and 
overall shape of the peak present in this plot. The position of the peak on the plot reports 
the principal axis of alignment.  For analysis, grayscale, 8-bit .TIF SEM micrograph 
images were cropped to 2048 x 2048 pixels.  FFT analysis was conducted using ImageJ 
software (NIH,http://rsb.info.nih.gov/ij) supported by an oval profile plug-in (created by 
William O’Connnell). The FFT data was normalized to a baseline value of 0 and plotted 
in arbitrary units ranging from 0 to 0.3. 
 
Uniaxial Tensile Testing.  Uniaxial tensile testing was performed on samples 
previously hydrated for 24 hours.  “Dog-bone” shaped samples were punched from the 
electrospun tubes and electrospun mats (2.75 mm wide at their narrowest point with a 
gage length of 7.5 mm) and tested on a MTS Bionix 200 testing system with a 100 N load 
cell (MTS Systems Corp.) and an extension rate of 10.0 mm/min.  Punches from 
electrospun tubes were taken in the circumferential direction (the direction of mandrel 
rotation), and punches from electrospun mats were taken in both the X direction 
(direction of mandrel rotation) and the Y direction (the direction perpendicular to mandrel 
rotation).  Peak stress, modulus, and strain at break were calculated using TestWorks 
version 4.  The sample size for each specimen was n = 6. 
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Vascular Dynamic Compliance.  Dynamic compliance was determined for 4 
mm inner diameter tubular grafts under simulated physiological conditions in accordance 
with section 8.10 of ANSI/AAMI VP20:1994 [280].  The specimens were tested in an 
ITEMS™ Bioreactor developed by Tissue Growth Technologies (Minnetonka, MN) filled 
with PBS at 37°C and lined with a thin latex balloon (Party Like Crazy, Target 
Corporation) to prevent graft leakage.  The bioreactor provided a cyclic (1 Hz, 
representing 60 beats per minute) pressure change to the inside of the graft; three 
different pressure levels (90/50, 120/80, and 150/110 mmHg) were investigated. 
Internal pressure was measured with a pressure transducer capable of measuring 
dynamic pressure up to 200 ± 2 mmHg, while the external diameter was recorded with a 
laser micrometer system with an accuracy of ± 0.001 mm.  Prior to insertion into the 
bioreactor, the grafts were soaked in PBS at 37°C for 24 hours, after which time their 
average wall thickness was measured.  From this the internal radii of the graft was 
determined and used in the following equation to calculate compliance for each 
specimen: 
( ) 412
112 10
/)(
% ×−
−=
PP
RRR
Compliance PPP      (7.1) 
Where R is the internal radius, P1 is the lower internal pressure, and P2 is the higher 
internal pressure [280].  Grafts were then fixed onto distal and proximal nozzles in the 
ITEMS with 2-0 Silk suture.  37°C PBS was pumped through the inner lumen, brought to 
a static pressure of 80 mmHg, and allowed to stress relax for a period of 15 minutes.  At 
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each pressure level (systolic/diastolic), the graft was allowed 500 cycles of stress 
relaxation prior to compliance measurement. 
 
Vascular Burst Strength.  Burst strength testing (n = 6) was completed using a 
device designed in accordance with section 8.3.3.3 of ANSI/AAMI VP20:1994 [280]. 
Tubes, 2–3 cm in length, were hydrated in PBS, fitted over 3.0 mm diameter nipples 
attached to the device, and secured with 2-0 silk suture.  Air was introduced into the 
system, increasing the pressure at a rate of 5–10 mmHg/s until the tubes burst. Results are 
reported as the pressure in mmHg at which tubes ruptured. 
 
Vascular Longitudinal Strength.  Longitudinal strength was performed on 
hydrated, whole graft samples (n = 6) in accordance with section 8.3.2.4 ANSI/AAMI 
VP20:1994 [280].  4 mm inner diameter grafts were cut to a length of 3.5 cm and tested 
on a MTS Bionix 200 testing system with a 100 N load cell (MTS Systems Corp.), a gage 
length of 2 cm, and an extension rate of 50.0 mm/min.  Peak load and strain at break were 
calculated using TestWorks version 4. 
 
Statistical Analysis.  Unless otherwise stated, all statistical analysis was based on 
a Kruskal-Wallis one way ANOVA on ranks and a Tukey-Kramer pair-wise multiple 
comparison procedure (α=0.05) performed with the JMP®IN 4.0.3 statistical software 
package (SAS Institute, Inc). 
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RESULTS 
 
Fiber Characterization.  SEM images (figure 7.1 and 7.2) were analyzed using 
fiber diameter measurements to determine average fiber size and FFT to determine fiber 
alignment [343, 344].  Previous studies determined that mandrel rotational speed at 6000 
RPM did not adversely affect fiber diameter.  However, in those studies a rectangular 
mandrel was used, which could alter the electrospinning parameters.  Therefore, it was 
thought that a change in fiber diameter could be possible at a higher rotational rate of 
8000 RPM and a cylindrical mandrel, where the electric field would stretch and strain the 
fibers as they approached the mandrel.  Furthermore, as fibers adhered to the surface of 
the spinning mandrel and were whipped due to high angular momentum they would be 
stretched and strained to an even higher degree. 
   195500 RPM 8000 RPM
  
PCL 
  
PCL: Silk 
  
PDO 
  
PDO: Silk 
Figure 7.1.  Scanning electron micrographs for PCL, PCL:Silk, PDO, and PDO:Silk 
blends high rotational rates of 500 RPM (left) and low rotational rates of  8000 RPM 
(right) on an 80 mm diameter mandrel.   All micrographs are taken at 3000x. 
 
 
 
According to the SEM images displayed in figure 7.1, there are clear fiber 
alignment differences between the scaffolds as the rotational rate is increased from 500 
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RPM to 8000 RPM.  The degree of alignment in a data image is reported by the height 
and shape of the peak generated by the FFT plot.  The higher the peak, the more precisely 
aligned the fibers are along a single axis of orientation.  There were no significant 
differences between fibers at different rotational rates according to fiber diameter 
measurements, agreeing with previous experiments.  FFT analysis (figure 7.3) of the 
images from figure 7.1 proves that alignment increases with increasing rotational rates, 
demonstrating a clear trend in higher peak values as the rotational rate is increased.  PDO 
increased incrementally with normalized values of 0.04, 0.19, and 0.30, PCL increased 
with values of 0.03, 0.21, and 0.28, and PCL:Silk increased with values of 0.07, 0.10, and 
0.23 for 500, 1000, and 8000 RPM, respectively.  PDO:Silk was an exception decreasing 
from 0.07 to 0.02 for 500 and 1000 RPM, respectively, but increasing to a value of 0.22 
for 8000 RPM.  The highest peak values came from pure synthetics, producing alignment 
values of 0.30 and 0.28 for PDO and PCL scaffolds, respectively.  When silk was added 
to the polymer blend, values tended to decrease. 
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500 RPM 8000 RPM
  
PCL 
  
PCL:Silk 
  
PDO 
  
PDO:Silk 
Figure 7.2.  Scanning electron micrographs for PCL, PCL:Silk, PDO, and PDO:Silk 
blends high rotational rates of 500 RPM (left) and low rotational rates of 8000 RPM 
(right) on a 4 mm diameter mandrel.   All micrographs are taken at 1760x. 
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Figure 7.3.  FFT alignment analysis of SEM pictures for ACL grafts containing PCL, 
PCL:Silk (left), PDO, and PDO:Silk (right) scaffold structure as a function of mandrel 
RPM with an 80 mm diameter mandrel. 
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Figure 7.4.  Average fiber diameter of PCL, PCL:Silk, PDO, and PDO:Silk blends at 
high rotational rates of 8000 RPM and low rotational rates of 500 RPM on a 4 mm 
diameter mandrel. 
 
 
 
Success in creating fiber alignment for ACL graft structures thereby led to a 
confident approach for vascular applications, using a smaller mandrel.  Fiber diameter 
results (figure 7.4) revealed that for mandrel rotations of 500 RPM and 8000 RPM, PCL 
had an average of   0.6 0.4 and 0.7± ± 0.3 µm, PCL:Silk had an average of 1.3 ± 0.3 µm  
and 0.9 0.4 µm, PDO had an average of 1.4± ± 0.6 and 1.2 ± 0.5 µm, and PDO:Silk had 
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an average of 1.0 0.3 and 1.0 0.2 µm, respectively.  Statistically significant differences 
between rotational rates of 500 and 8000 RPM existed only for the PCL:Silk blend.  
Again, it was determined that mandrel rotational rate did not have an impact on fiber 
diameter even with small mandrel diameters.  However, examining the SEM micrographs 
closely, fiber packing density is high for higher mandrel rotational rates, resulting in a 
more compact matrix.  These findings are consistent with previous testing [343].   
± ±
 Additional FFT analysis was performed on SEM images in figure 7.3 to 
characterize fiber alignment properties.  Images of both the inside and outside of each 
electrospun graft were taken and analyzed.  Results of FFT analysis are displayed in table 
7.1 and figure 7.5.   
 
Table 7.1.  FFT alignment analysis of SEM micrographs 
RPM (graft side) PCL PCL:Silk PDO PDO:Silk 
8000 (Inside) 0.07 0.10 0.09 0.10 
8000 (Outside) 0.13 0.06 0.10 0.08 
500 (Inside) 0.03 0.10 0.08 0.05 
500 (Outside) 0.05 0.10 0.10 0.12 
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Figure 7.5.  FFT alignment analysis of inside and outside graft SEM pictures containing 
PCL (top left), PCL:Silk (top right), PDO (bottom left), and PDO:Silk (bottom right) 
scaffold structure as a function of mandrel RPM with a 4 mm diameter. 
 
 
 
Uniaxial Tensile Testing for Ligament.  Initially looking at the FFT results from 
table 7.1 there is a clear distinction between the X and Y directions for both 1000 and 
8000 RPM, indicating that fibers are preferentially aligned in the X direction.  This 
distinction is more prevalent in synthetic polymers (PCL and PDO) than their blended 
counterparts (PCL:Silk and PDO:Silk), which demonstrates that the addition of Silk, in 
this case, provides for a less preferential direction when electrospun under these 
conditions.  Significant differences for the X direction demonstrated that as mandrel 
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RPM increased from 500 to 8000 RPM peak stress and modulus increased in an 
incremental fashion, indicating step-wise increases in alignment.  This can be shown with 
PCL where there was a 128 % increase between 500 and 1000 RPM and a 125 % 
increase between 1000 and 8000 RPM.  Additionally, significant differences existed 
between the X and Y directions for peak stress and modulus when scaffolds were 
electrospun at a rotational rate greater than 1000 RPM.  This further proves changes in 
scaffold alignment as there were incremental decreases in peak stress and modulus in the 
Y direction.  Additionally, the highest values for strain at break existed in the Y direction 
verifying fiber alignment in the X direction.  This can be shown with PDO where strain 
values increase from 3.0 to 5.7 mm/mm between 1000 and 8000 RPM. 
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Table 7.2.  Uniaxial tensile test results for the 80 mm diameter drum 
 Peak Stress (MPa) Modulus (MPa) Strain at Break 
(mm/mm) 
 X Y X Y X Y 
PCL       
500   
RPM 
3.9  0.3 ± 2.6  0.6 ± 9.4 ±  0.4 7.3 ±  0.7 0.9 ±  0.1 1.3 ±  0.2 
1000 
RPM 
8.9  1.5 ± 1.2  1.2 ± 18.0 ±  1.8 1.0 ±  0.1 1.0 ±  0.1 4.3 ±  0.4 
8000 
RPM 
20.0  2.3 ± 1.4  0.2 ± 42.7 ±  6.4 0.6 ±  0.2 1.0 ±  0.1 6.0 ±  0.6 
PCL:Silk       
500   
RPM 
1.4  0.2 ± 1.4  0.1 ± 13.4 ±  2.1 15.6 ±  0.9 0.5 ±  0.1 0.5 ±  0.2 
1000 
RPM 
2.1  0.1 ± 0.9  0.1 ± 11.1 ±  1.1 4.2 ±  1.0 0.5 ±  0.1 0.7 ±  0.1 
8000 
RPM 
4.8  0.4 ± 0.7  0.2 ± 16.2 ±  1.3 0.8 ±  0.2 0.5 ±  0.1 2.7 ±  0.7 
PDO       
500   
RPM 
4.6  0.4 ± 5.1  0.5 ± 12.3 ±  0.9 9.9 ±  1.2 2.4 ±  0.3 3.3 ±  0.5 
1000 
RPM 
8.1  0.1 ± 1.3  0.5 ± 23.1 ±  0.8 1.1 ±  0.3 0.7 ±  0.7 3.0 ±  0.7 
8000 
RPM 
12.5  0.5 ± 0.7  0.1 ± 35.7 ±  2.8 0.2 ±  0.1 0.7 ±  0.1 5.7 ±  0.6 
PDO:Silk       
500   
RPM 
2.3  0.2 ± 2.7  0.6 ± 1.7 ±  0.1 2.2 ±  0.3 1.5 ±  0.1 1.4 ±  0.3 
1000 
RPM 
3.9  0.3 ± 1.4  0.3 ± 3.7 ±  0.3 1.1 ±  0.1 1.3 ±  0.1 1.5 ±  0.2 
8000 
RPM 
7.6  0.4 ± 0.7  0.1 ± 20.5 ±  0.7 0.5 ±  0.1 0.6 ±  0.1 2.7 ±  0.1 
 
 
Uniaxial Tensile Testing for Vascular Graft.  Uniaxial tensile testing reported 
peak stress, tangential modulus, and strain to break for all samples tested.  Vascular grafts 
were splayed open and punched into “dog bone” shapes for materials testing.  It should 
be recognized that the event of punching “dog bones” from the grafts provides an initial 
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stress and compression to the inner lumen and outer portion of the graft, respectively.  In 
order to allow for consistency amongst the graft samples, all punches were clamped 
between the grips with slack and the slack was then carefully taken out to a force of 0.1 
N.  Figure 7.6 displays the results from the test. 
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Figure 7.6.  Uniaxial tensile test values for peak stress, tangential modulus, and strain to 
break for PCL, PCL:Silk, PDO, and PDO:Silk spun at both 500 RPM and 8000 RPM on 
a 4 mm diameter mandrel. 
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The results revealed two similar trends between peak stress and modulus, where 
electrospun fibers at high rotational rates demonstrate a higher modulus and peak stress.  
For peak stress, PCL, PCL:Silk, and PDO:Silk had values of 2.6, 1.1, and 0.9 MPa for 
500 RPM, while 8000 RPM had values of 5.2, 2.6, and 1.7 MPa, respectively.  Modulus 
displayed values for PCL, PCL:Silk, and PDO:Silk at 4.2, 3.5, and 1.9 MPa for 500 
RPM, and 8000 RPM had values of 5.0, 5.7, and 2.3 MPa, respectively.  PDO, however, 
displayed opposite characteristics with a higher peak stress and modulus for 500 RPM 
compared to 8000 RPM.  Amongst these grafts, pair wise differences were examined 
between the two rotational rates to determine significance.  Significant differences 
existed for PCL and PDO scaffolds for peak stress and only PDO scaffolds for modulus.  
No differences existed for strain to break. 
Examination of the data displays an encouraging trend whereby higher rotational 
rates induce a larger average peak stress and average modulus in all samples except for 
PDO.  If fiber alignment is present through the entire scaffold, then fibers aligned in the 
circumferential direction would contribute to an increase in peak stress and modulus.   
 
Longitudinal Strength Testing.  Whole grafts were cut to a length of 3.5 cm and 
clamped between two grips with a 100 N load cell for strength testing.  If fiber alignment 
were to occur throughout the entire wall of the graft sample, then a marked difference 
between the aligned scaffolds and random scaffolds should be present under uniaxial 
loading conditions perpendicular to the axis of alignment.  Peak force for PCL, PCL:Silk, 
PDO, and PDO:Silk displayed values of 20.9, 8.6, 16.5, and 16.4 N for 500 RPM 
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rotational rates, while 8000 RPM displayed values of 15.1, 8.8, 6.5, and 10.1 N, 
respectively.  According to figure 7.7 statistically significant differences for peak load 
exist between 500 and 8000 RPM for the synthetic scaffolds, PDO and PCL.  However, 
when silk was blended with the synthetics no differences were present.  Strain to break 
for longitudinal graft testing displayed a significant difference only between the high and 
low rotational rates of PCL, a trend that was opposite from the rest of the data set. 
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Figure 7.7.  Longitudinal strength values for peak force and strain to break on 3.5 cm 
whole graft samples of PCL, PCL:Silk, PDO, and PDO:Silk spun at 500 RPM and 8000 
RPM on a 4 mm diameter mandrel. 
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Burst Strength.  As the “gold standard” of vascular grafts, human saphenous 
vein (hSV) burst strength is commonly used as a comparison tool for the burst strength of 
other manufactured grafts.  HSV has been reported to reach an average burst pressure of 
1599 mmHg [345].  Vascular grafts were tested to determine if their values were 
comparable to HSV.  Overall, aligned fibers in the circumferential direction would 
require higher burst pressure strength in comparison to a more randomized matrix.  This 
was confirmed with the test results in figure 7.8, where mean comparisons between 500 
and 8000 RPM for PCL, PCL:Silk, PDO, and PDO:Silk were significantly different from 
each other. The grafts spun at 8000 RPM were superior in burst strength quality with 
values of 3095, 2009, 3336, and 1256 mmHg compared to grafts spun at 500 RPM which 
had values of 2202, 1237, 1152, and 834 mmHg for PCL, PCL:Silk, PDO, and PDO:Silk.  
Lastly, the majority of high rotational rate grafts exceeded the HSV average, while the 
majority of low rotational rates were lesser than the HSV average. 
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Figure 7.8.  Burst strength pressure (mmHg) values for PCL, PCL:Silk, PDO, and 
PDO:Silk at rotational speeds of 8000 and 500 RPM on a 4 mm diameter mandrel.  
Dashed line represents HSV average burst strength. 
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Dynamic Compliance Testing.  Compliance measurements were determined 
using three different pressure intervals of 90/50, 120/80, and 150/110 mmHg 
(systolic/diastolic).  The results are displayed in figure 7.9. 
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Figure 7.9.  Compliance determined from internal radii at three different arterial 
pressures (90/50, 120/80, and 150/110 mmHg). 
 
 
 
 PCL displayed an increase in compliance for pressures of 120/80 and 150/110 
mmHg when mandrel rotational rate is increased from 500 to 8000 RPM.  When silk was 
added to make a 50-50 blend with PCL, an increase in compliance was only seen for a 
pressure of 90/50 mmHg.  Thereafter, decreases were observed in both 120/80 and 
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150/110 mmHg as mandrel rotation was increased from 500 to 8000 RPM.  Consistent 
decreases in compliance were seen for PDO and PDO:Silk at all three pressure levels as 
mandrel speed was increased from 500 to 8000 RPM.  Significant differences amongst 
the three pressure intervals occur in both PCL spun at 500 RPM and PDO:Silk spun at 
500 RPM.  Differences between pressures at 90/50 and 150/110 mmHg were present for 
all grafts spun at 8000 RPM.  Significant differences were absent in both PCL:Silk and 
PDO grafts spun at 500 RPM.  In addition to these highlighted significant differences, the 
majority of the graft compliance values decrease with each interval.  This is consistent 
with previous findings for synthetics, synthetic and natural polymer blends, and native 
artery [20].     
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Figure 7.10.  Compliance determined from internal radii at 120/80 mmHg for PCL, 
PCL:Silk, PDO, and PDO:Silk at rotational speeds of 500 RPM and 8000 RPM on a 4 
mm diameter mandrel. 
 
 
 
 In figure 7.10, 120/80 mmHg arterial pressures were determined to have 
significant differences between 500 RPM and 8000 RPM scaffolds manufactured with 
PDO and PDO:Silk.  PDO had values decreasing from 1.1 to 0.3 % / 100 mmHg, and 
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PDO:Silk had values decreasing from 1.4 to 0.9 % / 100 mmHg as mandrel rotation was 
increased from 500 to 8000 RPM, respectively.  This translated to a 68 % and 35 % 
change for PDO and PDO:Silk, respectively.  Both PCL and PCL:Silk scaffolds did not 
have significant differences.  Instead, an average compliance increase was seen in PCL 
while PCL:Silk stayed even between the two mandrel speeds. 
 
DISCUSSION 
  
Fiber Characterization.  Fiber size and orientation can contribute to changes in 
anisotropy which can then lead to changes in material properties and scaffold 
functionality.  For the purpose of this study, scaffolds to mimic ACL and arterial 
geometry were being investigated to determine both fiber orientation and its impact on 
mechanical characterization as a function of mandrel rotational speed and mandrel size.  
Previous alignment studies have shown that both mandrel rotational speed and mandrel 
size play a large role in fiber alignment [346, 347].  Therefore, in order to develop highly 
aligned fibers for the purpose of ACL replacement, a mandrel with a diameter of 8 cm 
was used.  Small caliber arteries require a significantly smaller mandrel < 6 mm in 
diameter.  Therefore, a 4 mm diameter mandrel was used for arterial testing. 
 SEM characterization produced fiber diameter and degree of fiber alignment 
results for both ACL and arterial applications.  As mandrel speed increased, fiber 
diameter did not change for either mandrel size, indicating that fiber diameter is not 
influenced by mandrel rotational speed.  This is important in terms of mechanical 
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analysis, whereby a larger or smaller diameter can increase or decrease modulus.  
However, if nothing changes between the two groups, then it is then assumed that fiber 
orientation, in regards to this study, is the primary contributor to any mechanical changes 
observed.  
 FFT analysis for fiber alignment of both vascular and ACL grafts demonstrated 
visible differences between 500 RPM and 8000 RPM.  Vascular scaffolds tended to have 
a more compact matrix that was aligned to some degree while ACL grafts had equally 
compact matrices with highly aligned fibers.  The characteristics of both scaffold types 
can be directly attributable to the manufacturing process, displaying a clear difference 
between small diameter mandrels and large diameter mandrels.  Alignment at the small 
diameter level revealed that certain pure synthetics, such as PCL, could be manipulated 
through mandrel rotational rates.  However, certain pure synthetics, such as PDO, were 
nearly the same at both mandrel speeds.  This indicates that surface speed, molecular 
structure, fiber diameter, and its associated electrohydrodyamics play a role in fiber 
alignment, where fibers repel and attract one another in a particular fashion prior to 
landing on the mandrel.  Yang et al. [348] has studied electrohydrodynamics and 
demonstrated how electrospinning parameters can affect jet whipping.  In our case, this 
directly impacts fiber alignment, and, based on certain polymer blends, may require a 
threshold surface speed in order to result in higher degrees of alignment.  This can be 
seen with the large diameter mandrel, producing decreases in FFT alignment for silk 
blended polymers compared to pure synthetics. 
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Uniaxial Tensile Testing.  Tensile testing results present further defense for fiber 
alignment in both cases.  PCL and PDO displayed significant differences for peak stress 
and modulus between 500 and 8000 RPM for vascular and ACL scaffolds in the 
circumferential and X directions, respectively.  Interestingly, PDO vascular scaffolds 
demonstrated a significantly higher modulus and peak stress at 500 RPM than at 8000 
RPM.  This could be due to PDO’s specific electrical properties during the 
electrospinning process, where if the graft is spun at too high a speed then it will produce 
a more random matrix through inconsistent polymer deposition onto the mandrel surface.  
In addition to synthetics, biopolymers, such as gelatin, have been shown to exhibit similar 
behavior.  This was observed when spinning gelatin at 130 mg/ml transitioning from 
6000 to 7000 RPM, resulting in a decrease in peak stress from 2.7 to 1.7 MPa [343].  In 
our case, PDO could be creating a more random matrix at 8000 RPM, which could help 
to explain similar FFT results.   
When silk was blended with PCL and PDO in ACL scaffolds, significant 
differences were present in both blends for peak stress and modulus, however, vascular 
scaffolds were not different.  This again portrays the differences in electrospinning when 
another polymer is introduced, changing the electrodynamics and decreasing fiber 
alignment.   
 Y direction tensile testing was also performed on ACL scaffolds to compare to the 
X direction and show fiber preference (longitudinal tensile testing for vascular scaffolds 
is discussed in the next section).  Again fiber alignment was proven to be in the X 
direction where peak stress and modulus were higher when compared to the Y direction.  
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Additionally, strain to break was highest overall in the Y direction.  This data shows that 
when fibers are parallel to one another the force to break them increases because of fiber 
recruitment.  Instead, if fibers are perpendicular to the axis of force, then there is nothing 
to resist that force and the fibers pull apart. 
 
Vascular Longitudinal Strength Testing.  If fibers are aligned in the 
circumferential direction, then a whole scaffold sample tested in the longitudinal 
direction should exhibit a lower peak stress for higher rotational rates in comparison to 
lower rotational rates.  According to the data, both PCL and PDO showed pairwise 
differences between 500 and 8000 RPM, indicating that fibers were preferentially aligned 
in the circumferential direction.  Again, the addition of silk changed the electrospun 
scaffolds and produced no significant differences between 500 and 8000 RPM.  The 
overall results pointed towards a higher preferential alignment when scaffolds were 
electrospun at 8000 RPM.   
 
Vascular Burst Strength Testing.  Utilization of burst strength testing 
incorporates biaxial loading to failure, which provides an additional picture of scaffold 
anisotropy.  From the previous two tests, we were able to show that fibers preferentially 
align themselves in the circumferential direction.  If this is true, then burst strength in 
addition to the other tests would be higher for 8000 RPM then for 500 RPM.  Figure 7.8 
demonstrates a higher average burst pressure for all scaffolds spun at 8000 RPM.  
Inclusion of all fibers in the electrospun scaffold in the testing scenario demonstrated the 
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contribution of each individual fiber to the group of fibers surrounding it, thereby 
providing further strength for the whole scaffold instead of observing a small section of 
the scaffold which could exhibit slight differences introduced during the manufacturing 
process. 
 
Vascular Dynamic Compliance Testing.  Another whole scaffold test is 
dynamic compliance.  Much like the burst strength test preformed in the previous section, 
fiber behavior can be inferred at the macroscopic level under physiological pressures.  
The results of the test showed that both PDO and PDO:Silk had significantly higher 
compliance values at 500 RPM than at 8000 RPM, demonstrating fiber anisotropy in the 
circumferential direction at higher speeds.  Compliance results emulate results from burst 
strength testing and show that a stiffer, less compliant scaffold is present at 8000 RPM.   
 Trends in figure 7.10 show that when silk is blended with the synthetic, a higher 
average compliance value is reached.  These trends coupled with the encouraging cellular 
results from Soffer et al. [183] reveal the potential importance of silk in arterial tissue 
engineering.  Although further testing and optimization must be performed with silk 
blended scaffolds, results from this study and previous studies point towards a promising 
future. 
Vascular applications demonstrated that fibers preferentially aligned themselves 
in the circumferential direction compared to the longitudinal direction.  However, 
electrohydrodynamics and polymer type share an important role in regulating and 
optimizing electrospinning parameters.  Mostly, scaffolds spun at 8000 RPM were very 
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compact and stiff to the touch, characteristics which would decrease cellular infiltration 
and cause mechanical mismatch between the scaffold and artery which could then result 
in intimal hyperplasia.  Therefore, if the biological geometry of an artery were to be 
considered in vascular replacements, a good approach could be using a flat sheet of 
aligned fibers and rolling them onto a cylindrical mandrel at different angles. 
 
CONCLUSION 
 
 Silk has been explored as a replacement tool for ligaments, and its elastic nature 
creates a scenario that is primed for cyclic loading environments, providing low energy 
dissipation.  As an arterial replacement subject to repetitive pulsatile forces, silk is also 
beneficial and has been proven already to exhibit similar material properties in 
comparison to native artery [183].  Results from this preliminary study using PDO and 
PCL with and without silk, indicated that fiber alignment could be successfully achieved 
using a large diameter mandrel.  Additionally, varying the rotational speed on this 
mandrel allows the user to control the degree of alignment and its subsequent mechanical 
properties.  The small diameter mandrel, 4 mm, displayed mechanical characteristics 
indicating preferential fiber alignment, yet, as a vascular scaffold, its ability to distend 
with aligned, compact fibers provides far less compliance than that of random fibers 
which still seem to produce signs of alignment.  An alternative would be to roll a flat 
sheet of aligned fibers from the ligament set up.  As a natural protein, SF has shown to be 
a beneficial polymer for tissue engineering of both ligament and artery.  Further 
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optimization of the parameters associated with electrospinning will have laid the 
groundwork for future in vitro and in vivo experimentation. 
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CHAPTER 8 Creating Cellularized Ligament Analogues 
 
 
INTRODUCTION 
 
 
Ligament Structure.  Ligaments are dense connective tissues which attach bone 
to bone and act principally in tension to guide and restrict joint movements [349].  In the 
human knee there are four primary ligaments: the medial collateral ligament (MCL), 
lateral collateral ligament (LCL), posterior cruciate ligament (PCL), and ACL.  These 
four ligaments work both individually and in concert to resist unwanted motion in the 
knee.  Of the four knee ligaments, the ACL is the main stabilizer of the knee for athletic 
pivotal activities  and has attachment sites on the tibia and femur [350].  As such, ACL 
resists the anterior displacement of the tibia with respect to the tibia, as well as assisting 
in the resistance of hyperextension and playing a role in the rotational stability of the 
extended knee for internal and external tibial rotation [351].   
Gross dissection of the knee reveals the ACL to be an anisotropic collagenous 
structure wrapped in a thin synovial membrane.  The ACL is heterogeneous, with two 
distinct bundles playing two distinct roles: the anteromedial bundle (AM), taught in 
flexion, and the posterolateral bundle (PM), taught in extension.  ACL also has two bony 
insertion sites (one each on the tibia and femur), with each insertion site comprised to 
four distinct zones.  Zone 1 comprises the majority of the ligament and is composed 
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entirely of ligamentous tissue, zone 2 is a transition to fibrocartilage, zone 3 is stiffer 
mineralized fibrocartilage, and zone 4 is bone [268, 271, 352-354]. 
For this study the focus was on engineering zone1, the ligamentous tissue.  The 
ECM of zone 1 is composed almost entirely of type I collagen and water.  Type I 
collagen makes up 70-80% of a ligament’s dry weight, while water constitutes 60% of 
the wet weight.  Other ECM molecules present in ligamentous tissue include type III 
collagen (8% dry weight), type V collagen (12% dry weight), elastin (<5% dry weight), 
and proteoglycans (<1% dry weight) [271, 353].  Structurally, ligament has a hierarchical 
organization (figure 8.1) whose basic unit is parallel fibrils of collagen 30-100 nm in 
diameter which combine to form collagen fibers 1-20 µm in diameter.  The parallel 
collagen fibers then merge together to form a subfasicular unit between 100 and 250 µm 
in diameter.  Subfasicular units are surrounded by connective tissue known as the 
endotenon.  Endotenon wrapped subfasicular units then aggregate into collagen fascicules 
wrapped with epitenon connective tissue.  These fascicules are wrapped by a paratenon, 
followed by a synovial sheath which supplies blood flow to the ligament [268, 354].  The 
collagen fascicles experience a crimping pattern with an amplitude of <5 µm and period 
of 45-60 µm.  This crimp provides shock absorbing capabilities to the ligament and 
allows for 7-16% creep to occur prior to permanent deformation  [268, 349, 355]. 
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Figure 8.1.  A diagram of the cruciate ligament structure shown down to the individual 
collagen fiber level (top) [354], and the interaction between collagen fibrils and ligament 
FBs (bottom) [349]. 
 
 
The primary cellular component of ligamentous tissue is the FB.  These cells tend 
to be sparsely distributed throughout the ligament, and make up only a small volume of 
the total tissue.  Typically, FBs will take a fusiform shape (figure 8.1) and align 
themselves parallel to the collagen fibers [349].  FBs have also been seen to take on an 
ovoid shape, lacking extensive cytoplasmic processes, and arrange in columns between 
collagen fibers.  Regardless of their shape, these cells function to secrete and maintain the 
ECM of the ligament.  Due to low cell densities matrix turnover is often very slow, 
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partially explaining the poor reparative capacity of ACL.  Ligament also contains a 
limited number of vascular and neural cells  [353, 356]. 
Ligament Mechanics.  The in situ loading of the ACL is extremely complex and 
not easily modeled as the knee joint is a 6 degree of freedom joint.  As such, native 
ligament and ligament grafts are generally first tested to failure in tension as a bone-
ligament-bone complex.  The uniaxial tensile properties of ligament owe much to the 
tissues hierarchical collagenous structure.  When testing a ligament in tension, there are 
typically four main regions seen on the load-elongation curve (figure 8.2).  The initial 
‘toe’ region is a period of high elongation at low load due to the crimped nature of the 
structure.  ACL tends to have a larger ‘toe’ region than other collagenous structures (i.e. 
tendon) due to its anisotropic nature.  The presence of the two distinct bundles, the AM 
and PM, and their different physiologic roles, ensures that not all the collagen fibers will 
be tensed at the same time leading to an extended period of crimp removal.  Following 
the ‘toe’ region, when the collagen crimp has been exhausted, the ligament will 
experience a linear elastic region followed by a region where plastic deformation occurs, 
and eventually catastrophic failure [352].  In a study by Chandrashekar et al., in which 
human ACL was isolated and tested in tension to failure at 100% strain per second, ACL 
was found to exhibit a modulus of elasticity of 113 + 45 MPa, a failure stress of 24.36 + 
9.38 MPa, and a strain at failure of  0.28 + 0.07 mm/mm [357]. 
As with most biological materials ligament exhibits viscoelastic behavior, and is 
both time and history dependant.  It has been shown that preconditioning of ligament to 
low levels of strain results in rapid decreases in hysteresis and increases in both resting 
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length and stiffness.  This causes the ligament to act more like a spring and become more 
energy efficient.  Testing has also revealed ligament to be highly rate sensitive, with 
increases in loading rate leading to increases in failure load, extension to failure, energy 
to failure, and stiffness [352, 358].  The presence of elastin in ligamentous tissue assists 
in the elastic recoverability of the structure due to its spring-like nature and ability to 
recoil from tensile loading [353].  The presence of negatively charged proteoglycans 
provides the matrix with viscous properties.  The glycosaminoglycan chains which 
constitute proteoglycans attract water, resulting in proteoglycan swelling and entrapment 
among collagen fibrils.  This adds compressive strength to the ligament and causes the 
proteoglycans to act like hydraulic dampers [349]. 
Modulus: 
113+45 MPa  
Failure Stress: 
24.36+9.38 MPa  
Strain at Failure:  
0.28 + 0.07 mm/mm    
 
Figure 8.2.  Diagram of typical stress-strain curve for human ACL [359]. 
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Ligament Repair and Healing.  It has been well documented that the MCL, a 
ligament residing outside the articular capsule of the knee, has the ability to 
spontaneously repair itself.  Adult MCL repair is a 3 phase process that begins with 
hemostasis and inflammation, followed by cell proliferation and matrix deposition, and 
finally long-term remodeling.  Within the first 72 hours after injury, a hematoma will 
develop in the soft tissue adjacent to the wound, and inflammatory cells will invade the 
site.  These inflammatory cells (monocytes, leukocytes, and macrophages) release 
cytokines and growth factors to begin clean-up of the wound site and initiate repair.  FBs 
then enter the area and begin to produce ECM proteins, primarily collagen type III and 
type I, in a relatively disorganized manner, which then forms a vascular scar.  During the 
remodeling stage this scar is transformed into tissue more similar in structure to that of 
native MCL due to the production of greater quantities of type I collagen arranged 
parallel to the injured ligament [270, 271, 360, 361]. 
The ACL, an intra-articular ligament, exhibits an extremely poor reparative 
capacity.  In fact, rapid degeneration of the ACL has been observed following acute 
injury.  Blood flow to the ACL is provided by the thin synovial sheath surrounding the 
ligament.  When the ACL is injured, this sheath is damaged and blood flow and nutrient 
delivery is disrupted.  The dissipation of blood prevents the formation of a localized 
hematoma and ultimately results in retarded healing due to a lack of cytokines and 
growth factors [270].  Additionally, the damaged synovial membrane exposes the 
collagenous ligament tissue to a potentially hostile hemarthrotic fluid environment inside 
the articular capsule of the knee.  This combination of blood and synovial fluid has been 
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shown to contain degradatory enzymes such as collagenase, as well as have an adverse 
effect on FB proliferation.  The lack of mechanical stimulation within a ruptured ACL 
may also contribute to a lack of new ECM produced by hLFs [362].   
Tissue Engineering of Ligament.  The creation of an ideal tissue engineered 
ligament replacement requires a structural scaffold that can support cell activity, host 
reparative cells with the ability to produce ECM, and have an overall structure conducive 
to the repair process with appropriate nutrient supply [270].  The engineered ECM 
analogue should ideally have mechanical properties similar to those of native ACL; for a 
complex load bearing structure, this is no small feat and as such there are several major 
hurdles.  Foremost, the initial mechanical properties of the structure (i.e. ultimate stress, 
modulus, and strain at break) need to replicate those of ACL.  To prevent catastrophic 
failure, the mechanical properties of the implanted structure need to remain high in vivo 
as the material degrades and cells infiltrate and remodel the scaffold.  The ability to 
withstand multidirectional stresses and creep are also essential to ACL graft success 
[268]. 
There have been many different approaches taken to engineering ligament 
replacements.  Most involve the use of bioresorbable synthetic polymers such as PLA 
[268, 269, 273, 326, 327], PLGA [267, 269, 276, 328, 329], PCL [268, 270], and PDO 
[273, 363].  Natural biopolymers such as silk [22, 80, 83-85, 268, 270, 273, 330], and 
collagen [61, 268, 270, 273, 326] have also been used extensively.  These materials have 
been used almost exclusively as braided, knitted, or extruded micron scale fibers, with no 
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evidence of a ligament analogue composed entirely of electrospun nanofibers in the 
literature. 
Electrospinning Ligament Analogue Structures.  Electrospinning allows for 
the easy creation of scaffolds made of highly aligned fibers.  The degree of fiber 
alignment contained within an electrospun scaffold can be quantified through the use of 
FFT algorithm [343, 344].  Aside from obvious anisotropic mechanical advantages in the 
direction of fiber alignment (increased peak stress and modulus) [343, 344, 364], aligned 
fibers have been shown to effect cell behavior as well.  When FBs were cultured on 
highly aligned nanofibrous scaffolds, they exhibited a morphology similar to that seen in 
vivo and produced more ECM than FBs seeded on randomly aligned scaffolds [274, 275].  
MSCs have been shown to align themselves along the long axis of fibers with actin 
organization determined by the fiber orientation when seeded on aligned scaffolds [364]. 
There are several ways to create electrospun scaffolds of highly aligned 
nanofibers, most easily by altering the shape and rotational speed of the collection target.  
Solid and wire frame rotating drums have been shown to create aligned fibers at different 
rotational speeds for different polymers.  The use of a rotating knife edged disk has also 
proven successful.  Manipulation of the electric field, such as the use of a patterned array 
of conducting and insulating strips, can also create aligned scaffolds [132].  It is also 
possible to create 3-dimensional structures, as opposed to flat sheets, of aligned fibers by 
employing air-gap electrospinning (figure 8.3.).  Air-gap electrospinning requires the 
charged needle of the polymer solution to be placed equidistant between a pair of 
conductive parallel collectors.  The profile of the electric field created causes the 
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electrospinning jet to stretch itself across the gap between the two collectors and deposit 
aligned fibers between them.  The charge of the individual fibers creates a mutual 
repulsion which enhances their ability to align and be distributed evenly [132, 365]. 
The purpose of this study was to create aligned electrospun structures of SF, 
PDO, and PCL for ligament engineering fabricated through traditional electrospinning as 
well as air-gap electrospinning.   These scaffolds were characterized through SEM and 
FFT, had their structural and mechanical properties evaluated, as well as their levels of 
celllar affinity to determine which material and fabrication process were best suited for 
use as a ligament analogue structure. 
Grounded Targets
Polymer Solution
 
Figure 8.3. Schematic of air-gap electrospinning 
 
MATERIALS AND METHODS 
 
 SF Extraction.  SF was extracted from the cocoons of Bombyx mori silkworms 
(The Yarn Tree) through an established protocol [88].  Briefly, silk cocoons were cut into 
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pieces and boiled in a 0.02 M Na2CO3 (Sigma Aldrich) solution for 30 minutes to remove 
sericin gum, followed by thorough rinsing in DI water, and drying in a fume hood.  The 
SF was then dissolved in a LiBr (Fisher Scientific) solution at 60°C for 4 hours.  This 
solution was then dialyzed against DI water for 3 days using 3500 MWCO dialysis tubing 
(Fisher Scientific).  The SF solution was then frozen and lyophilized to provide a pure SF 
powder for electrospinning. 
 Scaffold Fabrication.  For the creation of randomly aligned scaffolds, a 
rectangular mandrel (2.5 cm wide x 10.2 cm long x 0.3 cm thick) rotating at 400 RPM 
and translating at 6 cm/s over a distance of 12 cm was used as the collecting target.  
Based upon preliminary electrospinning results (Appendix A), SF solution was dissolved 
in HFP at a concentration of 70 mg/ml or 100 mg/ml and was loaded into a Becton 
Dickinson syringe fitted with a blunt tip 18 gauge needle and dispensed at a rate of 4 
ml/hr with a KD Scientific syringe pump.  A charging voltage of +25 kv was applied to 
the needle tip, with an air-gap distance of 20 cm between the needle tip and the grounded 
mandrel.  Random PDO (Ethicon, Inc.) and PCL (MW 65,000 kDa, Sigma) scaffolds 
were electrospun at a concentration of 100 mg/ml from HFP with a flow rate of 6 ml/hr, 
charging voltage of +25 kv, and an air-gap of 20 cm.  Randomly oriented 50:50 blends by 
volume of SF:PDO (SPDO) and SF:PCL (SPCL) were electrospun using parameters 
identical to those of pure SF scaffolds.  These blends utilized solutions of 70 mg/ml SF 
and 100 mg/ml synthetic polymers.   
Aligned scaffolds of the aforementioned materials and blends were created using 
identical electrospinning parameters to those of the randomly oriented structures, but 
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rather than a slowly rotating rectangular mandrel, aligned scaffolds were electrospun onto 
an 8 cm diameter drum rotating at 8000 RPM and translating at 0 cm/s.  Following 
electrospinning, all samples were soaked in ethanol for 30 minutes to force β-sheet 
formation in the SF fibers [22]. 
 
 
Figure 8.4.  Photographs of preliminary air-gap electrospinning setup made from 1 ml 
syringe, cabinet door knobs, and insulating plastic coating. 
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 Air-gap electrospun constructs were fabricated using the system shown in figure 
8.4.  The preliminary air-gap electrospinning setup consisted of two conductive towers, 
with each constructed from a cabinet door knob (1 ¼” Satin Nickel Egg Knob, 
Gatehouse) attached to a plastic 1 ml Becton Dickinson syringe through which a heavy 
gauge wire had been run.  The entire system was then coated with an insulating plastic 
dip (Plasti Dip®, Plasti Dip International), and a small area (1 cm wide x 2 cm high) on 
the face of each door knob was scraped clean to provide a conductive surface.  The 
conductive towers were then mounted in a piece of wood with 5 cm between their faces.  
70 mg/ml SF solution was air-gap electrospun using a charging voltage of +25 kv on the 
needle tip, -5 kv applied to the conductive towers, a flowrate of 10 ml/hr, and a distance 
of 25 cm between the needle tip and the towers.  Pure PDO and PCL constructs, with 
concentrations and ratios identical to those used in standard electrospinning, were 
electrospun with a charging voltage of +22 kv on the needle tip, -5 kv applied to the 
towers, a flowrate of 16 ml/hr, and a distance of 25 cm between the needle tip and 
conductive tower.  SPDO and SPCL constructs were created with parameters identical to 
those of pure SF. 
 Scaffold Characterization.  Each of the electrospun scaffolds was characterized 
through SEM (Zeiss EV050).  Average fiber diameters were calculated by taking 60 
random fiber measurements from across the SEM image using ImageTool 3.0 software 
(Shareware provided by UTHSCSA).  Additionally, an FFT was used to quantify relative 
fiber alignment in each of the scanning electron micrographs using a method that has 
been previously described [343].  The FFT was performed on SEM micrographs taken at 
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500x (not shown) to provide a more complete representation of the entire scaffolds 
alignment than is visible in the 3000x images shown in figure 8.5. 
Porosity / Permeability Measurement.  Using a previously published method 
[311] the porosity of random, aligned, and air-gap electrospun scaffolds was determined.  
Briefly, 10 mm disks of each scaffold (n=3) were punched from the electrospun 
constructs, massed, and had their thicknesses recorded.  Porosity was then calculated 
using the following equation: 
1001 ×⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
DensityMaterialKnown
DensityScaffoldCalculatedPorosity                               (8.1) 
The calculated scaffold density was determined by dividing the mass of the scaffold by 
the total volume of the scaffold, while the material densities of SF (1.25 g/cm3), PDO 
(1.3 g/cm3), and PCL (1.14 g/cm3) are known. 
 Scaffold permeability was measured using a previously described method [311].  
Briefly, 10 mm samples of each scaffold (n=3) were punched from the electrospun 
constructs and allowed to soak in DI water for 1 hr prior to testing.  Sample thickness was 
recorded, and the samples were then placed in a permeability flowmeter with an applied 
pressure head of 120 mmHg.  The time for 10 ml of DI water to flow through a known 
volume of sample was recorded and the scaffold’s permeability was calculated as flow of 
fluid volume over 1 cm3 scaffold volume and time. 
Uniaxial Tensile Testing.  Dog-bone shaped samples (n=5) were punched from 
random (400 RPM), aligned (8000 RPM) and air-gap electrospun structures of SF (70 
mg/ml), PDO, SPDO, PCL, and SPCL.  These specimens were punched in two different 
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directions: parallel to the direction of mandrel rotation or (preferred fiber direction), or 
perpendicular to the direction of mandrel rotation (non-preferred fiber direction).  Testing 
samples taken from both directions would confirm fiber alignment and would serve as a 
better indicator of scaffold anisotropy than the strictly superficial SEM based FFT.  All 
specimens were then soaked in ethanol for 30 minutes for force β-sheet formation in the 
SF, followed by a 2 hour soak in DI water.  Samples were then uniaxially tested to failure 
at a rate of 10 mm/min using an MTS Bionix 200 testing system with a 100 N load cell 
(MTS Systems Corp.)  Peak stress, modulus, and strain at break were calculated using 
TestWorks version 4. 
Cellular Migration / Penetration.  Human dermal FBs (Cascade Biologics) were 
seeded onto SF (70 mg/ml), PDO, SPDO, PCL, and SPCL constructs fabricated through 
400 RPM, 8000 RPM, and air-gap electrospinning.  Two disks 6 mm in diameter were 
punched from each of the aforementioned material / fabrication combinations, disinfected 
(30 minute soak in ethanol followed by three 10 minute rinses in PBS), and placed in a 
96-well plate.  Each disk was then seeded with 50,000 FBs / well suspended in 50 µl 
Medium 106 (Cascade Biologics) supplemented with 1% penicillin-streptomyocin 
(10,000 Units/mL each, Gibco BRL Life Technologies) and 2% low serum growth 
supplement (Cascade Biologics).  Well plates were then placed in an incubator under 
standard culture conditions for 1 hour prior to the addition of an additional 150 µl 
Medium 106 and returned to incubation.  Culture media was completely changed every 
third day, and specimens were removed from culture on days 7 and 21 for Live/Dead® 
Cell Viability Assay (Molecular Probes) and histological evaluation (H&E staining).  
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Live/Dead® images were captured using a Nikon Eclipse TE300 under fluorescence at 
10x, while histology was imaged with the same microscope under normal light at 10x. 
Mechanical Degradation / Collagen Matrix Production.  To determine the 
rates of electrospun construct degradation and eventual replacement by native ECM, 
human dermal FBs (Cascade Biologics) were seeded onto SF (100 mg/m), SPDO, and 
SPCL electrospun scaffolds.  These scaffolds were all created with the 8 cm drum 
mandrel rotating at 8000 RPM using the parameters specified previously.  Dog-bone 
specimens (n=3) were punched from the electrospun mats, disinfected using the 
previously described method, and prepared for seeding and culture both statically and in a 
Rotary Wall Vessel Bioreactor (RWVB, Synthecon, Inc.).   
Static culture was done in 6-well plates.  Each well was filled with 400 µl of 12 
mg/ml polyhema in ethanol, which was then allowed to evaporate, to ensure cells would 
not adhere to the bottom of the well plate.  Three dog-bone specimens were then laid flat 
on the well plate and seeded with FBs at a concentration 150,000 cells/well (50,000 
cells/ml total volume in well) suspended in 1 ml of media (same as previous).  Plates 
were placed in an incubator under standard culture conditions for 1 hour to ensure cell 
attachment to the scaffolds had taken place prior to the addition of 2 more ml of media.  
Media was completely changed every third day and samples were removed at days 7, 14, 
21, and 28.  Control samples (no cells) were treated identically and were collected on 
days 7 and 28. 
Dynamic culture was done in 110 ml RWVBs.  Each bioreactor was sterilized by 
autoclaving, allowed to cool to room temperature, and filled with 60 ml of media (same 
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as previous).  Twelve disinfected dog-bone shaped specimens of the same material were 
added to each RWVB and allowed to sit for 30 minutes to soak up media and sink to the 
bottom of the bioreactor.  5.5x106 FBs suspended in 50 ml of media (50,000 cells / ml 
total volume in bioreactor) were added to each bioreactor.  The bioreactors were sealed 
and placed in an incubator under standard culture conditions.  The bioreactors were set to 
rotate at a constant 7 RPM, a speed that kept specimens from being pushed to the outer 
wall of the bioreactor while also preventing them from floating to the top of the 
bioreactor.  50 ml of media was changed once every 7 days, and samples were removed 
on days 7, 14, 21, and 28.  Control samples (no cells) were treated identically and were 
collected on days 7 and 28. 
At the end of each 7 day period samples were removed from culture and placed in 
PBS.  Samples were then uniaxially tested to failure on an MTS Bionix 200 in a method 
previously described.  Tested samples were then collected and stored for use with the 
SircolTM Collagen Detection Assay via a slightly modified protocol.  Briefly, individual 
samples were placed in 2 ml microcentrifuge tubes to which 1 ml of HFP was added to 
dissolve the electrospun construct.  This HFP was then allowed to evaporate and 1 ml of 
0.5 M acetic acid containing 2.5 mg/ml pepsin was added to the tube to solubilize any 
collagen contained within.  This solution was then centrifuged at 10,000 g for 10 min to 
remove any residual scaffold polymer, and the collagen containing supernatant was 
collected and tested using the standard Sircol protocol. 
Preliminary Microintegration of Air-gap Constructs.  While traditional cell 
culture requires several weeeks for cells seeded on the surface of an electrospun scaffold 
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to migrate and proliferate enough to create a cellularized structure, microintegration of 
simultaneously electrospun polymers and electrosprayed cells creates a cellularized 
structure during the electrospinning process [366].  To determine the effectiveness of the 
microintegration process, air-gap electrospun constructs of SF (70 mg/ml), PDO, SPDO, 
PCL, and SPCL were created using parameters identical to those listed previously.  These 
scaffolds were either electrospun simultaneously with cells, or were surface seeded after 
fabrication.   
For microintegration, a setup similar to that of figure 8.5 was used.  With polymer 
solution ready to be electrospun, 3x106 human dermal FBs (Cascade Biologics) were 
suspended in 1 ml of cell culture media (same as previous) and loaded into a 1 ml Becton 
Dickinson syringe fitted with a blunt tipped 18 gauge needle.  This cell solution was 
charged to +10 kv and dispensed by a KD Scientific syringe pump at such a rate that the 
cell loaded syringe would finish dispensing at the same time as the polymer loaded 
syringe (~4 ml/hr).  Upon completion, cellularized scaffolds were placed in a 6-well plate 
with 3 ml of culture media and incubated under standard culture conditions.  Media was 
completely changed after the first 8 hours and then again every third day.  Non-
cellularized constructs were placed in polyhema coated 6-well plates, and 3x106 FBs 
suspended in 1 ml of media were seeded on top of them.  Scaffolds were incubated for 1 
hour to allow for cell adhesion prior to the addition of 2 ml of media.  Media was 
completely changed on the same schedule as microintegrated constructs.  Samples were 
removed from culture after 28 days and fixed in paraformaldehyde (30 mg/ml in PBS for 
   233
10 min) prior to preparation for histological evaluation (H&E) and confocal imaging with 
DAPI staining (Zeiss LSM META NLO multiphoton laser scanning microscope). 
Cell Solution 
Polymer Solution 
 
Figure 8.5.  Schematic representation of a cellularized air-gap electrospun scaffold 
created through the microintegration of electrosprayed cell solution and electrospun 
polymer solution. 
 
 
Statistical Analysis.  All statistical analysis was based on a Kruskal–Wallis one-
way ANOVA on ranks and a Tukey–Kramer pairwise multiple comparison procedure (α 
= 0.05) performed with the JMP®IN 7.0 statistical software package (SAS Institute, Inc.).  
Graphical depictions of mean data were constructed with Microsoft Excel 2000, with 
error bars representing standard deviations. 
 
RESULTS AND DISCUSSION 
  
Scaffold Characterization.  Scanning electron micrographs of random, aligned and air-
gap electrospun structures are shown in figure 8.6.  Using the ImageTool software 
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program it was determined that the average fiber diameter was around 1 micron for each 
of the polymers regardless of the electrospinning process used in their fabrication (figure 
8.7).  However, the average fiber diameters ranged from 0.7 microns for air-gap 
electrospun PCL to 1.42 microns for aligned SF structures electrospun onto a drum 
mandrel rotating at 8000 RPM.  Statistical analysis revealed few significant differences 
between the fabrication methods for each polymer.  The synthetic polymers, PDO and 
PCL, had significantly smaller fibers created through air-gap electrospinning than 
through either the traditional random or aligned electrospinning process.  Air-gap 
electrospun scaffolds containing SF failed to be different from the other two fabrication 
methods.  This result was somewhat surprising as it was anticipated that there would be 
large differences in the fibers created through the air-gap electrospinning process and 
those fibers created through standard electrospinning simply due to the differences 
between the electrospinning parameters of the two.  The air-gap electrospinning process 
uses flowrates that were more than double those of the standard electrospinning process; 
historically increased flowrates lead to larger diameter fibers.  The significantly smaller 
diameter synthetic polymer fibers may potentially be attributable to the differences in the 
electric fields of the two methods, with standard electrospinning providing a simple 
grounded target while air-gap electrospinning provides a pair of charged targets that may 
actually draw and stretch the polymer fibers between them.  It should be noted that the 
air-gap electrospun PCL had a vastly different feel than the other air-gap electrospun 
materials, being much thiner and more fragile.  It may be necessary to alter the 
electrospinning concentration of PCL in future air-gap electrospinning studies. 
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SPDO 
PCL 
 
SPCL 
Figure 8.6.  Scanning electron micrographs of SF, PDO, SPDO, PCL, and SPCL 
electrospun at 400 RPM, 8000 RPM and through the use of an air-gap electrospinner.  All 
images taken at 3000x. 
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Figure 8.7.  Average fiber diameters of random (400 RPM), aligned (8000 RPM), and 
air-gap electrospun scaffolds. 
 
 
 
 FFT analysis of the electrospun structures revealed there to be distinct differences 
in the degree to which the structures were aligned.  As expected, the 400 RPM scaffolds 
exhibited no fiber alignment.  The 8000 RPM scaffolds exhibited fiber alignment in the 
direction of mandrel rotation, with the pure PDO scaffold being the most aligned and the 
pure SF scaffold being the least aligned.  The difficulty in aligning SF is evident 
throughout table 8.1, as the addition of SF to the synthetic polymers resulted in a drop in 
their degree of alignment.  Surprisingly, structures created through the air-gap 
electrospinning process exhibited less alignment than those created at 8000 RPM.  This 
may be attributable to the overall thickness of the structures and the lack of rotation of the 
collecting targets.  As such, while the polymer fibers are visibly highly aligned during the 
initial minutes of air-gap electrospinning, subsequent fiber collection occurs only on the 
   237
front surface of the already formed construct.  As the structure becomes increasingly 
thick the fibers may become increasingly random, resulting in a surface that appears to be 
fairly random under SEM.  To more accurately assess the alignment of the air-gap 
structures, it may be necessary to create thinner air-gap electrospun constructs and use a 
light microscope image to obtain more accurate FFT results.  The creation of an air-gap 
electrospinning system that has the ability to rotate the collecting targets to obtain an 
evenly distributed electrospun matrix may provide a way to create more uniformly 
aligned structures. 
 
Table 8.1.  Table of FFT peak intensity values achieved for scaffolds electrospun onto a 
mandrel rotating at 400 and 8000 RPM, as well as through the air-gap electrospinning 
method. 
 
Polymer Air-gap 400 RPM 8000 RPM 
Silk 0.037 0.044 0.144 
PDO 0.110 0.051 0.302 
SPDO 0.104 0.074 0.217 
PCL 0.145 0.051 0.284 
SPCL 0.156 0.076 0.238 
 
 
 Porosity / Permeability Measurement.  Scaffold porosity measurements are 
shown in figure 8.8.  As anticipated, most materials (except PCL) exhibited significantly 
higher porosities at 400 RPM than 8000 RPM.  Additionally, each polymer or polymer 
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blend of  the aligned air-gap electrospun structures were significantly more porous than 
the aligned structures created at 8000 RPM, and at least equal to if not more porous than 
the randomly aligned 400 RPM structures.  This confirms what one can visually infer 
from the SEM micrographs of figure 8.6, where the structures created at 8000 RPM 
appear to be very compact with little void space.  This demonstrates that the air-gap 
electrospinning method, while perhaps not creating scaffolds as aligned as those at 8000 
RPM (on the surface at least), does create a structure that is considerably more porous 
and thereby more conducive to cellular infiltration. 
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Figure 8.8.  Average porosity values for random (400 RPM), aligned (8000 RPM), and 
air-gap electrospun structures. 
 
 
 
 Surprisingly, permeability results (figure 8.9) revealed something completely 
contradictory to the results of the porosity testing.  It was anticipated that the more porous 
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air-gap electrospun structures would also be more permeable than their 8000 RPM 
counterparts, which would be less permeable than the 400 RPM structures due to their 
high fiber packing density.  However, this was not the case with the majority of the 
materials tested (SF, PDO, SPDO) exhibiting no significant differences between 
fabrication methods.  PCL containing scaffolds actually exhibited significantly higher 
permeabilities for the 8000 RPM scaffolds than both the air-gap and the 400 RPM 
structures.  While porosity and permeability are related, with more porous structures 
typically exhibiting a higher permeability, a change in one does not necessarily 
correspond to a change in the other.  Scaffold porosity, pore size and distribution, pore 
interconnectivity, and pore orientation and scaffold tortuosity all play roles in the 
hydraulic permeability of an ECM analogue scaffold [30, 31].  This is especially true 
with an electrospun structure, where the fiber organization is dynamic and can move 
freely in response to changes around it.  It may be possible that the application of the 120 
mmHg pressure head compressed the highly porous scaffolds and resulted in a structure 
with collapsed pores.  The highly aligned 8000 RPM scaffolds, being less porous, may 
have experienced less fiber shifting resulting in a less tortuous path for fluid flow.   
Regardless, the author maintains that the high scaffold porosities are more telling 
of the behavior of the structures than the permeability results.  In vivo these structures, 
intended for use as a ligament analogue, will not be subjected to high pressures that 
would force pore collapse like they would if they were to be used in a vascular grafting 
application.  In vitro cell culture will provide further insight into the ability for cells to 
migrate into the thickness of the structures 
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Figure 8.9.  Average permeability values for random (400 RPM), aligned (8000 RPM), 
and air-gap electrospun structures. 
 
 
 
 Uniaxial Tensile Testing.  The results of the uniaxial tensile testing of the 
random (400 RPM), aligned (8000 RPM), and air-gap electrospun structures, tested in 
two directions are shown in figure 8.10.  As expected, there were no significant 
differences between mechanical properties of the parallel and perpendicular directions of 
the randomly oriented 400 RPM structures, indicating the structures were isotropic due to 
their random nature.  Additionally, there were significant differences between the 
mechanical properties of the parallel and perpendicular directions of the 8000 RPM 
structures for all materials (except SF), confirming the anisotropy seen through SEM and 
FFT analysis.  Air-gap electrospun structures demonstrated some significant anisotropy, 
with PDO and SPDO having higher peak stresses and moduli in the parallel direction and 
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higher strain at break in the perpendicular direction.  Air-gap electrospun PCL and SPCL 
exhibited significantly higher peak stress and moduli in the parallel direction, with no 
significant differences in strain at break, while SF structures had no significant 
differences in mechanical properties with respect to testing direction. 
 There were also significant differences in the peak stress and moduli of the 
synthetic containing polymer structures created through air-gap electrospinning and those 
created through standard electrospinnig at 8000 RPM, with the air-gap structures being 
significantly weaker in the perpendicular direction.  These differences may simply be 
indicative of differences in the degree of fiber alignment between the two.  FFT results 
showed air-gap electrospun structures to be less aligned than 8000 RPM structures and 
mechanical testing would seem to confirm this.  The decrease in mechanical properties 
seen in the air-gap constructs may also be dependant upon their increased porosity, with 
the highly porous structures containing less fiber volume per dog-bone specimen to resist 
loading than the less porous 8000 RPM structures. 
 Surprisingly, regardless of fabrication method the pure SF structures exhibited no 
significant anisotropy.  Superficially this would seem to indicate that the SF structures 
were simply not aligned.  However, FFT results showed more surface alignment in the 
8000 RPM SF structures than in the air-gap PDO and SPDO structures, which both 
exhibited anisotropic mechanical properties.  The lack of demonstrable anisotropy of the 
SF structures is currently unexplainable and will need further investigation, but may be 
due to changes in the SF fibers when they become hydrated. 
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Figure 8.10.  Uniaxial tensile testing results of SF, PDO, SPDO, PCL, and SPCL at 400 
RPM, 8000 RPM, and air-gap electrospun.  Specimens were tested parallel to the 
direction of fiber orientation (=) and perpendicular to the direction of fiber orientation 
(+). 
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 Cell Migration / Penetration.  The Live/Dead® Cell Viability Assay was used 
not only to show viable FBs but to also provide insight into cell proliferation and 
migration of cells across the surface of the scaffolds, and show orientation of cells with 
respect to fiber alignment.  Live stained images taken at day 7 (figure 8.11) showed 
almost ompletely viable cell populations for all materials and fabrication techniques, with 
few dead cells (not shown) randomly scattered across the surface of the scaffolds.  
Scaffolds electrospun at 400 RPM, particularly those scaffolds containing SF, showed 
FBs that were spread out and exhibited no preferential direction of alignment.  Those 
scaffolds that were created at 8000 RPM contained FBs that had begun to align 
themselves along the direction of fiber alignment, while still maintaining spaces between 
the cells indicating that the orientation of the FBs was due to alignment with fibers as 
opposed to a forced orientation due to contact with neighboring cells.  Air-gap 
electrospun contstucts in general exhibited some degree of FB alginment, though less 
than seen in 8000 RPM scaffolds.  Air-gap electrospun constructs containing SF also had 
a large number of cells that were out of focus, similar to that of the 400 RPM scaffolds, 
possibly indicating some penetration of the cells into the scaffolds.  By day 21 (figure 
8.12) nearly all the scaffolds, with the exception of the pure SF, demonstrated a 
preferential direction of cellular alignment.  It is hypothesized that this cellular 
orientation was brought about by contact with neighboring cells as the FBs proliferated 
and free space on the scaffolds decreased.  This forced orientation left little distinction 
between fabrication techniques.  While nearly all of the scaffolds contained confluent 
sheets of FBs on their surfaces by day 21, the pure SF scaffolds did not.  These scaffolds 
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still contained cells that were out of focus, indicating that cells were not limited to simply 
attaching to the surface of the structure but had the opportunity to penetrate its thickness.  
This cellular penetration is critical to successful tissue engineering to allow for an 
acellular scaffold to become cellularized and eventually degraded and replaced by native 
ECM. 
   245
400 RPM 8000 RPM Air-Gap 
SF
PDO
SPDO
PCL
SPCL
 
Figure 8.11.  Live stained images of FBs seeded on SF, PDO, SPDO, PCL, and SPCL 
scaffolds taken after 7 days in culture.  All images taken at 10x. 
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Figure 8.12.  Live stained images of FBs seeded on SF, PDO, SPDO, PCL, and SPCL 
scaffolds taken after 21 days in culture.  All images taken at 10x. 
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 H&E staining of FB seeded constructs removed from culture on day 21 is shown 
in figure 8.13.  These images provide more conclusive evidence of cellular penetration 
into the thickness of the electrospun structures than the surface images of the Live/Dead® 
assay.  By day 21 FBs were seen to have migrated into all of the air-gap electrospun 
structures, with significant penetration seen in the pure SF structure.  As expected, the 
relatively low porosity 8000 RPM structures had little cellular presence below the surface 
due to their highly packed fiber organization.  Not surprisingly, histology of the high 
porosity 400 RPM structures looked very similar to that of the air-gap electrospun 
structures.  This may lead one to believe that scaffold porosity is responsible for 
successful cellular penetration.  However, looking at the air-gap electrospun PCL which 
exhibited the highest porosity (94%) and the similarly porous air-gap electrospun SF 
(92%) one sees that their histology is very different.  The SF structure was more 
conducive to cell penetration than the pure PCL structure.  This would indicate that 
scaffold porosity, while certainly a contributing factor to cell penetration, is not solely 
responsible for it.  It may be that fiber stiffness and surface chemistry play a large part in 
the ability, or desire, for cells to penetrate an electrospun scaffold. 
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Figure 8.13.  H&E staining of FB seeded SF, PDO, SPDO, PCL, and SPCL electrospun 
constructs taken after 21 days in culture.  All images taken at 10x. 
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Mechanical Degradation / Collagen Matrix Production.  Results of uniaxial 
tensile testing for both static and dynamic culture of dog-bone specimens seeded with 
FBs after 28 days are shown in figures 8.14 and 8.15, respectively.  Surprisingly, this data 
shows little difference between the two culture methods and virtually no change in 
mechanical properties after the 28 day time course.  Scaffolds of all three materials 
exhibited no significant differences between static culture and dynamic culture in peak 
stress, modulus, or strain at break.  Additionally, there was no statistically significant 
change in the mechanical properties of the materials taken at each of the four durations 
tested.  The implications of this result are two-fold.  First, this demonstrates that the 
polymers chosen for this study have not begun to break down after four weeks of culture 
in vitro.  This is a positive for a tissue such as the ACL, where cellular infiltration and 
matrix turnover are very slow, meaning that the electrospun ECM analogue will not 
degrade at a rapid pace and be resorbed to a point where it can no longer support load 
prior to the creation of substantial native ECM.  Second, this would indicate that if native 
collagen matrix had been produced by the cells attached to the scaffolds, this collagen 
was either not in sufficient quantities or of sufficient strength to significantly alter the 
mechanical properties of the electrospun structures.  This is undoubtedly a negative 
result, at it was anticipated that by the 28th day of culture, there would have been 
significant amounts of matrix produced which would have altered scaffold mechanical 
properties. 
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Figure 8.14.  Mechanical properties of electrospun materials after 28 days in static 
culture in a 6-well plate. 
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Figure 8.15.  Mechanical properties of electrospun materials after 28 days in dynamic 
culture in RWVB. 
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Results of the Sircol collagen quantification assay are shown in figure 8.16.  
These results showed there to be some significant differences between those dog-bones 
that were cultured statically and those that were cultured dynamically in the RWVB, 
while the majority of samples were not different from one another.  SPCL demonstrated a 
significant increase in collagen produced on day 21 in dynamic culture compared to other 
time points, while SPDO scaffolds exhibited no significant differences between time 
points or culture methods.  Pure SF scaffolds also exhibited an increased amount of 
collagen production at day 21 in dynamic culture, with days 14 and 28 of dynamic culture 
also being significantly higher than those of static culture.  In all, SF at day 21 of 
dynamic culture had by far the highest amount of collagen production.   
It is apparent from this data that the dynamic culture of FB seeded dog-bones aids 
in their production of ECM.  However, it should be noted that the standard deviations of 
the dynamic samples were much larger than those of the statically cultured samples.  This 
would seem to indicate that cell-scaffold interactions were less uniform in the RWVBs 
than in static culture.  In future work it may be beneficial to statically seed the specimens 
for a period of time prior to placing them in the bioreactor to ensure adequate interaction 
and adhesion of the cells to the scaffold, rather than allowing cells and specimens to 
interact haphazardly.  Yet, this random interaction demonstrated the affinity of FBs for 
the pure SF scaffolds as opposed to those containing synthetic materials.  From this 
result, coupled with the H&E staining of figure 8.13, one could assume that FBs 
successfully migrated into the pure SF scaffold and began to produce their own ECM 
while the FBs were less likely to attach to and penetrate the SPDO and SPCL scaffolds, 
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eventually forming confluent sheets on the surface.  Any matrix these surface dwelling 
cells produced was likely lost during media changes in culture or through handling of the 
specimens during mechanical testing, as opposed to matrix produced within the 
electrospun structure which would be somewhat protected. 
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Figure 8.16.  Results of Sircol collagen quantification assay for scaffolds cultured under 
both static (top) and dynamic (bottom) conditions.  Dashed line indicates minimum level 
of detection. 
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Preliminary Microintegration of Air-gap Constructs.  Microintegration of FBs 
into electrospun scaffolds by simultaneously electrospraying cells and electrospinning 
polymer was seen as a promising method to create a fully cellularized electrospun 
structure.  As such, air-gap electrospun constructs were created both with and without 
simultaneous electrospraying of cells.  Structures created without cells were surface 
seeded after fabrication for comparison to those structures that had been microintegrated.  
H&E stained histology of the surface seeded structures and the microintegrated structures 
after 28 days in culture are shown in figures 8.17 and 8.18, respectively, while DAPI 
stained confocal images are shown in figures 8.19 and 8.20.   
It was intended that microintegrated scaffolds of SF, PDO, SPDO, PCL, and 
SPCL would be created through air-gap electrospinning using previously estabilished 
parameters, however this was determined not to be possible for SF, PCL, and SPCL.   
Syringes of SF and FBs were setup in a fashion similar to figure 8.5, with the two 
syringed separated by 180°.  The SF formed fibers initially, however once the 
electrosprayed cell/media droplets made contact with the structure it dissolved.  While 
HFP has been shown to force β-sheet formation during electrospinning, it may not have 
had time to fully evaporate and dehydrate the fibers to make them non-soluble.  As such, 
it may not be possible to electrospin SF from HFP and create a microintegrated structure 
without the electrospun fibers dissolving.  Additonally, PCL, which was previously noted 
as being extremely fine and fragile, and SPCL experienced the formation of large holes in 
their fibrous structure where cell/media droplets made contact and were unable to be 
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removed from the electrospinniner.  Surprisingly, both the PDO and SPDO structures 
were electrospun and microintegrated without a problem and formed thick constructs 
nearly identical in size to those of the air-gap electrospun structures that had not been 
microintegrated. 
H&E staining showed significant cellular penetration into the air-gap electrospun 
scaffolds after 28 days in culture.  As expected from previous work, SF had cells migrate 
well into its thickness.  PDO, SPDO, and SPCL all demonstrated cellular penetration, 
while most surprisingly the pure PCL structure was almost completely cellularized after 
28 days. The penetration was more significant than that shown in figure 8.13, and may be 
due to the increased number of cells seeded on the structures and the additional week of 
culture time. 
Results of the microintegrated structures were not nearly as encouraging.  After 
28 days in culture, it was noted that the microintegrated pure PDO constructs had lost all 
mechanical stability and fell apart upon removal from culture.  As such the pure PDO 
structure was difficult to image, and consisted mostly of pieces of fibers held loosely 
together by FBs.  It has been hypothesized that the incorporation of a large number of 
cells into the PDO structure exacerbated the breakdown of the polymer and led to its 
premature loss of mechanical properties.  However, the SPDO microintegrated structure 
was completely intact after 28 days and appeared to have lost none of its mechanical 
stability, likely due to the presence of the slowly degrading SF.  Histology of the SPDO 
microintegrated structures showed there to be a large number of cells scattered 
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throughout the thickness of the structure, demonstrating some preliminary success in the 
microintegration of FBs and electrospun polymers. 
 
A B 
C D 
E 
 
Figure 8.17.  Histological evaluation of surface seeded air-gap electrospun SF (A), PDO 
(B), SPDO (C), PCL (D), and SPCL (E) after 28 days in static culture.  All images were 
taken at 10x. 
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Figure 8.18.  Histological evaluation of microintegrated air-gap electrospun PDO (A and 
B) and SPDO (C and D) after 28 days in static culture.  All images were taken at 10x. 
 
 
Confocal images further confirmed what was seen in the histology shown above.  
Surface seeded scaffolds exhibited a nearly confluent layer of FBs on the surface and a 
number of out of focus cells that appeared to have penetrated the surface of the structure.  
Both the seeded surface and the un-seeded surface were imaged to demonstrate that the 
electrospun fibers in fact autofluoresced, but appeared to be virtually non-existent in the 
images of the seeded side due to the nearly confluent layer of cells.  While difficult to 
discern definitively with only DAPI staining, it appears that many of the imaged nuclei 
(figure 8.19 A, C, E, and G) are of an ellipsoid shape in a uniform direction and may be 
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indicative of FBs that have oriented themselves along the preferred direction of fiber 
alignment. 
The microintegrated structures were also imaged on both sides, and again confirm 
what was seen previously in histology.  The PDO samples were nothing more than 
clumps of fragmented fibers with a small number of sporadically interspersed FBs, 
providing little information about the success of the microintegration technique with 
PDO.  Meanwhile, the SPDO samples revealed a number of cell nuclei visible on both 
imaged surfaces and a number of out of focus nuclei that appeared to reside below the 
surface.  Interestingly, the nuclei residing on the surface of the microintegrated SPDO did 
not have the same shape as those that were seen on the surface seeded structures.  Rather 
than being ellipsoid in a uniform direction, the nuclei on the microintegrated structure 
were very random in shape, possibly signifying a lack of orientation of their respective 
cells. 
In all, while the microintegration process was capable of creating a cellarized 
SPDO structure, it failed to create a structure with FBs oriented along the direction of 
fiber alignment.  Additionally, the process of microintegrating cells is quite difficult and 
poses a number of technical problems that make it exponentially more complicated than 
simple surface seeding.  While microintegration may present itself as a viable method for 
creating cellularized constructs in the future, currently the end product does not appear to 
be advantageous over traditional surface seeding. 
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Figure 8.19.  Confocal microscopy of statically 
seeded air-gap electrospun constructs.  Images 
are of both the seeded / unseeded surfaces of SF 
(A/B), PDO (C/D), SPDO (E/F), PCL (G/H), a
SPCL (I/J).  All images were taken at 20x. 
nd 
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Figure 8.20.  Confocal microscopy of air-gap electrospun PDO (A) and SPDO (B) 
microintegrated with FBs during the electrospinning process.  Images show both the top 
surface (C) and the bottom surface (D) of the scaffold after 28 days in culture.  All 
images were taken at 20x. 
 
 
 
CONCLUSIONS 
 
 In conclusion, the methods presented here for the creation of cellularized ligament 
analogue structures, air-gap electrospinning and the microintegration of cells into an 
electrospun structure, provided mixed results.  Air-gap electrospinning was capable of 
providing structures with enhanced porosity that played a major role in the penetration of 
   262
cells into the scaffold; however, these air-gap structures did not possess the same degree 
of fiber alignment or mechanical properties as highly aligned structures created through 
standard electrospinning methods.  Meanwhile, the simultaneous electrospraying of FBs 
and electrospinning of polymers was successful in creating cellularized structures but was 
usable with only a select few polymers.  These structures contained a distribution of cells 
throughout their thickness, but did not exhibit the same physiologic organization as 
native ligament which could be more closely achieved through standard surface seeding.  
The author believes that both fabrication techniques have a place in tissue engineering, 
but work needs to be done modifying the procedures to yield better results.
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CHAPTER 9 Conclusions and Future Research 
 
The creation of an ideal ECM analogue scaffold is a goal that tissue engineers 
have strived for since the inception of the field, and will have to work many years yet to 
achieve.  While superficially the ECM would seem like a simple thing to successfully 
replicate, a simple fibrous structure intended to support cell growth; the diversity and 
multifuncionality of the ECM in the human body make such a task daunting.  To replicate 
such a simple yet varied structure, one needs a fabrication technique that is equally as 
simple and widely adaptable.  Electrospinning has come to the forefront in ECM 
analogue scaffold fabrication because of its ability to be performed simply while allowing 
engineers to fabricate structures from an array of different materials.  In this study, a 
number of different fabrication and post-fabrication techniques were investigated to 
demonstrate the seemingly innumerable iterations available to tissue engineers employing 
electrospinning towards the creation of tissue specific ECM.  Through the blending of 
polymers, cross-linking of scaffolds, modification of fiber alignment, and alteration of the 
electrospinning setup, one can tailor a tissue engineering scaffold to fit nearly any tissue 
of the body. 
The first approach to scaffold modification was done simply through the blending 
of synthetic and natural polymers for use as vascular and urologic grafts.  PDO was 
blended with elastin in solution prior to electrospinning, and blended with fibrinogen at 
the needle tip through the use of a specially designed nozzle.  In both cases, the presence 
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of PDO enhanced the mechanical properties of the structure above that of the natural 
polymer alone, and enhanced the bioactivity of the scaffold above that of PDO alone.  
PDO:elastin proved promising as a vascular conduit, undergoing uniaxial tensile testing, 
dynamic compliance testing, suture retention testing, and in vitro cell culture.  
Mechanical properties similar to those seen in native vessel were achievable through the 
blending of the two polymers, while the presence of elastin also provided cells with a 
recognizable fibrous structure.  Fibrinogen, which is quickly broken down by cells in 
vitro was also enhanced by the blending with PDO.  Again, the blending of the polymers 
resulted in a mechanically viable structure that still exhibited levels of bioactivity well 
above those of purely synthetic scaffolds.   
Following the blending of natural and synthetic polymers, post-fabrication cross-
linking was investigated as a means to modify scaffold mechanical properties and rates of 
degradation.  Again using fibrinogen, because of its rapid rate of degradation and low 
mechanical stability, a number of different cross-linking agents were used (GLUT, EDC, 
and genipin) to varying effect.  It was found that both EDC and genipin were successful 
in enhancing scaffold mechanical integrity and retarding its rate of degradation.  While 
the use of these cross-linkers had a negative impact on scaffold bioactivity, it has been 
hypothesized that decreasing the degree of cross-linking would inversely affect the ability 
of cells to remodel the structure. 
Modifying the alignment of fibers in electrospun structures was also shown to be 
a way of altering the mechanical properties of an ECM analogue.  SF based structures 
were electrospun at a number of different mandrel rotational speeds and sizes to produce 
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scaffolds with varying degrees of fiber alignment.  When these structures were tested in 
tissue specific mechanical evaluations for ligament and vascular engineering, it was 
shown that, as in nature, different ECM replacement structures require different degrees 
of fiber alignment.  Structures composed of fibers aligned in the direction of rotation 
around a mandrel rotating at high RPMs, while effective as a ligament analogue, failed to 
produce vascular grafts with the compliance necessary to be successful.  
Finally, this study utilized air-gap electrospinning and the microintegration of 
cells to produce scaffolds for ligament engineering.  Rather than use a drum mandrel 
rotating at high RPMs to produce thin sheets of aligned fibers, air-gap electrospinning 
was used to create substantial structures with varying degrees of fiber alignment as 
revealed by FFT analysis.  Uniaxial tensile testing confirmed this alignment by 
demonstrating the anisotropy of the structures mechanical properties.  Air-gap 
electrospinning was also shown to produce highly porous structures that proved to be 
conducive to cellular penetration.  Microintegration was capable of producing 
cellularized scaffolds; however these cellularized structures did not contain FBs oriented 
along the direction of fiber alignment that is seen in native ligament. 
Overall, the results of this study highlight some of the ways that electrospinning 
can be used to tailor the properties of a scaffold to the requirements of a tissue both 
during and post-fabrication.  Through simple modifications like the blending of various 
polymers, cross-linking of scaffolds, and orientation of fibers, nearly every physical 
property of the scaffold (mechanical properties, rates of degradation, levels of bioactivity, 
porosity, permeabitliy, etc.) can be altered.  Additionally, dramatic changes to the way 
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that polymers are electrospun, through the mandrel-less air-gap electrospinning process 
and the microintegration of polymer and cells, further increases the options available to 
the tissue engineer attempting to create ideal tissue specific scaffolds.  
  
FUTURE RESEARCH 
 
Future work in this study will focus further on the creation of cellularized 
ligament analogue structures.  While the preliminary microintegration work presented 
here demonstrated that the process could be used to incorporate cells into electrospun 
structures, the author was not completely satisfied with the end result.  The creation of a 
cellularized structure straight off the electrospinner was intriguing, but a higher density of 
organized cells oriented with the direction of fiber alignment would be necessary to 
mimic the physiologic structure, and therefore function, of ligament.  Further work with 
the microintegration of cells and scaffolds would be interesting, as well as other methods 
of creating cellularized ligament analogues.  One such method may be to air-gap 
electrospin a relatively thin, highly porous structure and surface seed the structure with 
FBs.  Once the FBs have become confluent, the structure could be folded upon itself and 
sealed with fibrin glue, followed by dynamic culture in a RWVB.   
Additionally, more in depth mechanical evaluation would be needed on both 
acellular and cellularized structures.  This current study focused solely on uniaxial tensile 
testing to failure of electrospun structures, while future work should also include dynamic 
mechanical analysis.  Dynamic mechanical analysis provides insight into the mechanical 
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properties of a structure in its usable range, as opposed to uniaxial tensile testing which 
provides information into the ultimate properties of a material.  Dynamic mechanical 
analysis would also provide much needed information on the viscoelastic nature of the 
materials used, something that was not addressed in this study but is critical to success of 
a load bearing ligament replacement. 
Finally, the incorporation and investigation of a number of different chemokines 
into the electrospun scaffolds would be of interest.  A wide range of chemokines are at 
work in the body during the wound healing process and could be beneficial if 
incorporated into a ligament graft.  These chemokines could serve to attract FBs or even 
macrophages, which could then in turn release their own chemokines.  Chemokines could 
also be used to promote cellular proliferation or enhance matrix production.  In addition 
to an array of different chemokines, the incorporation and in vivo assessment of small 
wound resolution molecules known as resolvins would also be interesting.  
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APPENDIX A: PRELIMINARY ELECTROSPINNING OF SF 
 
 
MATERIALS AND METHODS 
 
SF Extraction.  SF was extracted from the cocoons of Bombyx mori silkworms 
(The Yarn Tree) through an established protocol [88].  Briefly, silk cocoons were cut into 
pieces and boiled in a 0.02 M Na2CO3 (Sigma Aldrich) solution for 30 minutes to remove 
the sericin gum, followed by thorough rinsing in DI water, and drying in a fume hood.  
The SF was then dissolved in a LiBr (Fisher Scientific) solution at 60°C for 4 hours.  
This solution was then dialyzed against DI water for 3 days using 3500 MWCO dialysis 
tubing (Fisher Scientific).  The SF solution was then frozen and lyophilized to provide a 
pure SF powder for electrospinning. 
Scaffold Fabrication.  Initial electrospinning was performed using three different 
concentrations of SF in HFP (TCI America, Inc.): 70, 100, and 150 mg/ml.  These three 
different concentrations constituted the spinnable range of the SF solution, and were used 
to provide insight into the fiber size and structural morphology of the electrospun 
scaffolds.  Preliminary electrospinning of SF was done using a standard electrospinning 
setup with a rectangular mandrel (2.5 cm wide x 10.2 cm long x 0.3 cm thick) rotating at 
400 RPM and translating at 6 cm/s over a distance of 12 cm to create randomly oriented 
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fibrous structures.  SF solution was loaded into a Becton Dickinson syringe fitted with a 
blunt tip 18 gauge needle and dispensed at a rate of 4 ml/hr with a KD Scientific syringe 
pump.  A charging voltage of +25 kv was applied to the needle tip, with an air-gap 
distance of 20 cm between the needle tip and the grounded mandrel. 
Scaffold Characterization.  Each of the electrospun scaffolds was characterized 
through SEM (Zeiss EV050).  Average fiber diameters were calculated by taking 60 
random fiber measurements from across the SEM image using ImageTool 3.0 software 
(Shareware provided by UTHSCSA). 
Uniaxial Tensile Testing.  Uniaxial tensile testing was performed on dog-bone 
shaped samples punched from the electrospun scaffolds (2.75 mm wide at their narrowest 
point with a gage length of 7.5 mm) and tested on a MTS Bionix 200 testing system with 
a 100 N load cell (MTS Systems Corp.) an extension rate of 10.0 mm/min.  Samples 
(n=3) were tested both dry and after a 30 minute soak in ethanol followed by a 1 hour 
soak in DI water.  The ethanol soak was performed to force β-sheet formation in the SF 
fibers [22]. 
 
RESULTS AND DISCUSSION 
 
 Scaffold Characterization.  SEM revealed fibrous structures for all three 
concentrations of SF electrospun (figure A.1).  SF electrospun at 70 mg/ml exhibited an 
average fiber diameter of 0.72 + 0.3 microns, 100 mg/ml produced average fiber 
diameters of 1.64 + 0.8 microns, and 150 mg/ml produced average fiber diameters of 3.68 
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+ 1.5 microns (figure A.2).  Interestingly, the fibers produced by the 150 mg/ml 
concentration SF solution appeared to be completely flat and ribbon-like as opposed to 
the round fibers produced by the 70 mg/ml SF concentration.  The 100 mg/ml SF 
concentration resulted in a mixture of both large flat fibers and smaller round fibers.  This 
transition to ribbon-like fibers is evident in the increasing standard deviations of figure 
A.2.  As SF concentration increases, and ribbon-like fibers become more prevalent, the 
standard deviation of the fiber diameters also increase.  This flattened fiber morphology, 
coupled with their large average diameter, makes the 150 mg/ml concentration SF 
scaffolds non-ideal for tissue engineering applications, as historically it has been shown 
that sub-micron scale diameter fibers produce less of an immune response than larger 
diameter fibers [187].  
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Figure A.1.  Scanning electron micrographs of electrospun SF at 70 (top left), 100 (top 
right), and 150 mg/ml (bottom).  All images were taken at 3000x. 
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Figure A.2.  Average fiber diameter of SF electrospun from three different 
concentrations. 
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 Uniaxial Tensile Testing.  The results of both dry and hydrated uniaxial tensile 
testing of preliminary SF scaffolds are shown in figure A.3.  These results revealed 
significant differences between concentrations in the peak stress and modulus of the dry 
samples, yet no significant differences between concentrations in strain at break.  
Hydration resulted in significant changes in scaffold strength with hydrated moduli being 
nearly 20 times lower than dry moduli regardless of SF concentration.  Surprisingly, there 
were few significant differences in the mechanical properties (70 mg/ml peak stress 
different than 150 mg/ml, and 150 mg/ml strain at break different from the other two 
concentrations) between concentrations of hydrated SF scaffolds.  This would indicate 
that as the electrospun SF becomes hydrated, regardless of starting concentration, its 
mechanical properties stabilize at some base level. 
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Figure A.3. Peak stress, modulus, and strain at break values achieved for uniaxial tensile 
testing of preliminary electrospun SF scaffolds. 
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